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Introduction  
In current medical practice, there is a clear trend towards minimally invasive 
procedures in surgery and radiology. Medical imaging is very often used for diagnosis but 
also in percutaneous image guidance. One of the challenges that physicians still encounter 
is to accurately guide interventional tools such as needles to the region of interest for an 
effective treatment. Most percutaneous image-guided procedures such as tissue biopsy are 
performed under ultrasound, CT, MR, or X-ray. Ultrasound is widely used for guidance 
however it requires a lot of experience for proper and accurate needle guidance to the 
region of interest. X-ray is another real-time imaging that has the drawback of lacking 
soft tissue contrast information. CT and MR enable soft tissue visualization; however 
they require to be combined with ultrasound or X-ray for real-time guidance and 
visualization of the distal end of the tip of the interventional tools. Thus, there is a clear 
need to have sensing capabilities at the tip of the interventional tools to confirm its 
position in the region of interest for an effective treatment. To this aim, several 
biomedical research groups investigated optical sensing at the tip of interventional probes 
to provide feedback on the tissue type during a procedure and subsequently confirm the 
position of the tip in the region of interest. 
Diffuse reflectance spectroscopy is an optical technique that enables tissue 
characterization by measuring the spectral response of tissue-light interaction. Broadband 
light is emitted via an optical fiber and is collected with another optical fiber after light 
absorption and scattering in the tissue. The collected light is acquired with a spectrometer 
that can resolves light in the visible and near infrared wavelength range below a micron. 
The use of light is clinically appealing as it can detect physiological and biological 
changes whereas medical imaging only provides morphological information. Relevant 
biological parameters, namely blood oxygenation and content in the probed volume, 
could be extracted from the tissue spectral response to light illumination. These blood-
derived parameters have shown to be of great relevance to distinguish between normal 
and dysplastic tissues. However, no existing studies investigated the potential of diffuse 
reflectance spectroscopy in the infrared beyond 1000 nm due to the limitation of silicon 
detectors to sense light at wavelengths above a micron.  
This thesis focuses on investigating diffuse reflectance spectra acquired at the 
distal end of a custom-made needle in a wavelength range extended to 1800 nm as 
opposed to the commonly used wavelength range presented in existing studies in 
literature. Because of the limited sensitivity of silicon detectors to measure beyond 1000 
nm, an InGaAs detector was added to a silicon detector to measure spectra between 500 
and 1800 nm. The hypothesis is that additional biological chromophores, besides the 
blood-derived chromophores, have an optical signature in the infrared wavelength range 
which can be used for advanced tissue characterization. Different evaluation techniques 
have been used to validate a mathematical model that derives the physiological and 
biological tissue composition from the spectra. The impact of the wavelength range 
extension on the clinical diagnosis has been assessed for different medical applications in 
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Introduction 
the field of oncology. For each investigated organ such as breast, lung, and liver; a 
combination of parameters set enables discrimination of the abnormal tissue from healthy 
tissue. Multivariate data analysis methods and other statistical tools used throughout this 
thesis assessed the clinical performance of diffuse reflectance spectroscopy between 500 
and 1800 nm for tissue diagnosis and confirmation of the location of the needle tip for 
tissue biopsy or treatment. 
The ultimate goal of this thesis is to highlight the potential of diffuse reflectance 
spectroscopy in the demarcation of malignant and benign tissues from normal tissue 
based on the parameters that are derived from the spectral signals over a wide wavelength 
range in an image-guided clinical setting.  
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Chapter 1 
Abstract 
Over the last decade, several groups working on biomedical optics have developed 
setups to perform diffuse reflectance spectroscopy measurements acquired with fiber 
optic probes for clinical diagnosis. Several clinical studies were conducted to discriminate 
healthy from dysplastic tissue using different classification methods. Two different 
approaches have been used: a purely statistical approach where the unprocessed spectra 
are directly related to the clinical diagnosis, and a method that first analyses the spectra 
making use of the knowledge of tissue optics and then relate the outcome to the clinical 
diagnosis. The aim of this review is to present an overview of various models for 
analyzing reflectance spectra that are employed by different groups as well as the type of 
clinical studies conducted by these groups.  
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Chapter 1 Modeling diffuse reflectance spectroscopy: a review 
1. Introduction 
Optical spectroscopy is a field that has been growing over the last two decades 
with a strong emphasis on evaluating the diagnostic performance given a clinical 
application. 
There are three methods used by the biomedical photonics community to describe 
the reflectance in order to extract the optical properties from which physical and 
physiological parameters can be deduced: time domain [1-4], frequency domain [2, 4-6] 
and steady-state domain [7-9]. In the case of time-resolved measurements, what is 
actually measured is not a spectrum but the temporal changes of a near infrared (NIR) 
femto- or pico- second pulsed laser source measured with a near infrared photo multiplier 
tube (NIR-PMT) in a single or narrow band wavelength. From the measured time 
response of the tissue, one could assess the peak time value in combination with the 
integral of the measured signal that enables the determination of the absorption and 
reduced scattering coefficients [7]. By using multiple lasers at different wavelengths, the 
optical properties over a wide wavelength range can be estimated. Similarly, in the 
frequency-resolved domain, modulated light is detected after its interaction with the tissue 
and it is subsequently phase-shifted and amplitude demodulated. From both the phase 
shift and the modulation of the detected signal for different frequencies, one can 
determine the absorption and scattering coefficients from the real and imaginary part of 
the wave number [10]. In the steady-state domain, a broadband white light source is most 
commonly used to illuminate the tissue by making use of optical fibers and the reflected 
light is collected with another or the same fiber after being subject to scattering and 
absorption. From this measured diffuse reflectance spectra the absorption and scattering 
coefficients can be deduced [9].  
Various approaches were developed by different research groups to translate the 
acquired spectral data into clinically relevant parameters. There are three main 
approaches that can be distinguished in literature. The first approach is to directly 
correlate the raw measured spectra with the classical diagnosis. This method does not 
require any data processing and uses spectral analysis techniques such as principal 
component analysis, neural networks, and partially least squares discriminant analysis. 
The second approach consists of first translating the spectral data into physical properties 
such as the absorption and reduced scattering coefficients for different wavelengths on 
which the statistical analysis are performed and then investigate the correlation with the 
classical diagnosis. This method requires prior knowledge of light-tissue interaction. The 
third approach translates these optical properties into biologically relevant parameters. 
This uses additional prior knowledge on the optical properties of various biological 
substances that absorb and scatter light. These last methods require mathematical models 
that describe the measured diffuse reflectance spectra in terms of input parameters. 
The third approach, having received the most attention, will be discussed in more 
detail here. An overview of the recent developments in this model based approach will be 
presented. A plethora of efforts in investigating the validity of these models was 
performed in order to validate the reliability of the parameterization of the measured 
optical spectra. Thorough validations and assessments of the models are generally done 
by evaluating their outcome when applied to measurements with actual a priori known 
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optical properties of phantoms [11]. A list of all the existing biological chromophores that 
have been used so far in literature is given. Finally, an overview of the clinical 
applications that were investigated with diffuse reflectance spectroscopy such as 
treatment monitoring, complication prediction, needle guidance, tumor margin 
assessment and optical biopsy. 
The aim of this review is to present the wide panoply of ways of analyzing diffuse 
reflectance spectroscopy measurements aiming at extracting the relevant clinical 
parameters. 
2. Modeling of optical spectra 
Definition 
 Diffuse reflectance spectroscopy corresponds to the study of light absorption and 
scattering as a function of wavelength. Depending on the nature of the material that is 
being illuminated, light could either travel through the media along the direction of 
illumination or be diffused due to the turbidity of the media. 
 In the biomedical field, additionally to absorption, light interaction with tissue is 
influenced by the biological substructures that scatter light such as mitochondria, 
connective tissue, nuclei, etc. 
 
Analytical models to translate spectral measurements into optical properties 
Several groups use a derivation of the diffusion theory to describe the measured 
spectra with a well-defined analytical model. From the Boltzmann transport equation, the 
light propagation in turbid media can be described and is based on energy conservation by 
accounting for the amount of photons in a specific volume at a certain position per unit 
solid angle and time [12]. An analytical solution can be obtained by solving the 
Boltzmann transport equation under the diffusion approximation assumptions which are 
namely: (a) the fluence rate due to the highly forward scattering can be converted into 
fluence rate due to an isotropic scattering by expressing the scattering as reduced 
scattering using the similarity principle [1]. By doing such, the tissue anisotropy factor is 
taken into account with the scattering to obtain the reduced scattering 
 
  
          , (1) 
 
where    and   are the tissue scattering and anisotropy, respectively. (b) In case of highly 
scattering media such as in tissue, the fluence rate   satisifies the diffusion equation 
 
         ⁄               
               , (2) 
 
with   being the absorption coefficient of tissue, c the celerity of light in tissue,   being 
the source term truncated after the first order spherical harmonics corresponding to low 
anisotropy photon sources in the tissue, and   is the diffusion constant assumed to be 
constant for homogenous media and is expressed as 
 
   [       
  ]⁄  . (3) 
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This approximation holds as long as the tissue absorption is small compared to the 
reduced scattering while the inverse of the reduced scattering is larger than the source-
detector separation  . (c) The third assumption is that the source terms in equation (2) 
consist of a distribution of single scattering sources along the axis normal to the boundary 
between the tissue and the source surface. 
 The diffusion equation can be solved analytically given specific boundary 
conditions that correspond to specific geometries. Throughout this review, the semi-
infinite media geometry is described as it is the most commonly used in literature. The 
semi-infinite media geometry corresponds to the fact that the tissue medium is delimited 
by the non-scattering probe and the scattering tissue medium [9]. The boundary condition 
can mathematically be expressed as  
 
                ⁄        , (4) 
 
meaning that the flux is null at the interface between the tissue and the probe [13] with 
    being the coordinate of the boundary along the normal to the interface. In Eq. (4),   
is a parameter that depends on the refractive index of the tissue and the surrounding 
medium. From the fluence rate obtained by solving the diffusion equation (Eq.2) given 
the boundary condition in Eq. (4), the reflectance   from the medium is calculated as the 
current across the boundary via Fick‟s law i.e. 
 
                 ⁄      . (5) 
 
In the case of the time-resolved domain, the reflectance of light   as a function of 
the absorption and reduced scattering coefficients as well as the radial distance   from the 
source at     as found by Farrell et al. [9] 
 
     
  
  
[  (     
 
 ̃ 
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       ̃ 
 ̃ 
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 ̃ 
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       ̃ 
 ̃ 
 ] (6) 
 
with      [      
     ]
  ⁄  being the effective attenuation coefficient,    
  
    
     ⁄  being the albedo and          
     the location of the virtual scattering 
source. The extrapolated boundary condition is expressed as       . Furthermore, 
 ̃     
       ⁄  is the distance between the single scattering source and the collecting 
fiber, and  ̃           
       ⁄  is the distance between the image source and the 
collecting fiber.  
 
Analytical models to transform optical properties into biological, biochemical and 
physiological parameters 
Generally, a broadband white light source is used to illuminate the tissue and the 
reflected light is collected with a spectrometer. From a single reflectance measurement, it 
is not possible to extract both absorption and reduced scattering coefficients at a given 
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wavelength; therefore at least two different source-detector distance separations are 
required for that aim. On the other hand, by using a priori wavelength-dependent 
knowledge of the scattering and the absorption coefficient of the chromophores present in 
the measured tissue, it is possible to estimate the concentrations or volume fractions of 
the various biological substances from a single reflectance measurement. The absorption 
coefficient is generally expressed as the sum of the various chromophores absorption 
coefficients weighted by the corresponding concentration or volume fractions: 
 
      ∑ [  ]    
 
       , (7) 
 
with [  ] and        are the concentration and the absorption coefficient of the i-th out of 
the total amount N of chromophores present in tissue. The absorption coefficients as a 
function of the wavelength of each chromophores are known from literature and are used 
as a prori knowledge to fit the measured absorption in order to estimate the 
concentrations [  ] of each of the various biological constituents. The reduced scattering 
can be expressed as a function of wavelength by considering a Mie and a Rayleigh 
scattering contribution [14]: 
 
  
          
             
   , (8) 
 
with      and           corresponds to the Mie and Rayleigh reduced scattering 
amplitude, respectively. The   parameter corresponds to the Mie reduced scattering slope 
and correlates with the average particles size. When computing the reduced scattering 
with the Mie theory, it was observed that   decreases with the average diameter of the 
particles according to a Lorentzian cumulative function [15]. In a similar way as for the 
absorption coefficient, non wavelength-dependent parameters such as the reduced 
scattering amplitudes and slope are fitted from the estimated total reduced scattering   
 
. 
 Regarding the steady-state domain, one could use a single reflectance 
measurement only and estimate the clinical related parameters without having to estimate 
the optical properties beforehand. Indeed, by implementing Eq. (7) and (8) in Eq. (6), the 
chromophores concentrations and reduced scattering amplitudes and slopes can be 
immediately determined because the wavelength-dependency is replaced by a priori 
knowledge of the absorption coefficient of the various chromophores and the reduced 
scattering was assumed to be a power law function. In this way, the fitting model locks 
onto the spectral features and shapes of the measured reflectance. In the case of time-
resolved and frequency-resolved domain, only two equations are used to estimate the two 
optical parameters for each wavelength that is used for the light source. Subsequently, N 
parameters are derived by fitting the estimated absorption coefficient from the linear Eq. 
(7) and 3 parameters from Eq. (8) by applying a non-linear fit. In principle, min(N,3) 
number of wavelengths for light source is sufficient to estimate the various parameters of 
interest. However, in the case of the steady-state domain where only a single reflectance 
measurement is used to determine the parameters, there are N+3 parameters to fit from a 
highly non-linear equation such as Eq. (6).  
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Empirical models 
 In many cases, miniaturization of the optical probes requires a small source-
detector optical fiber separation. As a result, the mathematical assumptions behind 
diffusion theory are no longer valid. Therefore empirical models were developed by 
several groups to extract the optical properties. In most cases, the mathematical empirical 
models are either developed by modeling the reflectance measurements of a wide range 
of phantoms with different known optical properties or by using Monte-Carlo based 
approach. 
 The group of Bigio has started diffuse reflectance spectroscopy measurements in 
the mid-90 [16] using elastic scattering spectroscopy approach and principal component 
analysis to evaluate the differences in the measured spectra. A decade later, they have 
modeled the reflectance measurement for a 250 μm fiber distance separation by using the 
following empirical expression for R: 
  
       
                   
    ⁄   , (9) 
 
with    ⟦    ⟧  being constant coefficients derived from reflectance Monte-Carlo 
simulations and experiments for different absorption and reduced scattering coefficients 
[17]. From this model, inserting Eq. (7) and (8) enables the extraction of the clinical 
relevant parameters. 
  Zonios et al. have slightly modified the expression derived from diffusion theory 
Eq. (6) making it suitable for short fiber distance separation [18-19]. From measurements 
in polystyrene bead suspensions with known optical properties, they empirically defined 
two parameters    and    that are a scaling factor for the reflectance R and an effective 
radius replacing the actual fiber distance  , respectively. They have also developed an 
empirical model which seem to have similar performance than the modified diffusion 
theory approximation solution [20] 
 
       
 ⁄        
 ⁄    , (10) 
 
with     and    being two parameters that are derived from a reflectance measurement of 
a phantom with known optical properties. 
Another approach to estimate clinical relevant parameters is to make use of 
different path lengths in the steady-state domain as suggested by the group of Sterenborg 
in 2003 [21]. With this technique, the apparent path length is independent of the optical 
properties of the tissue but depends only on the fiber diameter as has been verified by 
Monte-Carlo simulations and experimental measurements on phantoms with known 
optical properties. Typically, for fiber diameters of 400 and 1000 microns, the apparent 
path length would be of 320 and 700 microns, respectively. Differential path length 
spectroscopy enables very shallow probing of the tissue. This has the advantage of 
assessing the optical properties of superficial tissue layers with a thickness below a 
millimeter and can be very useful to detect precancerous lesions with morphological and 
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physiological changes typically occurs in the mucosa. The reflectance model for the 
differential path length spectroscopy measurements is expressed as follows 
      
           , (11) 
 
with    being a proportionality constant that depends on the distance between the fiber 
and the calibration standards (spectralon) and   being the apparent path length that is 
proportional to the optical fiber diameter. 
In 2008, the same group developed a similar model for single fiber measurements 
which is used for light delivery and collection. The reflectance is modeled by the 
mathematical expression in Eq. (11). Similarly to the differential path length 
configuration, the apparent path length is a function of the fiber diameter and depends on 
the optical properties of the probed tissue [22]. From Monte Carlo simulations and 
phantoms measurements with a wide range of optical properties, the apparent path is 
empirically found to be 
 
  [   
         ] [   
        
                
   ]⁄  , (12) 
 
with        being the optical fiber diameter and [           ]  [               
                        ]  four parameters derived from the Monte Carlo and 
phantoms study of known optical properties. 
 
Probabilistic models 
Analytical expressions derived from the diffusion equation work well for simple 
geometries such as for semi-infinite media. For more complicated geometries additional 
approximations are required to come to analytical expressions for the measured 
reflectance spectra that may impact the accuracy with which the optical properties can be 
derived from the model. 
For complex geometries where the distance between the emitting and collecting 
fibers is small and for which the shape as well as the optical properties of the probe 
influence the reflectance measurements, an alternative to the analytical models is a 
probabilistic approach of solving the transport equation. This approach has the ability to 
cope with cases where the media is not highly scattering i.e. where the absorption 
coefficient greater than the reduced scattering coefficient. The most commonly used 
probabilistic model for the photon transport in tissue is the Monte Carlo approach [23-
24]. This approach requires the absorption and scattering coefficients as well as the 
anisotropy factor as input parameters. The probability density function expressed as an 
exponential distribution is then given by 
 
              
          , (13) 
 
which corresponds to the probability that a photon is being scattered and absorbed within 
a path length   along the photon direction of propagation. This distance is randomly 
sampled based on a uniformly distributed random number   [   ] as follows 
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                ⁄  . (14) 
 
Two additional probability density functions,      and     , are required to determine 
the deflection angles along the polar and the azimuthal orientations, respectively. The 
probability density function for the polar distribution describes the angular distribution of 
the scattering and is often modeled by the formulation of the phase function suggested by 
Henyey-Greenstein yielding the polar angle to be expressed as [25] 
 
       [
 
  
(     (
    
       
)
 
)] , (15) 
 
whereas the azimuthal distribution is often assumed to be uniformly distribution ranging 
between zero and 2  and therefore the azimuthal angle is given by 
 
      . (16) 
 
From these distributions, the reflectance can be computed by simulating for a large 
number of photons (typical several millions or more) their trajectories. Such a large 
number is required to statistically reduce the standard deviations of the reflectance for a 
given set of optical parameters. The photons are launched from the source into the tissue 
with a unity weight and are gradually decreased for each step with a weight that derives 
from the Beer-Lambert law which relates the absorption to the initial light intensity and 
the path length. Each photon is subject to angular deflections described by Eq. (15) and 
(16) at each scattering event. For each incremental step size, the position of each photon 
is recorded along the path length. Given its iterative aspect, this approach is much more 
time consuming than the analytical models whether they are empirical or derive from 
diffusion theory. 
 Table 1 summarizes the types of modeling and measurement domains that are 
being used by the several research groups in the field of biomedical photonics. The 
amount of publications related to clinical studies is also displayed. Additionally, the fiber 
source-detector separation distance is also given. 
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Table 1. Overview of technological specification of the optical spectroscopy devices by 
several research groups. 
Group, location Type of model 
Wavelength 
range  
source-detector 
separation 
Bigio, Boston 
University, USA 
Empirical 350-800 nm 0.7-3.2 mm 
Cubeddu, 
Politecnico Milano, 
Italy 
Diffusion Theory 600-1100 nm Larger than 1 cm 
Feld, MIT, USA Diffusion Theory 375-750 nm 1 mm 
Jacques, Oregon 
University, USA 
Diffusion Theory 450-950 nm 2.5-3 mm 
Philips Research, 
The Netherlands 
Diffusion Theory 500-1600 nm 2.5 mm 
Ramanujam, Duke 
University, USA 
Probabilistic 350-600 nm Below 1 mm 
Sterenborg, 
Erasmus MC, The 
Netherlands 
Empirical 375-1060 nm Single fiber, 0.2-1 mm 
Tromberg, 
Beckman Laser 
Institute, USA 
Diffusion Theory 650-1000 nm Larger than 1 cm 
Tunnell, Texas 
University, USA 
Look-up table 375-700 nm Below 1 mm 
Zonios, University 
of Ioannina ,Greece 
Diffusion Theory 
Empirical 
450-1000 nm Below 1 mm 
 
Inhomogeneities 
Diffusion theory assumes a semi-infinite homogenous medium but this is 
obviously an assumption that does not fully describe the morphological tissue complexity. 
The effects of inhomogeneities are expected to be largest for large sampling volumes and 
disappear for sampling volumes of dimensions smaller than the diffusion length. 
Doornbos et al. [26] used spatially resolved diffuse reflectance with source detector 
separations up to 20 mm. On the basis of diffusion theory calculated absorption spectra, 
the measurements could not be fitted properly with the absorption spectra of the present 
chromophores. He observed smoothening of the absorption spectra. He and others found 
that this artifact could be fitted by adding an offset to the fit of the absorption spectrum, 
i.e. a wavelength independent constant absorption coefficient. Sterenborg et al. [27] 
showed that the measured spectra could be fitted with the known set of absorbers up to 
the measurement noise with differential pathlength spectroscopy (DPS) technique using 
400 micron fibers. That the sensitivity of the method to inhomogeneities is related to the 
size of the sampling volume with respect to the diffusion length and that the effects of 
inhomogeneities are expressed as misfits in certain spectral regions is illustrated by an 
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experiment by Nachabé et al. [28]. He used the method described above with a sampling 
volume of a couple of mm
3
. His measurements were performed through a needle inside 
tissue. Inside muscle and fat his spectra fitted perfectly, while close to a boundary spectral 
misfits occurred. The same smoothing was observed as in the spectra of Doornbos et al. 
The relation to the ratio between sampling volume and diffusion length is obvious: when 
sampling larger volumes, inhomogeneities cause spatial changes in fluence rates that 
diffusion theory mistakenly interprets by assuming incorrect optical properties. 
 
3. Fitting a model to measurements and fit quality assessment 
Model inversion 
In order to extract the optical properties from a measurement, a non-linear 
inversion is used to minimize the residual between the reflectance measurement and the 
model. To derive the clinically related parameters, the absorption coefficients of the 
chromophores of interest are fixed parameters in the model whereas the concentrations 
parameters in Eq. (7) are free parameters. With respect to the reduced scattering, the 
amplitudes and the slope are the free parameters. The first step in the inversion problem is 
to use an initial starting guess values for the model which will be used for a forward 
computation of the reflectance and that will be compared to the measurement. The free 
parameters are then iteratively updated until the sum of squares error is minimized. The 
most commonly used nonlinear least-squares inversion algorithm that is used is the 
Levenberg-Marquardt algorithm whereas few people presented other inversion techniques 
such as Nelder-Mead direct search simplex method [29], genetic algorithm [30] and 
Gauss-Newton [31].  
Some groups have different approaches with respect to the recovery of the free 
parameters such as look-up table principles based on Monte Carlo forward calculations of 
reflectance [32] or with phantoms with known optical properties are used to extract the 
physiological and biological constitution of the measured tissue [33]. Briefly, reflectance 
measurements from a set of phantoms with various absorption and reduced scattering 
coefficients are performed. The reflectance values can be mapped from the wavelength 
space to a 2D optical property space creating a sparse matrix for the reflectance. 
Subsequently, this space is interpolated to uniformly spaced data points of optical 
properties to obtain a look-up table for diffuse reflectance values.  
 
Modifications to the absorption coefficient expression 
 Investigators that were interested in determining blood volumes and its 
oxygenation level could not estimate the proper values from phantoms with known blood 
content when measuring the spectra for short wavelengths. At the beginning it was 
thought that the assumptions of the diffusion theory did not hold due to the fact that 
absorption of blood at short wavelengths was very high [34]. However, in the mid-90s, 
some groups investigated whether the cause was due to the difference in path lengths of 
the photons for the different wavelengths. As a matter of fact, as blood is not 
homogenously distributed in tissue but confined in small structures such as vessels, the 
photons at wavelengths below 500 nm have a much higher chance to be completely 
absorbed when being in a vessel as compared to the photons at higher wavelengths (cf. 
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Figure 1). Several groups looked into correction factors for the non-homogenous 
distribution of chromophores and mainly hemoglobin derivatives. Computational studies 
modeled distributions of hemoglobin in blood vessels in order to assess a pigment 
packaging correction factor [35-37]. Although it took almost a decade after its publication 
to be used by the field, nowadays most of the algorithms apply this correction factor to 
the absorption coefficient in Eq. (7). The most commonly used expression of the pigment 
packaging factor that assumes that blood is confined in cylindrical shaped tubes of 
diameter   derived by Verkruysse et al. and given by 
 
  [           ]      ⁄  . (17) 
 
In most cases, the absorption coefficient in Eq. (17) corresponds to the absorption of 
hemoglobin derived parameters only. In Eq. (7), the   factor is multiplied to the terms 
related to the chromophores that are considered to be subject to the pigment packaging 
effect [38]. More recently, a couple of experimental studies based on phantoms confirmed 
the importance of having such a factor to correct in the model [39, 40]. 
 Often Eq. (7) is implemented in a slightly different form where the total blood 
volume fraction and the oxygen saturation in blood are estimated instead of the 
concentration of oxygenated and deoxygenated hemoglobin: 
 
  
             [      
               
  ] , (18) 
 
with   
     and   
   being the absorption coefficient of oxygenated and deoxygenated 
hemoglobin, respectively; considering a concentration of hemoglobin in full human blood 
of 150g/L. The total blood volume fraction and the oxygen saturation level are noted as 
       and     , respectively. This formulation has the advantage of self-constraining 
     parameter between 0 and 1. Furthermore, it also reduces the covariance between 
       and      than between the Hb and HbO2 concentrations. Similarly, an equivalent 
notation is adopted for water and lipid where the sum of these two absorbers and the lipid 
fraction within this sum are estimated instead of their respective concentrations [28]. 
 
Modification of the reduced scattering expression 
 To obtain a more stable fit, the reduced scattering coefficient in Eq. (8) is often 
normalized to a specific wavelength in order to obtain amplitudes of the reduced 
scattering which is constrained to smaller ranges. Furthermore, instead of estimating 
separately the reduced scattering amplitudes due to Mie and Rayleigh scattering, fitting a 
Mie-to-total scattering fraction reduces the covariance. The implemented reduced 
scattering in the models could be thus expressed as follows 
 
  
      [     ⁄  
            ⁄  
  ] , (22) 
 
with    being a normalization wavelength,   the reduced scattering amplitude at    and   
the Mie scattering fraction within Mie and Rayleigh scattering. 
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Confidence intervals 
 The first question that arises after fitting a model to the measurements is whether 
the estimated values of the free parameters do make sense. Amelink et al. [41] published 
an extensive study to demonstrate the added value of computing the confidence intervals 
of the estimated free parameters as it gives indication on the bias in the obtained values. 
The computation of the confidence interval is described in detail by Amelink et al. [41] 
and a comparison of confidence intervals on simulated spectra with different level of 
synthetic noises as well when fitting with a missing absorber where demonstrated to 
present the effect on the values of the intervals. Briefly, to compute the confidence 
interval for each free parameter, the covariance matrix is first approximated as the 
multiplication of the reduced chi-square by the inverse of the hessian of the chi-square 
with respect to the free parameters. The confidence intervals correspond to the square root 
of the diagonal elements of the covariance matrix. 
 
F-test for number of parameters and model assessments 
 As in any research field that requires fitting a model to a measurement, 
researchers should be very careful when adding additional parameters to their model. By 
adding additional free parameters, it is possible to reduce the residual whilst biasing the 
actual values of the parameters. 
 As mentioned in section 3, the main absorbers in human tissue are Hb, HbO2, H2O 
and lipid which are also all together the most abundant biological substances in the 
human body. Therefore, the related parameters to these absorbers will properly lock onto 
the spectral shape. In principle, by including the free parameters related to the reduced 
scattering, the fit curve should overlay with the measurement curve yielding a small 
residual. However, in some cases the residual has a spectral shape suggesting a missing 
chromophore in the model or that the model does not describe well enough the 
measurements. 
 In order to evaluate whether adding a chromophore or improving the model by 
adding an extra free parameter is necessary, an F-test can be applied by using the chi-
square values from fitting the measurement with and without the additional free 
parameters. If the obtained F-value is close to unity, the initial model is the one that 
describes the measurements best. However if the F-value is greater than unity there are 
two possible interpretations. Either, the model with the additional parameters describes 
the measurements best or the model with lower amount of fitting parameters is the most 
suitable. To know which of these two conditions is correct; the computation of the p-
value from the F-value is required [27]. 
 
4. Biological chromophores 
As most of the models use the absorption or extinction coefficients of the various 
chromophores of interest as fixed input arguments, it is of high importance to have the 
most accurate coefficients for each chromophore for which the concentration is estimated. 
This section gives an overview of most of the biological chromophores that were 
investigated in literature. 
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Blood derived chromophores 
 Deoxygenated and oxygenated hemoglobin (Hb and HbO2) are the two main 
chromophores that are investigated by the biomedical photonics community as they are 
the two main optical absorbers that can be measured with silicon detector based 
spectrometers. These two biological substances are of great interest from a clinical point 
of view as they can be combined to define the oxygenation level of blood i.e. the 
concentration of HbO2 over the sum of both hemoglobin derivatives. The oxygenation 
level of blood is an important indicator of hypoxia [42] as well as tumor [43-45]. 
 Absorption coefficients of Hb and HbO2 measured by Scott Prahl are available for 
the biomedical photonics community in the website of the Oregon Medical Laser Center 
[46]. Another set of coefficients is also available in a book written by Zijlstra et al. which 
also reports the coefficients for different pH and temperature of the blood samples as well 
as coefficients for various animals [47]. Additionally, the book contains absorption 
coefficients of other blood derivatives such as methemoglobin (metHb), sulfhemoglobin 
(SHb), and carboxyhemoglobin (COHb). 
 Amelink et al. investigated which of the sources provides the most reliable 
coefficients as it is very important to have the most accurate absorption coefficients to 
properly fit the measurements [48]. He concluded that the absorption coefficients reported 
by Zijlstra et al. allowed most accurate fitting of the measurements. Figure 1 depicts the 
absorption coefficients of Hb and HbO2 by Prahl and Zijlstra. 
 
 
Figure 1. Hb and HbO2 absorption coefficients by Prahl [61] and Zijlstra [47]. 
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Water 
 Water is one of the most abundant biological substances in human body ranging 
from 60 to 80% in body weight [49]. Therefore, water is also one of the most important 
biological chromophore that is estimated with spectroscopy technique. Within the visible 
wavelength range, the absorption coefficient of water is insignificant. However, in the 
infrared, water has several absorption peaks with absolute values above one cm
-1
, as 
depicted in Figure 2, which are the most dominant absorption peaks in the infrared range. 
Water absorption coefficients change significantly for different temperatures [50]. 
Measurements of water absorption coefficients made at different temperatures ranging 
from 30 °C up to 45 °C demonstrated that the higher the temperature, the more the 972-
nm absorption peak of the water shifts to lower wavelengths. The shift is roughly 5 nm 
for an increase in temperature from 30 to 40 °C accompanied with typically 5%  higher 
absorption values. Additionally, it appeared that the water absorption value at 1192 nm 
decreases with negligible shift of the peak [50].  
Among the various research groups involved in estimating water volume fractions 
from spectroscopy measurements, the group of Tromberg and Cubeddu always estimate 
this component as they are mainly interested in water composition in breast (cf. Table 2). 
However, given the wavelength range for their measurements, only one single absorption 
peak at 972 enables determination of water fractions. Extending the measurement range at 
least up to 1600 nm is advisable as additional water absorption peaks exist (cf. Fig. 2). It 
was proven that in case of using the steady-state diffusion theory model, extension of the 
wavelength range significantly improved the confidence in estimating the water volume 
fractions [28].   The group of Sterenborg and Zonios occasionally determined water 
volume fractions in case of breast and skin measurements, respectively (cf. Table 2). 
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Figure 2. Water absorption coefficient [54]. 
 
Lipid 
In the human body, lipids are mainly found in adipose tissue such as subcutaneous 
fat layers as well in visceral fat surrounding the organs. They are main components of cell 
membranes and therefore could be found everywhere in the body. The lipid concentration 
in adipose tissue ranges from 60 to 87% for adults and 23 to 47% for infants [51].  
One of the very first lipid absorption coefficient measurements that was made 
available to the community was presented by Conway et al. who measured pork lard from 
800 to 1080 nm [52]. This measurement was performed by Van Veen et al. starting from 
400 nm and showed additional peaks of weak absorption coefficient up to 800 nm [53]. 
Nachabé et al. has performed measurement of lipid between 900 and 1600 nm [50] and 
re-measured the absorption coefficient from 400 up to 2200 nm as shown in Figure 3 
[54]. 
Lipid is composed of three types of fat: saturated, monounsaturated, and 
polyunsaturated fat. Typically, human subcutaneous fat is composed of 21%, 46%, and 
33% of saturated, monounsaturated, and polyunsaturated fat, respectively. The variations 
in composition of fat types yield to slight variations in the absorption peaks. For example, 
lipid constituted of 42%, 46%, and 12% of saturated, monounsaturated and 
polyunsaturated, respectively, shows an additional absorption peak at 1170 nm [50].  
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Figure 3. Lipid absorption coefficient [54]. 
 
β-Carotene 
 β-carotene is one of the carotenoids which is mainly found in the skin, blood 
stream, and adipose cells. In human breast studies [43, 55-57], it showed to be an 
important absorber in adipose tissue as well as in oral cancer clinical studies [58] and 
vessel plaque detection [59]. This chromophore has its main absorption peak at 482 nm as 
depicted in Figure 4. The extinction coefficient of β-carotene depends on the substance it 
was diluted. Comparing the extinction coefficients of this absorber when it is dissolved in 
hexane and in lipid-rich tissue, respectively, as depicted in Figure 4, it shows that the 
extinction peak is 25 nm broader in the green wavelengths when diluted in lipid-rich 
tissue. Besides, the absolute value of the extinction coefficient at 482 nm is lower. 
 Most of the groups that use β-carotene in their model consider the extinction 
coefficient with this absorber diluted in adipose cell as it is expected to be in human body. 
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Figure 4. Absorption coefficient of β-carotene diluted in hexane and in adipose cells. 
 
Bilirubin 
 Bilirubin is a yellow liquid that is mainly found in the spleen and in the liver. In 
case of an excess of bilirubin secretion in the liver, it can no longer be stored in bile and 
therefore it flows in the blood stream and leaks into the tissue yielding the skin to become 
yellowish. 
 Similarly to β-carotene, bilirubin extinction coefficients depend on the media in 
which it was diluted. Kanick et al. presented bilirubin diluted in albumin extinction 
coefficients and it appeared to have its maximum at 467 nm whereas bilirubin diluted in 
chloroform has its peak at 453 nm [60] as depicted in Figure 5. 
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Figure 5. Absorption coefficient of bilirubin diluted in chloroform and in albumin [88]. 
 
Organ specific chromophores 
Some other studies investigated other chromophores that are organ specific such 
as skin, liver and breast. 
In the field of dermatology, melanin is an important absorber that is always taken 
into consideration in the model and is expressed as a power law 
  
                 ⁄        [61] or as an exponential decay function    
        
   [                ⁄  ]  with      being the minimum wavelength value for the 
fitting range and    being a fit parameter [62].  
Recently, measurements on liver showed the need to add the bile absorption 
coefficient for liver measurements as this organ is extremely abundant with bile ducts and 
demonstrated that bile concentrations are significantly different in liver metastases 
compared to healthy liver tissue [63].  
Taroni et al. investigated the absorption coefficient of collagen in the wavelength 
range from 600 to 1100 nm and demonstrated that it improves the fit mainly for 
measurements performed on dense breast tissue [64-66]. Nachabe et al. measured the 
collagen absorption coefficient of collagen from 500 to 1600 nm and presented the 
collagen concentration in various tumors types of breast tissue [67]. 
 Table 2 summarizes the different absorbers that are used in the different studies of 
various groups. 
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Table 2. Overview of biological chromophores used for specific organs by the various 
research groups developing optical spectroscopy tools for medical applications. 
Group, location Organ
 
Absorbers used in model 
Bigio, Boston 
University, USA 
Muscle [68] 
 
 
Hb, HbO2 
Cubeddu, 
Politecnico Milano, 
Italy 
Breast [64-66] 
 
 
 
Hb, HbO2, H2O, Lipid, Collagen 
Feld, MIT, USA Breast [55] 
Oral [58, 69] 
Cardiovascular [59,70] 
Cervix [71] 
 
Hb, HbO2, β-carotene 
Hb, HbO2, β-carotene 
Hb, HbO2, β-carotene, Ceroid 
Hb, HbO2, β-carotene 
 
Jacques, Oregon 
University, USA 
Gastrointestinal [72-74] 
 
Hb, HbO2 
Philips Research, 
The Netherlands 
Breast [67] 
 
Muscle [28] 
Neuro [75, 76] 
Liver [54, 63] 
 
Hb, HbO2, H2O, Lipid, β-carotene, 
Collagen 
Hb, HbO2, H2O, Lipid 
Hb, HbO2, H2O, Lipid 
Hb, HbO2, H2O, Lipid, Bile 
Ramanujam, Duke 
University, USA 
Breast [45, 56, 57, 77-81] 
Cervix [82, 83] 
Head and Neck [84, 85] 
 
Hb, HbO2, β-carotene 
Hb, HbO2, β-carotene 
Hb, HbO2 
Sterenborg, Erasmus 
MC, The 
Netherlands 
Breast [43] 
Head and Neck [86] 
Lung [21, 42, 87] 
Lung [88] 
Oral [89] 
Oral [90] 
Gastrointestinal [91] 
Urology [92] 
Hb, HbO2, β-carotene 
Hb, HbO2 
Hb, HbO2 
Hb, HbO2, Bilirubin 
Hb, HbO2 
Hb, HbO2, β-carotene 
Hb, HbO2 
Hb, HbO2 
 
Tromberg, Beckman 
Laser Institute, USA 
Breast [10, 44, 93-105] 
 
Hb, HbO2, H2O, Lipid 
 
Tunnell, Texas 
University, USA 
Skin [33, 40] 
Skin [106, 107] 
 
Hb, HbO2 
Hb, HbO2, Melanin 
Zonios, University of 
Ioannina ,Greece 
Gastrointestinal [18] 
Skin [15, 19, 62, 108, 109] 
Skin [110] 
Skin [111] 
Hb, HbO2  
Hb, HbO2, Melanin 
Hb, HbO2, H2O, Melanin  
Hb, HbO2, MetHb 
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5. Clinical applications 
Diagnosis 
 The most common clinical application is cancer diagnosis where malignant tissue 
is discriminated from the surrounding healthy tissue in order to assess tumors margins. 
For this aim, several tools were developed ranging from hand-held probes [44, 81] to pen-
like probes [55-57] and needle-like probes [21, 43, 75, 76]. Most of the studies clearly 
showed that there is a significant difference in blood oxygenation level between 
malignant and non-malignant tissues with non-malignant being less oxygenated. The 
same holds for the reduced scattering amplitude with higher values in malignant tissues 
compared to non-malignant tissues. These observations are independent of the organs. In 
many cases, the total amount of blood is also a discriminator with higher volume fractions 
in non-malignant tissues related to angiogenesis. It was also demonstrated that in the case 
of breast cancer the healthy tissue is rich in β-carotene compared to the malignant tissue 
as β-carotene is abundant in adipose tissue [43, 55-57, 67]. Groups that measure spectra 
above 900 nm are able to estimate water and lipid volume fractions and proved that 
obviously it is possible to discriminate non-malignant tissue as adipose tissue is rich in 
lipid [44, 67]. However, it is important to note that very often glandular tissue is included 
as non-malignant tissue and the statistics can be biased due to the fact that glandular is 
mainly rich in connective tissues.  
 Another organ that received a lot of attention is skin due to the fact that it is easily 
accessible. The group of Zonios has the largest experience in dermatological investigation 
with diffuse reflectance spectroscopy and showed that the main discriminator between the 
cancerous tissue and benign tissue is the melanin decay factor km. The group of Tunnell 
has been over the last five years active in investigating skin cancer diagnosis and showed 
that they can classify basal cell carcinoma from squamous cell carcinoma and benign skin 
tissue with a sensitivity and specificity ranging from 89% to 97% and 25% to 89%, 
respectively [106]. 
With respect to cervical cancer, several studies investigated the change in optical 
properties for different grades and it was demonstrated that blood volume fractions 
increases with the grade level [82, 83]. 
Colon tissues have also been investigated with diffuse reflectance spectroscopy to 
diagnose polyps and cancer [18, 112]. It was shown that blood volume fraction is the 
main discriminator between malignant and non-malignant and being less abundant in 
normal tissue. Another organ from the gastrointestinal system that was investigated by 
Amelink et al. is the esophagus where it was shown that blood volume fractions is also 
higher in cancer compared to healthy mucosa from the Barrett‟s esophagus. 
Diffuse reflectance spectroscopy investigations on the oral cavity showed that 
blood is a discriminator between cancerous tissue and normal tissue as well as the 
scattering amplitude and slope [89]. 
The group of Sterenborg has a lot of experience in lung cancer diagnosis where 
they showed that the blood oxygenation level is lower in cancerous tissue compared to 
healthy tissue using differential pathlength spectroscopy technique [21, 42, 87]. More 
recently, they have investigated the difference between metastasis and normal lymph 
nodes in the lung by integrating a single fiber in a fine-needle and showed that both blood 
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volume fraction and its oxygenation level are significantly different for the two types of 
lymph nodes [88]. 
A paucity of liver studies cannot allow for a clear conclusion with respect to the 
parameters that show differences between tumors and healthy tissue. Nachabé et al. 
performed a study to investigate the difference between colorectal metastasis in liver and 
the surrounding healthy tissue. It was shown that bile is a very important discriminator 
being more abundant in healthy tissue than the tumors. Similarly to breast and cervical 
cancer, it was shown that the reduced scattering amplitude is significantly higher in 
tumors. Furthermore, water showed similar trends to the scattering amplitude; the reason 
being that water is attracted to necrotic tissue that is abundantly present in most colorectal 
liver metastases. The high water content of collagenous stroma in general, and tumor 
induced stroma play a role as well. Another type of diagnosis investigated by Nachabé et 
al. corresponds to non-alcoholic fatty liver disease (NAFLD) diagnosis [54]. NAFLD is 
considered to be positively diagnosed for hepatic lipid accumulation as low as 5% and 
therefore very accurate tools are required to properly estimate the fat fraction. Nachabé et 
al. showed by comparing fat estimation with diffuse reflectance spectroscopy with other 
commonly used methods such as MR spectroscopy, MAS-NMR spectroscopy, high 
performance thin layer chromatography and histopathology being the gold standard. They 
concluded that diffuse reflectance spectroscopy provides comparable hepatic fat 
quantification for the various methods as well as clear differences in fat between a chow 
control mice group and a high fat diet mice group. 
Few studies exist with respect to the head and neck cancer. Breumer et al. [85] 
showed significant difference between squamous cell carcinomas and healthy tissue based 
on the blood oxygenation level. The cardiovascular field is also not very much 
investigated. The group of Feld did perform studies on distinguishing thrombotic plaques 
from vulnerable plaques and showed that they can classify both tissues with a sensitivity 
and specificity of 93% and 72%, respectively [59]. 
 
Tumor margins assessment 
 The group of Ramanujam has a wide experience in diffuse reflectance 
spectroscopy for breast cancer investigation and has recently developed a multiple fiber 
probe setup to evaluate breast tumor margins subject to surgery removal.  
They have showed in a study by Wilke et al. [78] that they reached sensitivity of 79% of 
the pathological close/positive margins and a specificity of 67%. More recently, a study 
by Kennedy et al. [81] showed that the reduced scattering amplitude and the blood 
volume fraction are both significantly higher in malignant tissue compared to the 
surrounding healthy breast tissue. 
 
Chemotherapy response monitoring 
The group of Tromberg has investigated the relation between the fit parameters 
and breast cancer chemotherapy responses. Monitoring the response to therapy can 
improve survival and reduce morbidity [44, 99, 100, 113]. 
Jakubowsky et al. used diffuse reflectance spectroscopy to monitor tumor 
responses to neoadjuvant chemotherapy prior to doxorubicincyclophosphamide therapy as 
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well as at several time points over the course of three treatment cycles of 68 days [100]. 
By investigating the tumor to normal tissue contrast in blood, water, lipid and blood 
oxygenation prior to treatment and comparing the values over a 10-week period, they 
showed that blood and water fractions dropped more than 50%, whereas lipid remained 
constant and the oxygenation level increased. Within only 5 days, half of the blood and 
water changes occurred making these two chromophores of high interest for breast 
chemotherapy monitoring. 
Shah et al. performed a similar study where diffuse reflectance spectroscopy 
measurements were employed in conjunction with magnetic resonance imaging (MRI) to 
assess tumor responses to presurgical neoadjuvant chemotherapy [99]. The study was 
conducted on patients with ductal carcinoma in situ breast tumors and the measurements 
were performed after the first and fourth cycles of doxorubicincyclophosphamide 
regimen. Spectral measurements are used to quantify bulk tissue optical and physiological 
parameters, which are mapped to T2- and T1-weighted contrast-enhanced MRI images. 
Initial spectroscopic measurements show high tumor/normal contrast in blood and water 
fraction colocalized with regions of strongly enhancing T2-wieghted signals. After the 
fourth cycle of chemotherapy, decreases in peak MRI contrast-enhancement values and 
apparent lesion volume (20% to 25% reduction in the spatial extent of the tumor) and a 
38.7% drop in mean blood content were observed. 
Tromberg et al. [113] performed a study on 12 young patients aged from 30 to 39 
years and investigated the potential of detecting tumors in pre-menopausal women and 
monitor the neoadjuvant chemotherapy. They showed that blood, water, and lipid volume 
fractions as well as the blood oxygenation level showed significant differences between 
normal and tumor. They came up with an empirical parameter called tissue optical index 
(TOI) corresponding to the product of deoxygenated hemoglobin concentration multiplied 
by the water fraction and divided by the lipid fraction to evaluate the response of tumors 
to chemotherapy. A 50% decrease in TOI within a single week after neoadjuvant 
chemotherapy was observed. 
Cerussi et al. [95] conducted a study where the goal was to investigate how early 
during the chemotherapy treatment can one predict whether a patient is a responder or not 
based on the fit-parameters derived from diffuse reflectance spectroscopy. Discrimination 
analysis based on the combination of deoxygenated hemoglobin concentration and water 
fractions classified responders from non-responders with 100% sensitivity and specificity 
within a single week after the treatment. 
From all these studies conducted by the group of Tromberg, it can be suggested 
that diffuse reflectance spectroscopy has a strong potential in properly monitoring 
chemotherapy responses as well as developing new strategies for individualized patient 
care. 
 
Photodynamic and radiotherapy monitoring 
 Photodynamic treatment (PDT) is an emerging treatment that is used to treat and 
reduce tumors size. It requires a photosensitizer such as aminolevulinic acid (ALA-5) that 
is absorbed by cells and coverted into protoporphoryn IX (PPIX). Subsequently, a single 
wavelength light is shined on the tumor causing light absorption by PPIX and causing 
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energy transfer from PPIX to oxygen. The reaction between the oxygen and the biological 
substances in the tumor provoke tissue damage. However the PDT dose of photosensitizer 
and light delivery can vary for patient to patient and therefore there is a crucial need in 
monitoring PDT. The group of Sterenborg performed several studies to monitor 
oxygenation during PDT procedures and showed increase in blood content as well its 
oxygenation at the treated tumor sites [86]. Similar study by Bargo et al. corroborated 
with these findings [72]. 
 Another type of treatment monitoring corresponds to irradiation treatment 
monitoring. Vishwanath et al. performed a preclinical study to investigate whether a final 
treatment outcome could be estimated from optical signatures in a murine model of head 
and neck cancer when treated with radiation [84]. They performed the study on 23 nude 
mice exposed to 39 Gy of radiation and 11 other as control group exposed to sham 
radiation. The measurements were performed until 17 days after treatment and they 
demonstrated that an increase in blood oxygenation can be observed starting 5 days post-
treatment and last up to 17 days. 
 
Complications prediction 
 Recently, the group of Jacques has investigated the potential of diffuse reflectance 
spectroscopy to predict anastomotic complications and gastric ischemic conditions during 
conduit creation [73, 74]. They have demonstrated that patients that had anastomotic 
complications showed to have higher blood content with lower oxygenation level 
measured in the distal gastric conduit. This study was performed in 23 patients during 
esophagectomy from which 8 showed anastomotic complications. They came to the 
conclusion that decreased oxygenation level in blood at either the completion of conduit 
or anastomosis is predictive of complication with a sensitivity and specificity of 71%. 
 
Needle guidance 
Diffuse reflectance spectroscopy sensing integrated in needles (e.g. biopsy 
needles) has shown to be a promising real-time feedback tool for improving percutaneous 
procedures. Van Veen et al. clearly showed the advantage of having real-time optical 
sensing feedback for breast biopsies [43]. Being able to discriminate the tumor site from 
the healthy tissue is of great relevance for clinician to be able to acquire the biopsy in the 
tumor site for further histopathological analysis. As a consequence, the total amount of 
repeated biopsy could be reduced. 
Rathmell et al. showed the added value of spinal needles with integrated optical 
fibers to be able to confirm the localization of the tip of a needle in the epidural space 
[75]. Based on the total amount of lipid that is estimated with diffuse reflectance 
spectroscopy, the epidural space can be accurately identified and discriminated from the 
surrounding tissues such as the ligamentum flavum or the cerebral spinal fluid (CSF).  
 
6. Conclusion 
Diffuse reflectance spectroscopy measurements acquired from fiber-optic hand-
held probes are extremely relevant for several clinical applications. As emphasized in this 
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review, the choice of the model should be carefully made by taking into consideration the 
geometrical aspects of the probe. The most common way of validating a model is to 
recover the optical properties from phantoms measurements with known optical 
properties. Several mathematical tools exist to evaluate the reliability of the estimated 
parameters as well as to investigate whether additional parameters need to be added to the 
model. 
Multitude of preclinical and clinical studies has been conducted and most of them 
converge to the same conclusions with respect to the analysis of the clinically relevant 
parameters in the aim to discriminate different types of tissues. However, the comparison 
between the different tools and the performance of the analysis is not always 
straightforward as there is a big variety of method, wavelength range, chromophores 
considered in the models, etc. that can influence the comparison. 
Anyhow, using diffuse reflectance spectroscopy showed sensitivity and specificity 
to discriminate malignant from non-malignant tissues ranging from 53% to 100% and 70 
to 100%, respectively. The performance of such diagnosis can be improved by combining 
fluorescence spectroscopy and also Raman spectroscopy. 
Diffuse reflectance spectroscopy has been intensively used in the clinic and 
demonstrated great potential in several clinical applications thanks to its minimal 
invasiveness and high optical contrast between various chromophores that enables tissue 
discrimination.   
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Chapter 2 
Abstract 
We demonstrate a method to estimate the concentrations of water and lipid in 
scattering media such as biological tissues with diffuse optical spectra acquired over the 
range of 900 – 1600 nm. Estimations were performed by fitting the spectra to a model of 
light propagation in scattering media derived from diffusion theory. To validate the 
method, spectra were acquired from tissue phantoms consisting of lipid and water 
emulsions and swine tissues ex vivo with a two-fiber probe.  
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1. Introduction 
Diffuse optical spectroscopy (DOS) is a widely used technique that can provide a 
wealth of clinically-relevant information about the physiological composition of tissues 
[1-4]. DOS measurements can be obtained non-invasively with an optical fiber probe, 
making them well-suited for guiding tissue resections during open surgeries. In the field 
of biomedical spectroscopy, many studies have focused on the estimation of the 
concentrations of deoxy-hemoglobin (Hb) and oxy-hemoglobin (HbO2). In the visible and 
near infrared wavelength ranges, these two chromophores are often the dominant 
absorbers in biological tissue [1-6]. However, lipid and water concentrations can also be 
of interest to discriminate between malignant and normal tissues in the breast [7] and to 
distinguish benign lesions from cysts in breast [8] in particular when employed in fiber-
tissue probes. 
The estimation of lipid and water concentrations with DOS in the 900-1000 nm 
wavelength range was addressed by several studies [9-10]. These studies focused on 
measurements on phantoms made of intralipid or emulsions made with different kinds of 
oils. However, very few studies have focused on the estimation of lipid and water 
concentrations in biological tissues with DOS with wavelengths above 1000 nm [11-13]. 
This wavelength region is potentially attractive from the standpoint of measuring 
concentrations of water and lipid because absorption features of these chromophores are 
more prominent than those in the 900-1000 nm range. 
Several methods have been demonstrated for estimating optical properties and 
chromophore concentrations from DOS measurements. Several models have been widely 
used over the last decade such as analytical solutions derived from diffusion theory [1, 
14], differential path length spectroscopy [6, 15], combined frequency-domain and 
continuous wave broadband diffuse optical spectroscopy [7, 10] and empirical models 
based on Monte Carlo simulations and experimental phantoms with known optical 
properties [14, 16-19]. However, these studies were only applied to wavelengths ranges 
below 1000 nm. 
The model proposed in this study utilizes an analytical solution of a diffusion 
theory approximation to light propagation in scattering media. First described by Farrell 
et al. [14], it expresses the intensity of received light as a function of the optical 
properties of the medium, i.e. the absorption and the scattering, and the distance between 
the emitting source and location at the surface of the medium where it is received. To the 
authors‟ knowledge, this study represents the first application of the Farrell model to DOS 
measurements in the wavelength range of 900 to 1600 nm. 
 To validate the estimation method, DOS measurements were performed on tissue 
phantoms consisting of custom emulsions for which the lipid and water content were 
accurately known. Commercial food products, such as butters and margarine, were also 
utilized as phantoms. To investigate the accuracy of the algorithm with different 
scattering properties, the particle size distribution (PSD) was varied. To provide an 
indication of the relevance of this method for deriving concentrations from biological 
tissue, spectra were acquired from swine tissue ex vivo.  
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2. Materials and methods 
2.1 Experimental setup 
A 1.3 mm diameter optical probe was used for which the distal end was angled 70 
degrees. The probe contains two optical fibers with axis of symmetry parallel to the axis 
of symmetry of the probe therefore the fibers were separated at the distal end by a 
distance of 2.48 mm (center to center). Figure 1 shows a sagittal cross-section of the 
probe where the two lines inside the probe correspond to the axis of symmetry of the two 
optical fibers. The optical fibers are low-OH fibers from Ocean Optics of 220 microns 
diameter with a core of 200 microns and an NA of 0.22. One fiber is connected to a 
Tungsten Halogen broadband light source with an integrated shutter (Ocean Optics, HL-
2000-HP) and the second fiber is connected to a spectrometer with a spectral response 
from 800 to 1700 nm. The spectrometer has a holographic grating (150 grooves/mm and 
1250 nm blaze) and an InGaAs sensor array of 512x1 pixels and a pixel size of 500x50 
microns (Andor Technology, DU492A -1.7).  
 
 
Figure 1. Schematic sketch of the sagittal cross-section of the probe. The distal end is on 
the left side and the two lines inside the probe correspond to the axis of symmetry of each 
of the two optical fibers. 
 
2.2 Data pre-processing 
The data was acquired via an interface where the integration time can be set 
between 1µs and several minutes. To suppress the dark current, the detector is 
thermoelectrically cooled to a temperature of -50ºC. A wavelength calibration was 
performed to assign a wavelength value to each pixel of the detector. This was done by 
fitting a second order polynomial to a set of atomic lines from an Argon light source with 
peaks at known wavelengths. 
The spectra S(λi) that were processed to estimate the amount of lipid and water 
were calibrated by first acquiring an intensity calibration spectrum C(λi). To this aim, the 
reflectance of a white reflectance standard (LabSphere, WS-1-SL) was measured. A 
custom made probe-holder was made to hold the probe tightly and keep the surface of the 
optical fibers at the distal end parallel to the reflectance standard at a fixed distance of 2 
mm. The white reflectance standard reflects the light uniformly over the probe surface 
and this spectrum was used as the system response to compensate for the spectral shape 
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of the light emitted by the lamp and the wavelength-dependent sensitivity of the detector 
as well as any wavelength-dependent sensitivity in the optics and gratings of the system. 
This calibration step was followed by a background measurement in order to minimize 
the impact of the ambient light, dark current and the electric offsets of the detector. As 
soon as the detector temperature was stable and the light output was stable (roughly 5 
minutes after starting our setup), the calibration was performed before each set of 
measurements. 
The spectrum of the tissue can be described as a function of wavelength with the 
following equation: 
 
      
              
             
     
 
where      ,       and       are the calibrated tissue spectrum, the effective measured 
tissue spectrum and the white reflectance standard measured spectrum, respectively. After 
each tissue measurement, a background measurement         is acquired by shuttering 
the light input and subtracted from      . A background measurement         is also 
acquired after the measurement of the white reflectance standard      . 
 All the measurements discussed throughout this paper were taken by placing the 
surface of the optical fibers at the distal end parallel and in contact with the phantoms and 
the tissues. Having polished fibers at an angle and the size of the optical fibers surface did 
not hamper our parameter estimation since the distance between the emitting and 
collecting fibers was sufficiently large (i.e. 2.48 mm) so that it did not influence our 
spectral fitting. For much shorter fiber distance separation, the effective radius of the 
optical fibers and the probe of the geometry influence the reflectance measurements and 
thus should be taken into account [17, 19].  
 
2.3 DOS model and data analysis 
Several models [14, 16-20] have been described in literature to express the 
intensity of light collected by a fiber after several scattering and absorption events in a 
diffuse medium. The model that is used in this paper is expressed in equation (2) and 
corresponds to the solution of the diffusion equation for a semi-infinite medium and is a 
widely accepted model in the field of biomedical photonics [14]. This analytical 
expression for the diffuse reflectance           
        is a function of the distance ρ 
between the emitting and collecting fiber, the absorption coefficient       and the 
reduced scattering coefficient   
     and is given by 
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where          [     
 ]   ⁄  is the effective attenuation coefficient and    
      
     is the location of the virtual scattering source. The extrapolated boundary 
condition is expressed as        where A is a parameter that depends on the refractive 
index of the tissue and the surrounding medium. An analytical model for A was described 
in [14] which expresses A as a function of the relative refractive index and the critical 
angle. We made the assumptions that the difference in refractive index of tissue and the 
optical fibers is small and therefore considered that there were no refractive index 
mismatch which leads to set A=1. Furthermore,     [     
 ]    is the diffusion 
constant,   ̃     
       ⁄  is the distance between the single scattering source and the 
collecting fiber, and  ̃           
       ⁄  is the distance between the image source 
and the collecting fiber. In this model, the reduced scattering coefficient   
          
is a function of the scattering coefficient    and the anisotropy parameter  . However, the 
reduced scattering parameter can be approximated by a power law function as   
  
 (
 
  
)
  
 with amplitude   and where   is a parameter related to the particle size [4]. Here  
   is a normalization wavelength that is set to 1200 nm and thus   corresponds to the 
reduced scattering at this specific wavelength (    
             ). The absorption 
coefficient is expressed as: 
 
               
                  
             
 
where        and        are the water and lipid volume fractions respectively and; 
  
         and   
         are the absorption coefficient of water and lipid, respectively. 
 Data were analyzed by fitting equation (2) to the processed measurement data 
obtained by equation (1) in order to estimate the optical properties of the probed samples. 
The parameter ρ that corresponds to the distance between the emitting and collecting fiber 
is a fixed input argument set at 2.48 mm. Equation (1) and (2) are related by a 
wavelength-independent constant. This constant corresponds to the ratio between the 
fraction of light from the calibration standard collected by the fiber and the light from the 
measured phantoms. The fitting locks onto the spectral shape of the measurements while 
the constant, which is also derived from the fitting, accounts for the absolute value of the 
fitting. The fitting procedure of the spectrum is a Levenberg-Marquardt minimization 
method available in Matlab, which produced an estimation of the parameters       ,     , 
  and  . The advantage of this way of fitting is that the absorption coefficients of pure 
water and pure lipid are input to the model that constrains the spectral shape. The 
following section describes in detail how we obtained, from measured spectra, these two 
wavelength dependent absorption coefficients that are essential for the fitting procedure. 
Moreover, the reduced scattering coefficient is defined by the amplitude parameter a and 
slope parameter b only. In contrast, refs [7, 10] fit equation (3) to pre-fitted absorption 
and reduced scattering or measured optical properties for a set of wavelengths.  
In order to assess the reliability of the estimated parameters, the goodness of fit 
was assessed with the covariance matrix [21]. 
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The model holds when the reduced scattering is greater than the absorption and 
the distance between the optical fibers is greater than the scattering length. Moreover, the 
medium should be homogenous. In this paper, our phantoms and tissue measurements 
fulfill these assumptions to some extent. 
 
2.4 Absorption measurement of lipid and water 
It should be emphasized that accurate tables of extinction coefficients as a 
function of wavelength are required to estimate the exact amount of chromophores [15]. 
In order to ensure the optimization of the fits to the model, we decided to measure our 
own absorption spectra of water and lipid in the wavelength range of 900 to 1600 nm. 
The absorption properties of lipid and water were computed based on transmission 
measurements at constant temperature of 30 degrees through cuvettes of 0.1, 0.2, 0.5 and 
1 cm width with a 1-nm resolution spectrophotometer [Lambda 900 Spectrometer, Perkin 
Elmer]. These measurements were made at different temperatures ranging from 30 
degrees up to 45 degrees to assess the dependence of the absorption values to 
temperature. It appeared that there were no changes in the absorption of lipid. In the case 
of water, the higher the temperature the more the 972 nm absorption peak of the water 
shifts to lower wavelengths (roughly 5 nm for an increase of temperature from 30 to 40 
degrees) resulting in a higher absorption value (5% relative increase of the absolute 
value). Additionally, it appeared that the water absorption at 1192 nm decreases with 
negligible shift of the peak. Figure 2.a and 2.b show the absorption coefficient of water at 
30, 34, 37 and 40 degrees Celsius for different wavelengths ranges (a linear scale was 
applied to the figure to highlight the differences).  
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Figure 2. Absorption coefficient of water at different temperature for the wavelength 
range of 900 to 1100 nm (a) and 1100 to 1300 nm (b). Full line, dashed-line, dotted-line, 
dashed and dotted line correspond to measurement at 30, 34, 37 and 40 degrees 
respectively. 
 
 Figure 3 depicts the absorption coefficients of water   
         and lipid   
       
between 900 and 1600 nm at 30 degrees Celsisus. The type of lipid that was used was 
100% beef fat. The absorption peaks at 930, 1040, 1211, 1392 and 1413 nm are in good 
agreement with measurements performed by Van Veen [22] in the visible-NIR range and 
Anderson in the NIR–Mid IR range [11]. The water absorption peaks at 972, 1192 and 
1453 nm are also in good agreement with the measurments reported by Hale and Querry 
[23]. Besides, the absolute value of the measured absorption of the lipid and water is in 
good agreement with that published by Anderson [11]. 
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Figure 3. Absorption spectra of water and fat from 900 to 1600 nm. 
 
2.5 Tissue phantom preparation 
Phantoms were made by mixing three ingredients: 100% beef fat (commercial 
frying fat), water, and an emulsifier (Triton X-100 from Roche). According to the 
technical data sheet of the commercial frying fat, the solid fraction compositions (SFC) 
were respectively 37% at 20 degree Celsius, 20% at 30 degrees Celsius and 4% at 40 
degrees Celsius. The beef fat was melted by heating it to a temperature such that the SFC 
is less than 1% to make it completely liquid and thus easy to mix with water. Taking this 
into consideration, the water, the lipid and the emulsifier were heated up to 50 degrees, 
below the cloud temperature of the Triton X-100 which is 65 degrees and high enough to 
get a liquid lipid. The amount of emulsifier comprised 4% of the total amount of lipid that 
was used to prepare the phantoms as suggested by Merritt et al [10]. The three ingredients 
were mixed together at the same temperature with a kitchen blender (Philips HR1363) at 
high speed for a minute. Samples of 40 ml with 10%, 30% and 60% lipid-to-water ratio 
were prepared. Half of each solution was poured in separate containers to ultrasonicate 
the content. An ultrasonication probe (IKA T25 digital Ultra-Turrax) was used to reduce 
the particle size and thereby to change the scattering properties of the emulsions. Thus six 
samples were prepared in total, with three different lipid-to-water ratios and different 
particle size distributions. 
The particle size distribution (PSD) of each of the six samples was measured with 
an apparatus based on the coulter principle (Multisizer 3 coulter counter from Beckman 
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Coulter). This apparatus could not resolve submicron particle sizes due to the limited 
dynamic range of the system. The PSD of the six emulsions we prepared in the lab is 
shown in Figure 4. The first row of figures corresponds to the measurements performed 
on the samples that were mixed with the kitchen blender. The second row corresponds to 
the samples which were ultrasonicated. By comparing the PSD of the ultrasonicated with 
the non-ultrasonicated samples for each of the various lipid-to-water ratios, it appears that 
the maximum of the distribution shifts to the smaller particle size as expected. However, 
the standard deviation of the particles size is higher for lower lipid content so if one wants 
to obtain a more uniform PSD for low lipid content samples it is necessary to use other 
techniques. 
 
 
Figure 4. Particle size distribution measurements (PSD) of the emulsions. The top row 
graphs show the PSD of the emulsions that were blended with a kitchen blender for the 
10% (a), 30% (b) and 60% (c) lipid-to-water ratio respectively. The bottom row shows 
the PSD of the same emulsions after applying an ultrasonic mixing for the 10% (d), 30% 
(e) and 60% (f) lipid-to-water ratio respectively. 
 
3. Results and discussion 
Figure 5 and 6 show the measured spectra at a temperature around 30 degrees of 
the different lipid and water emulsions (dashed line) and the corresponding best fits (solid 
line). The presence of lipid in the sample is correlated with the narrow peak at 1211 nm 
which is an absorption signature of lipid. Moreover, for the sample that contains more 
lipid than water, the 930 nm absorption peak of lipid is clearly visible in the measured 
spectrum. Above 1400 nm, the intensity is null and this is due to the very high absorption 
of water above this specific wavelength given the fiber distance separation. 
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Figure 5. Results of the fitting (Line curves) on the measured spectra (Marker curves) of 
the different emulsions mixed with a blender. 
 
The estimated parameters for each phantom emulsion are displayed in Table 1 and 
the variances of the fitted values derived from the calculation of the covariance matrix are 
displayed between brackets next to the estimated values. The estimation of the lipid-to-
water ratio is within 5% error from the true value. 
 
Table 1. Estimation of the optical properties of the custom emulsions without and with 
ultrasonication. 
Lipid-to-
water ratio 
10 % 30 % 60 % 
Ultra-
sonication 
Yes No Yes No Yes No 
Water (%) 
86.5 
(±2.2) 
86.7 
(±2.6) 
70.1 
(±2.2) 
69.3 
(±1.6) 
41.0 
(±1.2) 
41.7 
(±1.0) 
Lipid (%) 
11.5 
(±1.6) 
10.8 
(±1.9) 
29.7 
(±2.4) 
30.0 
(±1.8) 
58.2 
(±2.3) 
57.8 
(±1.8) 
  
  (120 nm) 
(cm
-1
) 
26.3 
 (±0.4) 
29.5 
(±0.5) 
64.2 
(±1.0) 
72.3 
(±0.8) 
84.4 
(±1.0) 
87.1 
(±0.9) 
b  
0.06 
(±0.06) 
0.29 
(±0.07) 
0.40 
(±0.06) 
0.70 
(±0.04) 
0.56 
(±0.04) 
0.87 
(±0.04) 
 
The scattering parameter increased with the amount of lipid in the sample. This 
was expected since the lipid is the only scatterer in the various samples. The estimated 
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slope value varied with respect to the scatterer size [4]. From the estimated parameters for 
the slope, it appeared that the slope for the ultrasonicated samples was greater than for the 
non-ultrasonicated samples. This observation correlates with the PSD measurements as 
discussed in the beginning of this section i.e. high slope values for samples with small 
average particles size. 
 
 
Figure 6. Results of the fitting (Line curves) on the measured spectra (Marker curves) of 
the different emulsions mixed with a blender and the sample preparation included an 
ultrasonication process. 
 
In summary, we have shown with the set of custom made phantoms, that we could 
estimate the amount of water and lipid for different reduced scattering profiles from 
spectroscopic measurements with our optical probe using a fit to a diffusion 
approximation model. The following step was to complement the validation with a 
phantom study with a wider range of lipid-to-water ratios. 
Measurements on commercial lipid-water samples such as butter and margarine 
were also performed at room temperature in order to further validate our method and to 
highlight the difference in the spectra for a wider range of lipid-to-water ratios. Butter 
samples with 25%, 35%, 60% and 83% lipid content, and a 40% lipid content margarine 
sample were also measured. A suspension of 320 mg of BaSO4 in 20 ml of water was 
prepared so that we had a light scattering sample without lipid in order to mimic muscle-
like tissue with 0% lipid. 
Figure 7 depicts the different measurements of the commercial butters (dashed 
line) and the respective best fits (solid line). It is important to notice that the absorption 
spectra of lipid and water both have an absorption peak around 1200 nm wavelength, but 
that the widths of these peaks are different. The lipid peak is much narrower than the 
water peak. For increasing concentration of lipid with respect to water, the measurements 
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depicted in Figure 7 show a narrowing of the peak in the spectra in the vicinity of 1200 
nm. 
 
 
Figure 7. Fits (line curves) to the measured spectra (data points curves) of the solution of 
BaSO4 in water (a) and the 25% (b), 35% (c), 40% (d), 60% (e) and 83% (f) lipid content 
commercial butters and margarine. 
 
The fitting routine was performed on the measurements to estimate the amount of 
lipid and to compare it with the value written on the packages of the commercial samples. 
The results from the fits are summarized in Table 2 and reveal that with our method it is 
possible to retrieve the amount of lipid with a deviation below 5% in comparison with the 
amount of lipid indicated on the commercial packages. 
Several reasons can explain the deviation that were encountered and also the wide 
range of scattering between the different commercial samples. The fact the absorption 
spectrum derived from beef fat was used as a reference absorption spectrum in the fitting 
routine is potentially a source of error since it is a different kind of fat than in butters. 
Butter, margarine and animal fats (e.g. lard) are known to be composed of different kind 
of fats which are divided into three families: saturated fat, monounsaturated fat and 
polyunsaturated fat. Butter is mainly composed of saturated fat (typically 66% saturated, 
30% monounsaturated and 4% polyunsaturated fat) whereas margarine is mainly 
composed of monounsaturated and polyunsaturated fat (typically 21% saturated, 46% 
monounsaturated and 33% polyunsaturated fat) and animal fat of saturated and 
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monounsaturated fat (typically 41%, 47% and 12% of respectively saturated, 
monounsaturated and polyunsaturated fat). 
 
Table 2. Estimation of the optical properties of the BaSO4 in water (A), 25% lipid content 
butter (B), 35% lipid content butter (C), 40% lipid content margarine (D), 60% lipid 
content butter (E) and 83% lipid content butter (F). 
 Sample 
 A B C D E F 
Water (%) 
93.6 
(±2.5) 
74.6 
(±1.5) 
63.9 
(±1.1) 
57.3 
(±1.1) 
36.1 
(±0.8) 
13.8 
(±0.5) 
Lipid (%) 
0 
(±4.6) 
25.2 
(±1.7) 
36.0 
(±1.6) 
42.7 
(±1.8) 
63.7 
(±2.0) 
85.4 
(±2.5) 
  
  (1200 nm) 
(cm
-1
) 
1.7 
(±0.5) 
43.7 
(±0.4) 
68.5 
(±0.6) 
94.9 
(±0.9) 
75.0 
(±0.7) 
53.7 
(±0.6) 
b  
0.55 
(±0.03) 
0.01 
(±0.03) 
0.03 
(±0.02) 
0.33 
(±0.02) 
0.09 
(±0.03) 
0.01 
(±0.03) 
 
Figure 8 depicts the absorption coefficient of 100% lipid-content oil composed of 
10% saturated, 30% monounsaturated and 60% polyunsaturated fat; and the beef fat. One 
major difference is the presence of an extra absorption peak at 1170 nm and slight 
difference in the absolute value of the absorption. The most optimal fit would be obtained 
by using the same type of fat of each commercial sample to estimate the amount of lipid 
in the various commercial samples. Therefore, we decided to just use the absorption 
coefficient from the beef fat as the reference for lipid in the fitting. The more unsaturated 
the fat is, the larger the molecule. As a result, the scattering can vary significantly from 
sample to sample depending on the distribution of the different types of fat in the butter 
(e.g. industrial margarine is composed of droplets of 5 to 10 microns diameter size). 
In the case of the custom emulsions, it can clearly be seen that the fitting curve 
between 900 and 1000 nm is not accurate compared to the rest of the wavelength range. 
This is mainly due to the temperature of the sample. The PSD measurements were done 
just before the actual acquisition of the spectra and thus the temperature of the samples 
was not constant. Several studies, such as Ref. [24], showed that the absorption 
coefficient of water is sensitive to temperature. Thus, the effect of temperature on the 
absorption coefficient of water is important to take into consideration.  
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Figure 8. Comparison between two types of lipids: the dashed line corresponds to the 
beef lipid whereas the full line curve corresponds to 100% lipid oil (sunflower oil). 
 
 Figure 9 shows ex vivo measurements (marker curves) of excised tissue from a pig 
and their respective fit curves (line curves). The measurements were performed on 
subcutaneous fat, muscle, visceral fat and white matter from the spinal cord by inserting 
the tip of the probe in the tissue. In Table 3, the estimated parameters for each tissue are 
summarized. Due to the fact that for the wavelength range of study, hemoglobin and 
oxygenated hemoglobin have their highest absorption values (roughly 2cm
-1
) between 
900 and 1000 nm, whereas water is the dominant absorber above 1000 nm as pinpointed 
in [25]; we did not include these two absorbers in the fitting routine. Our ex vivo tissue 
samples did not contain more than 1% of total blood volume fraction and thus 
hemoglobin did not have any influence on the fit parameters. 
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Figure 9. Fits (line curves) to the ex vivo tissue measurements (data point curves) of 
subcutaneous fat (a), muscle (b), visceral fat (c) and white matter (d). 
 
The estimated values are in agreement with those published from previous studies 
[26-29]. The composition in lipid and water of the subcutaneous fat was defined in Ref. 
[28] as being of 14% water and 86% fat which is in perfect agreement with our reported 
result. The estimation of water and from the muscle measurement is around 75% which is 
within the range of 60% to 80% of water in muscle whereas the estimated lipid content is 
roughly 2% within the 0% to 8% range [29]. In visceral fat, the estimation of lipid is 74% 
within the lipid content range of 60% and 90% in adipose tissue [29]. White matter is 
mainly axons surrounded with myelin; this physiological property is also in agreement 
with our finding from the acquired spectrum. From the estimation of the optical 
properties, it follows that white matter contains about 25% of lipid and the rest is water 
which is slightly above the reported 20% [29]. The scattering amplitudes that are 
estimated from the measured tissues are within the range of values available in Ref. [27]. 
Ref. [6] and Ref. [26] respectively presents the scattering of different tissues and fatty 
breasts which are comparable to our results. The scattering slope values estimated are 
within the range of 0.18 to 2.84 described in Ref. [26]. 
The absorption and reduced scattering coefficient can be computed thanks to the 
relation described in equation (3) and the power law function, respectively. Figure 10 
shows the optical properties for each of the ex vivo tissue measurements that were 
computed once the fit parameters in table 3 were obtained.  
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Figure 10. Absorption and reduced scattering coefficients of the ex vivo tissue 
measurements of subcutaneous fat (a), muscle (b), visceral fat (c) and white matter (d). 
Although the reduced scattering coefficient above 1350 nm is lower than the 
absorption coefficient, it is still possible to estimate the proper volume fraction of water 
and lipid. In particular, the fact that water and lipid have sharp peaks in the 900 to 1000 
nm wavelength range and around 1200 nm makes the estimation of the amount of water 
and lipid in the full range of 900 to 1600 nm still possible. For wavelengths below 1350 
nm, the reduced scattering coefficient is larger than the absorption coefficient. Since the 
reduced scattering coefficient is modeled by a power law for the whole wavelength range, 
the reduced scattering amplitude and slope constrained the fit and thus it is possible to 
evaluate the optical properties, despite the fact that absorption can be higher than the 
reduced scattering above 1350 nm. However, for low-lipid content tissues with low 
reduced scattering, care must be taken since the method may become inaccurate. If the fit 
deviates from the measurements for wavelengths above 1350 nm, this would be a sign 
that the applied model is no longer valid. For high-water content tissue, the signal can 
become null, given our fiber distance separation which also allows for a more stable fit. 
One can notice that around 1200 nm the absorption coefficient of water and lipid have 
roughly the same absolute values making this ratio less sensitive to errors in the fit model. 
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Table 3. Estimated optical properties of various swine tissues measured ex vivo. 
 Subcutaneous fat Muscle Visceral fat White matter 
Water (%) 12.2 (±0.5) 74.6 (±2.2) 24.9 (±0.9) 76.8 (±1.5) 
Lipid (%) 89.6 (±5.0) 1.9 (±1.2) 74.0 (±4.1) 26.4 (±1.3) 
  
  (1200 nm) (cm
-1
) 4.5 (±0.6) 3.1 (±0.2) 5.3 (±0.7) 6.0 (±0.3) 
b  1.76 (±0.21) 1.17(±0.08) 1.92 (±0.33) 1.58 (±0.24) 
 
4. Conclusion 
To accurately estimate water and lipid content in a small volume (e.g. a few mm
3
), 
a higher extinction is preferable than that of the commonly used 900 to 1000 nm 
absorption peaks. In the wavelength range from 900 to 1600 nm, one finds more 
absorption peaks with higher absorption coefficients. We performed accurate 
measurements of the water and lipid extinction coefficient to allow us to obtain a reliable 
estimation of these two chromophores in mixtures. 
We have demonstrated in this study that we can accurately estimate the amount of 
lipid and water with a diffuse optical spectroscopy technique in the near infrared for 
wavelengths in the range of 900 to 1600 nm. The phantom study proved that we can 
estimate, within less than 5% error, the amount of lipid and water in the various samples 
that were prepared. Furthermore, by applying ultrasonication to our phantoms to shrink 
the particle size, we have seen that the slope of the reduced scattering increased without 
effecting the estimation of water and lipid content. The validation of our method was 
completed with the estimation of the concentration of lipid in commercial food samples 
with known lipid content. 
This phantom study is complemented by ex vivo measurements and analysis that 
provides information on the optical properties of different tissues. The amount of lipid 
and water will prove to be important for discriminating healthy and cancerous tissue. 
With our method, we could provide real-time clinical feedback to physicians on the 
amount of lipid and water of tissue with the goal to classify between normal, malignant 
and benign samples when acquiring spectra from fiber-tissue probes. 
 
5. Acknowledgments 
We are grateful to Roy le Clercq and Marcel Böhmer from Philips Research for 
their help in experiments. We also thank Gerald Lucassen, Martin Vernhout, Jean 
Schleipen and Walter Bierhoff from Philips Research and Arjen Amelink from Erasmus 
Medical Center for their collaboration.  
This work is supported by a European Commission Marie Curie contract MEST-
CT-2004-007832. 
 61 
 
Chapter 2 
Estimation of lipid and water concentrations in scattering media withdiffuse reflectance 
spectroscopy from 900 to 1600 nmEstimation of lipid and water concentrations in 
scattering media with diffuse reflectance spectroscopy from 900 to 1600 nm 
References 
1. G. Zonios, L. T. Perelman, V. M. Backman, R, Manoharan, V. D. Fitzmaurice, 
Jacques Van Dam, and Michael S. Feld, “Diffuse reflectance spectroscopy of 
human adenomatus colon polyps in vivo”, Appl. Opt. 38, 6628-6637 (1999) 
2. J. R. Mourant, I. J. Bigio, J. Boyer, T. M. Johnson and J. Lancey, “Elastic 
scattering spectroscopy as a diagnostic for differentiating pathologies in the 
gastrointestinal tract: preliminary testing”, J. Biomed. Opt. 1 , 192-199 (1996) 
3. M. P. L. Bard, A. Amelink, V. N. Hegt, W. J. Graveland, H. J. C. M. Sterenborg, 
H. C. Hoogsteden and J. G. J. V. Aerts, “Measurement of Hypoxia-related 
parameters in bronchial mucosa by use of optical spectroscopy”, American 
Journal of respiratory and critical care medicine 171 (2005) 
4. G. Zonios and A. Dimou, “Light scattering spectroscopy of human skin in vivo”,  
Optics Express 17, 1256-1267 (2009) 
5. G. Zonios, J. Bykowski, and N. Kollias, “Skin melanin, hemoglobin, and light 
scattering properties can be quantitatively assessed in vivo using diffuse 
reflectance spectroscopy”, J. Invest. Dermatol. 117, 1452-1457 (2001) 
6. A. Amelink, O.P. Kaspers, H. J. C. M. Sterenborg, J. E. Van der Wal, J. L. N. 
Roodenburg, M. J. H. Witjes, “Non-invasive measurement of the morphology and 
physiology of oral mucosa by use of optical spectroscopy” Oral Oncology 44, 65-
71 (2008) 
7. A. E. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler and B. J. Tromberg, “In 
vivo absorption, scattering of 58 malignant breast tumors determined by 
broadband diffuse optical spectroscopy”, J. Bio. Opt. 11(4), 04 4005 (2006) 
8. A. Pifferi, P. Taroni, A. Torricelli, F. Messina, R. Cubeddu, and G. Danesini, 
“Four wavelength time-resolved optical mammography in the 680-980 nm range”, 
Opt Lett. 28, 1138-1140 (2003) 
9. R. Michels, F. Foschum, and A. Kienle, “Optical properties of fat emulsion”, 
Optics Express 16, 5907-5925 (2008) 
10. S. Merritt, G. Gulsen, G. Chiou, Y. Chu, C. Deng, A. E. Cerussi, A. J. Durkin, B. 
J. Tromberg, O. Nalcioglu, “Comparison of water and lipid content measurements 
using diffuse optical spectroscopy and MRI in emulsion phantoms”, Technology 
in cancer research and treatment 2, 563-569, (2003) 
11. R. R. Anderson, W. Farinelli, H. Laubach, D. Manstein, A. N. Yaroslavsky, J. 
Gubelli, K. Jordan, G. R. Neil, M. Shinn, W. Chandler, G. P. Williams, S. V. 
Benson, D. R. Douglas, and H. F. Dylla, “Selective photothermolysis of lipid-rich 
tissues: a free electron laser study”, Lasers Surg. Med. 38, 913-919 (2006)  
12. A. N. Bashkatov, E. A. Genina, V. I. Kochubey, and V. V. Tuchin, “Optical 
properties of human skin, subcutaneous and mucous tissues in the wavelength 
range from 400 to 2000 nm”, J. Phys. D: Appl. Phys. 38, 2543-2555 (2005) 
13. T. L. Roy, and S. N. Thennadil, “Optical properties of human skin in the near 
infrared wavelength range of 1000 to 2200 nm”, J. Biomed. Optics 6, 167-176 
(2001) 
 62 
 
Chapter 2 
14. T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of 
spatially resolved, steady-state diffuse reflectance for the non-invasive 
determination of tissue optical properties”, Med. Phys. 19, 879-888 (1992) 
15. A. Amelink, T. Christiaanse, and H. J. C. M. Sterenborg, “Effect of hemoglobin 
extinction coefficient spectra on optical spectroscopic measurements of blood 
oxygen saturation”, Optics Letter 34, No. 10, 1525-1527 (2009) 
16. P. R. Bargo, S. A. Prahl, T. T. Goodell, R. A. Sleven, G. Koval, G. Blair, and S. L. 
Jacques, “In vivo determination of optical properties of normal and tumor tissue 
with white light reflectance and an empirical light transport model during 
endoscopy”, J. Biomed. Opt. 10, (2005) 
17. G. Zonios, I. Bassukas, and A. Dimou, “Comparative evaluation of two simple 
diffuse reflectance models for biological tissue applications”, Appl. Optics 47, 
4965-4973 (2008) 
18. J. Sun, K. Fu, A. Wang, A. W. H. Lin, U. Utzinger, and R. Drezek, “Influence of 
fiber optic probe geometry on the applicability of inverse models of tissue 
reflectance spectroscopy: computation models and experimental measurements”, 
Appl. Opt. 45, 8152-8162 (2006) 
19. R. Reif, O. A‟Amar, and I. J. Bigio, “Analytical model of light reflectance for 
extraction of the optical properties in small volumes of turbid media”, Appl. Opt. 
46, 7317-7328 (2007) 
20. A. Amelink, H. J. C. M. Sterenborg, M. P. L. Bard, and S. A. Burgers, “In vivo 
measurement of the local optical properties of tissue by use of differential path-
length spectroscopy”, Opt. Lett. 29, 1087-1089 (2004) 
21. A. Amelink, D. J. Robinson, and H. J. C. M. Sterenborg, “Confidence interval on 
fit parameters derived from optical reflectance spectroscopy measurements”, J. 
Biomed. Opt. 13, (2008)  
22. R. L. P. van Veen, H. J. C. M. Sterenborg, A. Pifferi, A. Torricelli, E. Chikoidze, 
and R. Cubeddu, “Determination of visible near-IR absorption coefficients of 
mammalian fat using time- and spatially resolved diffuse reflectance and 
transmission spectroscopy”, J. Biomed. Optics 10, (2005) 
23. G. M. Hale and M. R. Querry, “Optical constants of water in the 200-nm to 200-
micrometer wavelength region”, Appl. Opt. 12, 555-563 (1973) 
24. K. Buijs, and G. R. Choppin, “Near-Infrared of the structure of water”, J. Chem. 
Phy. 39, 2035-2041, (1963) 
25. A. Roggan, M. Friebel, K. Dorchel, A. Hahn, and G. Muller, “Optical properties 
of circulating human blood in the wavelength range of 400-2500 nm”, J. Biomed. 
Optics 4, (1999) 
26. R. L. P. van Veen, W. Verkruysse, and H. J. C. M. Sterenborg, ”Diffuse 
reflectance spectroscopy from 500 to 1060 nm by correction for inhomogenously 
distributed absorbers”, Opt. Let. 27, (2002) 
27. V. V. Tuchin, “Tissue optics: light scattering methods and instruments for medical 
diagnosis” Second edition, SPIE tutorial text in optical engineering,170-191 (SPIE 
Press, Washington, 2007)  
 63 
 
Chapter 2 
Estimation of lipid and water concentrations in scattering media withdiffuse reflectance 
spectroscopy from 900 to 1600 nmEstimation of lipid and water concentrations in 
scattering media with diffuse reflectance spectroscopy from 900 to 1600 nm 
28. J. Wang and R. N. Pierson,  “Disparate hydration of adipose and lean tissue 
require a new model for body water distribution in man”, Journal of Nutrition 106, 
1687-1693, (1976) 
29. F. A. Duck, “Physical properties of tissue: a comprehensive reference book”, 
Academic Press, Harcourt Brace Jovanovich, Publishers, (1990) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 64 
 
Chapter 2 
 
 
  
 
Chapter 3 
Estimation of biological chromophores using 
diffuse reflectance spectroscopy: benefit of 
extending the UV-VIS wavelength range to 
include 1000 to 1600 nm 
 
 
 
 
 
 
 
 
 
 
 
 
Rami Nachabé 
Benno H. W. Hendriks 
Marjolein van der Voort 
Adrien E. Desjardins 
Henricus J. C. M. Sterenborg 
 
Biomed. Opt. Exp. 2011 November, 1: 1433-1442  
 66 
 
Chapter 3 
Abstract 
With an optical fiber probe, we acquired spectra from swine tissue between 500 
and 1600 nm by combining a silicon and an InGaAs spectrometer. The concentrations of 
the biological chromophores were estimated by fitting a mathematical model derived 
from diffusion theory. The advantage of our technique relative to those presented in 
previous studies is that we extended the commonly-used wavelength ranges of 500 and 
1000 nm to include the range of 1000 to 1600 nm, where additional water and lipid 
absorption features exist. Hence, a more accurate estimation of these two chromophores is 
expected when spectra are fitted between 500 and 1600 nm than between 500 and 1000 
nm. When extending the UV-VIS wavelength range, the estimated total amount of 
chromophores approached 100% of the total as present in the probed volume. The 
confidence levels of the water and lipid related parameters increases by a factor of four. 
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1. Introduction 
Diffuse optical spectroscopy (DOS) has been widely used as a tool for 
determining optical properties of tissue. Such tools are investigated as an aid for detecting 
cancers [1-4], for monitoring changes in tissue optical properties that reflect 
morphological and physiological changes [5], and for monitoring therapy response for 
instance in photodynamic therapy [6]. Several methods exist to extract optical properties 
of tissue-like diffuse media such as time-resolved [7-8], frequency-domain [9], spatially-
resolved continuous wave [10-11], combined frequency-domain and continuous wave 
broadband diffuse optical spectroscopy [3], and empirical models based on Monte-Carlo 
simulations and experimental phantoms of known optical properties [5, 12-13]. 
Most of the studies [2, 14-19] focused on the estimation of chromophore 
concentrations in the ultraviolet and visible wavelength range (typically between 350 and 
800 nm) where deoxygenated and oxygenated hemoglobin are the main optical absorbers. 
Measurements in breast [2, 14-15] or on the skin [16] showed absorption from additional 
chromophores such as beta-carotene and melanin, respectively. Several studies used 
wavelength ranges extended up to 1000 nm [3, 17-18] in order to determine 
concentrations of water and lipid, which have distinct absorption peaks at 972 and 930 
nm, respectively [18-19]. These studies [3, 17-19] used probes with fiber separations up 
to 1.7 cm. For probes with much shorter separation between the collecting and emitting 
fibers, the absorption dips in the reflectance due to lipid and water will also be much 
smaller since the transmitted light decays exponentially with the path length and the 
absorption coefficient (Beer‟s law). Thus, measurements of water and lipid content in this 
wavelength region using photon pathlengths of a few mm only will not be very accurate. 
Extending the commonly used wavelength range of 500 to 1000 nm up to 1600 nm 
enables the measurement of additional absorption peaks of water and lipid with 
absorption values that are an order of magnitude higher than those in the lower 
wavelength region. Although not extensively reported, not constraining the fitting 
parameters [17] often leads to an estimated summed volume of chromophores 
significantly different from a total of 100%. This could either mean that there is a 
biological entity within the probed volume that does not have optical absorption peaks 
(e.g. melanin) or that the model requires modifications. The present paper aims to 
investigate if the use of this extended wavelength region increases the accuracy of the 
measurement without constraining any of the fit parameters. 
The applicability of an analytical solution that derives from diffusion theory to 
determine the optical properties was extensively studied and validated for wavelength 
ranges below 1000 nm [10-11]. In a former study [20], the absorption coefficients of 
water and lipid between 900 and 1600 nm (I9001600) were measured and the applicability 
of the diffusion theory model to this wavelength range was validated for phantom 
measurements with known amounts of water and lipid. 
To investigate whether having an additional spectrometer that can measure in the 
infrared up to 1600 nm can effectively improve the estimation of water and lipid 
concentrations, we compared the values of the parameters derived from the fits applied 
for two different wavelength ranges: the classical range from 500 to 1000 nm (I5001000) 
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and the extended range from 500 to 1600 nm (I5001600). Measurements on in vivo swine 
tissues were performed with combined silicon and InGaAs spectrometers and were 
analyzed by fitting an analytical model to the two wavelength ranges of interest. In order 
to assess the improvements to the fits when adding the InGaAs spectrometer, we 
compared the confidence intervals [21] of the estimated parameters obtained from both 
fits. 
 
2. Methods 
2.1 Instrumentation 
A schematic diagram of the setup is shown in Fig. 1. The setup consists of an 
optical probe with three optical fibers with a NA of 0.22, a spectrometer with a silicon 
detector (Andor Technology, DU420A-BRDD), a spectrometer with an InGaAs detector 
(Andor Technology, DU492A-1.7) and a tungsten halogen broadband light source with an 
integrated shutter (Ocean Optics, HL-2000-HP). The optical probe has a diameter of 1.3 
mm and its distal end is polished at an angle of 20 degrees in order to ease its insertion in 
the animals. The probe contains three 200 μm core diameter optical fibers with axis of 
symmetry parallel to the axis of symmetry of the probe. One optical fiber is connected to 
a light source. The second and third optical fibers are connected to the spectrometer with 
a silicon detector and the spectrometer with an InGaAs detector, respectively. The silicon 
detector is a matrix of 1024 by 255 pixels with pixel size of 26x26 microns whereas the 
InGaAs detector is a single array of 512 pixels with a pixel size of 500x50 microns. The 
spectral resolution for the silicon and InGaAs detectors are 4 and 10 nm, respectively. At 
the tip of the probe, the three optical fibers distal ends form an isosceles triangle in such a 
way that both collecting fibers were embedded side by side with a center-to-center 
distance of 370 microns and separated by a distance of 2.48 mm from the emitting fiber. 
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Figure 1. Sketch of the optical setup: it consists of a halogen lamp that is connected to a 
fiber and two spectrometers that are connected to two separate fibers that are located 
next to each other at the tip of the probe. 
 
2.2 Data acquisition and pre-processing 
The calibration and the generation of the spectra acquired with the InGaAs 
spectrometer was described elsewhere [20]. Briefly, the calibration procedure consisted of 
assigning a wavelength value to each pixel of the detector, then measuring a white 
reflectance standard to compensate for the spectral shape of the light emitted by the lamp 
and the wavelength-dependant sensitivity of the detector and the optics in the grating of 
the system; and a background measurement to compensate for the dark current and 
electric offsets of the detector. The tissue spectra are computed by dividing the measured 
spectra in tissue corrected for background by the calibration measurement of the white 
reflectance standard. We applied the same process for the spectra acquired with the 
silicon spectrometer. The spectra obtained from both spectrometers have an overlapping 
wavelength range between 900 and 1000 nm which was used to compute the matching 
factor to form continuous spectra from 500 and 1600 nm. For all the acquired spectra, the 
matching factor should be ideally equal to one but is on average 0.9±0.3. This is due to 
the fact that the light is collected via two separate fibers and in an inhomogeneous 
medium there might be a sampling error. To avoid this artifact, one single fiber should be 
connected to a fiber splitter in order to collect the light from the same sampling volume. 
However, using a fiber splitter will reduce the light transmission by more than 50% and 
thus longer integration times might be needed to achieve a good signal-to-noise ratio 
making real-time feedback impossible. 
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2.3 Tissue measurements 
Measurements were performed on three anaesthetized swine after approval from 
the internal review board of the animal lab facility. The swine were originally dedicated 
for a different clinical study; however we were allowed to perform our measurements. 
Spectra were taken at different locations within the animals, where the position of the tip 
of the optical probe was confirmed by X-ray or ultrasound imaging. Tissue boundaries 
were avoided in order to measure in volumes as homogenous as possible. 
The integration time for a single spectrum acquisition ranges from a quarter of a 
second to two seconds but most spectra were acquired with an integration time of one 
second yielding to a signal-to-noise ratio of 200:1 and 120:1 for the Silicon and InGaAs 
detector, respectively. However, all measurements on the white reflectance standard for 
calibration were made with an integration time of two seconds. For both spectrometers, 
the integration time was kept the same. In total, we obtained 296 spectra including 143 
measurements on various fatty layer structures (from which 56 subcutaneous fat in the 
back of the pig and 87 visceral fat in the epidural space) and 153 muscle measurements in 
the back of the three animals. 
 
2.4 Analytical model 
The acquired spectra were fitted with the analytical model developed by Farrell et 
al. [10] which has the absorption coefficient  aμ λ  and the reduced scattering coefficient
 ,sμ λ , in cm
-1
, as input arguments. In a previous work [20], this model was described and 
used to estimate water and lipid concentration and its validity was shown in the 900-1600 
nm wavelength range. 
A double power law function was used to describe the wavelength dependence of 
the reduced scattering (cf. Eq. (1)). The first law corresponds to the contribution of Mie 
scattering [22-24] whereas the second power law corresponds to the contribution of 
Rayleigh scattering which can be significant in the visible wavelength range [25]. The 
reduced scattering is expressed in cm
-1
 and is a function of wavelength: 
 
   
-b -4
,
s MR MR
0 0
λ λ
μ λ =a ρ + 1-ρ .
λ λ
    
         
    (1) 
 
In Eq. (1), 0 is a normalization wavelength set to 800 nm and the parameter a
corresponds to the reduced scattering amplitude at this specific wavelength. The reduced 
scattering corresponds to the sum of Mie and Rayleigh scattering and, therefore, MR  is 
defined as the Mie-to-Rayleigh fraction of the scattering. The reduced scattering slope of 
the Mie scattering is denoted b  and is related to the particle size [26]. 
The main chromophores that absorb in the visible and near infrared are 
hemoglobin derivatives in the blood (deoxy-hemoglobin and oxy-hemoglobin) [27, 28], 
water and lipid [18, 20, 29]. Instead of modeling the absorption coefficient  aμ λ  as the 
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sum of absorption coefficients weighted by the respective concentrations of the four 
chromophores of interest, we decided to express the absorption coefficient as: 
 
            Blood Water Lipida BL a WL WL a WL aμ λ =C λ ν μ λ +ν 1-α μ λ +α μ λ .     (2) 
 
The absorption coefficients of hemoglobin in blood, water and lipid are  Bloodaμ λ , 
 Wateraμ λ  and  
Lipid
aμ λ , respectively; and are depicted in Fig. 2. The absorption 
coefficient of blood is multiplied by the blood volume fraction    BL 2ν = Hb + HbO , 
where  Hb  and  2HbO  correspond to the concentration of deoxygenated and 
oxygenated hemoglobin, respectively;  and a correction factor  C λ  that accounts for the 
effect of pigment packaging [30] and alters for the shape of the absorption spectrum. The 
correction factor is given by 
 
 
  
 
Blood
a
Blood
a
1-exp -2Rμ λ
C λ =
2Rμ λ
     (3) 
 
where R  corresponds to the effective vessel radius. The absorption coefficient of 
hemoglobin in blood is given by 
 
       2HbOBlood Hba BL a BL aμ λ =α μ λ + 1-α μ λ .     (4) 
 
Here  2HbOaμ λ  and  
Hb
aμ λ  represent the basics extinction coefficient spectra of 
oxygenated and deoxygenated hemoglobin, respectively, assuming a blood hemoglobin 
content of 150 g/l (typical value for human blood). The oxygenated hemoglobin fraction 
in the total amount of hemoglobin is noted       BL 2 2α = HbO HbO + Hb and is 
commonly known as the blood oxygen saturation. Similarly    WL 2ν = H O + Lipid  and 
      WL 2α = Lipid Lipid + H O  where  Lipid  and  2H O  correspond to the 
concentration of lipid (density of 0.86g/ml) and water, respectively. They correspond to 
the total amount of water and lipid in the probed volume and the lipid fraction within this 
volume, respectively. This way of relating the water and lipid parameters in the 
expression of the absorption coefficient defined in Eq. (2) rather than estimating 
separately the water and lipid volume fraction corresponds to a minimization of the 
covariance of the basis functions for fitting resulting in a more stable fit.  
From the acquired spectra we derive eight parameters: a , b , MRρ , R , BLν , BLα , 
WLν  and WLα . Hence three parameters define the reduced scattering coefficient, and five 
components the absorption coefficient, from which three are related to blood and the two 
other to water and lipid. Although not commonly used when fitting beyond 500 nm, a 
Rayleigh scattering term and the correction factor for pigment packaging were used [17]. 
According to an F-test with p<0.001 [31], the fit is improved for 64% and 89% of the data 
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when considering Rayleigh scattering and the pigment packaging factor in the model, 
respectively. The spectra were fitted over the 500-1000 nm and 500-1600 nm wavelength 
ranges using a non constrained nonlinear least-squares Levenberg-Marquardt fitting 
algorithm. The confidence intervals on the estimated parameters at a confidence level of 
99% were assessed from the square roots of the diagonal elements of the covariance 
matrix [21]. 
 
 
Figure 2. Absorption coefficient of deoxygenated hemoglobin (full line), oxygenated 
hemoglobin (dashed line), water (dotted line) and lipid (dashed-dotted line) from 500 to 
1600 nm. 
 
A detailed study on the validation and calibration of the model in the 900-1600 
nm wavelength range was described in Ref. 20 based on phantom experiments. Given the 
extensive literature descriptions of the model validation in the 500-1000 nm wavelength 
range [10-11], only a validation comparable to the one in Ref. 10 was performed to make 
sure that the model estimates the correct blood volume faction with our setup. A set of 
phantoms that consist of human blood diluted in a scattering solution (80 mg of oil-free 
scattering powder in PBS) were prepared to obtain blood volume fractions of 0.5, 1, 5 and 
10% of a total phantom volume of 10 ml for each dilution. As soon as the blood was 
extracted from the subject, a blood oxygen saturation of 98.9% was measured with a 
blood gas analyzer (RapidPoint 405) before the preparation of the phantoms. When 
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comparing the estimated blood volume fractions with the actual values, a linear 
regression of equation y=0.97x-0.01 was obtained (R
2
=0.993). A blood oxygen saturation 
of 96.1±2.3% was estimated which is in good agreement with the value estimated by the 
blood gas analyzer. 
 
3. Results and discussion 
Fig. 3 shows typical diffuse optical spectra measured on a muscle and a fat layer 
respectively with the corresponding fit over I5001600. Moreover, it also shows the 
residual. 
 
 
Figure 3. Typical measurement of muscle and fat layer (dotted line), and the 
corresponding fits and residuals between 500 and 1600 nm (full line). 
 
When measuring with a silicon spectrometer, it is possible to estimate the amount 
of water and lipid due to the absorption peaks of these two chromophores that exist in the 
900 to 1000 nm wavelength range. However it is interesting to investigate whether any 
advantages arise from adding an InGaAs spectrometer to accurately estimate the amount 
of water and lipid. Table 1 summarizes the average values that are estimated from fitting 
at I5001000 (Fit 1) and I5001600 (Fit 2) and their respective average confidence intervals. It 
is clear from Table 1 that the total amount of chromophores (i.e. BLν + WLν ) is closer to 
100% when the fit is applied over I5001600. As a matter of comparison, there is a 
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significant difference (t-test, p<0.05) from a 100% total amount of chromophores for 67% 
of the spectra fitted over I5001000 and only 28% when fitted over I5001600. 
Among the 28% of the spectra for which the t otal amount of chromophores is 
statistically different from 100%, a few spectra gave numbers statistically higher than 
100% when fitting between 500 and 1600 nm. A number of effects might be the cause of 
this. The temperature of the animals decreased during the measurement sessions thus the 
water temperature in the body decreased. Therefore, the absorption coefficient of water 
which is temperature dependant need to be adapted in the fitting [20]. Moreover the type 
of lipid that is used in the fit is from beef fat and not from swine. As lipid is composed of 
different types of fat such as unsaturated, monosaturated and polysaturated fat; the beef 
fat can be chemically different from swine fat. This difference in fat provides differences 
in absorption coefficient of lipid [20]. As it can be seen in the residual curve of the fat 
layer measurement in Fig. 3, the largest deviations are around 1100 and 1200 nm where 
the main difference in absorption values of fat exists as presented in Fig. 8 of reference 
20. 
 
Table 1. Average estimated parameters and  corresponding average confidence intervals 
for fat layers and muscle as derived from fitting over I5001000 (Fit 1) and I5001600 (Fit 2). 
 Fat layers (n=143)  Muscle (n=153) 
Parameters 
Fit 1 
500-1000 
Fit 2 
500-1600 
 
Fit 1 
500-1000 
Fit 2 
500-1600 
a  (cm
-1
) 5.2±1.7 6.3±0.7  4.0±1.0 4.6±0.4 
b  0.7±0.3 0.8±0.1  0.7±0.3 0.6±0.1 
MR  (%) 98±8 98±6  93±10 87±6 
R  (μm) 23±9 15±5  27±8 19±4 
BL  (%)
(*)
 1.0±0.3 0.8±0.1  2.4±0.6 2.0±0.2 
BL  (%) 21±5 21±7  27±5 25±5 
WL  (%)
(*) 
112±30 95±5  114±42 89±5 
WL  (%) 60±5 68±1  10±13 18±3 
(*)
Significant difference from 100% of the sum with p<0.05 for 67% of all the spectra 
when Fit 1 is applied and 28% of the spectra when Fit 2 is applied. 
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Figure 4. Estimated water and lipid volume fraction (dots) when fitting between 500 and 
1000 nm versus 500 and 1000 nm and the respective mean and standard deviation. 
 
Figure 5 shows in a log-log scale for each of the parameters BLν , BLα , WLν  and 
WLα  the comparison of the confidence intervals for the two wavelength ranges of interest. 
Computing the average of the ratio of the confidence intervals obtained for both fits 
shows that extending the wavelength range up to 1600 nm narrows the confidence 
intervals of the water and lipid related parameters on average by a factor of four and the 
total blood volume fraction of a factor of two whereas no improvements are seen for the 
blood saturation levels. 
A Spearman‟s rank correlation test [17] is performed to assess the correlation 
between the values obtained for the two different wavelength ranges. Such a test 
determines whether strong correlation exists between the estimated parameters for both 
wavelength ranges. However, there could be high correlation despite a different 
dispersion (statistical variability) of the values and therefore a statistical test is required to 
determine whether the standard deviations of the estimated values are of the same order 
for both fits. The Levene‟s test [32] was applied to investigate whether there are 
significant differences between the dispersion of the estimated parameters from both fits. 
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Figure 5. Comparison of confidence intervals obtained when fit is applied between 500 
and 1000 nm and 500 and 1600 nm of the blood volume fraction (stars), blood saturation 
(circles), water and lipid volume fraction (crosses) and lipid fraction in the total volume 
(squares). 
 
Table 2 provides the Spearman‟s rank correlation coefficient for each parameter 
and indicates which parameters have significant differences with respect to the values and 
the dispersion of the values based on the analysis of variance and Levene‟s tests. The 
confidence intervals of the Spearman‟s correlation coefficients were computed by using a 
Fisher‟s z-transformation [32] with p<0.05. From Table 2, it is clear that adding the 900-
1600 nm data induces statistical differences for WLν  and WLα . One can notice that the 
lipid fraction parameter is the only parameter that does show significant difference in 
values but not in dispersion. As seen in Table 1, the lipid fraction estimated over I5001000 
is smaller than when fitting over I5001600. However the values do vary between 0 and 
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100% and therefore there is a non-significant difference in the dispersion of the estimated 
value for this parameter. From Table 2, the Spearman‟s correlation factors are considered 
to be high (above 0.8) except for the scattering related parameter and the water and lipid 
volume fraction. 
Although there is a significant difference in the reduced scattering amplitude 
values a  for both fits, their correlation factor is only as high as 0.75 and not more. It is 
thus interesting to know the cause of this effect. For this purpose, a t-test was performed 
for all the estimated values of reduced scattering to know which data points give 
significant differences with p<0.05. Fig. 6.a. depicts the data points for which there is no 
significant difference in the estimated reduced scattering amplitude values for both fits 
(blue stars) and those for which there is difference (red diamonds) according to the t-test. 
 
Table 2. Spearman’s correlation rank for each estimated parameter and parameters that 
show significant differences in value and dispersion. 
Parameters 
Spearman‟s correlation 
factor of the estimated 
values 
Significant difference 
of the estimated 
parameters values with 
p<0.05 for the analysis 
of variance test 
Significant difference 
of the dispersion of the 
estimated parameters 
with p<0.05 for the 
Levene‟s test 
a  (cm
-1
)
 0.75±0.05 + + 
b  0.22±0.10 - - 
MR  (%)
 
0.55±0.08 + + 
R  (μm)  0.82±0.03 - - 
BL  (%) 0.81±0.04 - - 
BL  (%) 0.87±0.02 - - 
WL  (%) 0.50±0.09 + + 
WL  (%) 0.90±0.02 + - 
 
From Fig. 6.a, it can be seen that the values which are different all have low 
reduced scattering amplitudes. By plotting the corresponding water and lipid volume 
fractions that were estimated (cf. Fig. 6.b.), we observe that the values that show 
significant differences in the reduced scattering amplitudes mainly corresponds to the 
spectra for which WL  was estimated to be larger than 100% when the fit is applied 
between 500 and 1000 nm. When fitting up to 1600 nm, the estimated WL  for these 
spectra approaches 100% and the reduced scattering amplitude becomes higher. Thus 
when the reduced scattering amplitude of the measured tissues is low (i.e. smaller than the 
inverse of the fiber distance separation of 5cm
-1
), its covariance with WL  is high which 
leads to an incorrect estimation of the latter parameter. Besides, a change in the estimated 
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reduced scattering amplitudes also induces a change in the estimation of the blood 
volume fraction (cf. Fig. 6.c.). The amount of blood is overestimated when fitting over 
the 500 to 1000 nm wavelength range in case of low reduced scattering samples. 
Otherwise, the blood volume fraction values are not altered whilst the amount of water 
and lipid volume fraction is improved. 
By fitting up to 1600 nm where additional absorption features of water and lipid 
exist, the covariance with the reduced scattering as defined in Eq. (1) is smaller and still 
allows for a reliable fit when the reduced scattering coefficient is low. In case the fit is 
performed between 500 and 1000 nm, for small reduced scattering values, the scattering 
is underestimated whereas the absorption due to water, lipid and blood is overestimated. 
 
 
Figure  6. Comparison of the estimated reduced scattering amplitude when fit is applied 
between 500 and 1000 nm (Fit 1) and 500 and 1600 nm (Fit 2) where the circles 
correspond to no statistical difference in absolute values and the crosses with statistical 
differences (a). The corresponding water and lipid volume fractions shows larger 
deviation from 100% when Fit 1 is applied (b). The corresponding blood volume fraction 
shows overestimations of the values when Fit 1 is applied (c). 
 
4. Conclusion 
We have presented a comparison on the estimation of the absorption and reduced 
scattering related parameters when fits are applied to spectra measured in the commonly 
used wavelength range of 500 to 1000 nm acquired with a  silicon detector and the 
wavelength range of 500 to 1600 nm obtained when adding an InGaAs spectrometer. The 
fitting procedure was deliberately performed without constraining the values. Judging on 
the confidence intervals computed for each estimated parameter, having an additional 
spectrometer to measure up to 1600 nm provides up to four time higher confidence on the 
estimation of the water and lipid related parameters due to the presence of additional 
absorption features above 1000 nm. The blood volume fraction showed a factor of two 
improvement in the confidence intervals when fitting up to 1600 nm. The covariance 
between the reduced scattering amplitude and the water and lipid volume fraction is high 
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for low reduced scattering amplitudes leading to errors in the estimation of absorbers if 
the fit is applied between 500 and 1000 nm.  
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Abstract 
Objectives: To validate near infra-red (NIR) based optical spectroscopy 
measurements of hepatic fat content using a minimally invasive needle-like probe with 
integrated optical fibers enabling real-time feedback during percutaneous interventions. 
The results were compared with magnetic resonance spectroscopy (MRS) as validation 
and with histopathology, being the clinical golden standard. Additionally, ex vivo magic 
angle spinning nuclear magnetic resonance (MAS-NMR) spectroscopy and high 
performance thin layer chromatography (HPTLC) were performed for comparison. 
Materials and Methods: Ten mice were used for the study of which half received 
a regular chow diet and the other half a high fat diet to induce obesity and hepatosteatosis. 
The mice were imaged with a clinical 3-Tesla MR to select a region of interest (ROI) 
within the right and left lobes of the liver, where MRS measurements were acquired in 
vivo. Subsequently, optical spectra were measured ex vivo at the surface of the liver at six 
different positions immediately after resection. Additionally, hepatic fat was determined 
by MAS-NMR spectroscopy and HPTLC. Histopathologic analyses were performed and 
used as the reference standard. Pearson‟s correlation and linear regression analysis were 
done to assess the correlation of the various techniques with NIR. A one-way analysis of 
variance including post hoc Tukey‟s multiple comparison tests were used to study the 
difference in fat estimation between the various techniques. 
Results: For both of the mice groups, the estimated fat fractions by the various 
techniques were significantly similar, P = 0.072 and 0.627 for chow diet and high fat diet 
group, respectively. The Pearson‟s correlation value between NIR and the other 
techniques for fat determination showed the same strong linear correlation (P above 
0.990, P < 0.001); whereas for histopathology which is a rather qualitative measure, the 
Pearson‟s correlation value was slightly lower (P = 0.925, P < 0.001). Linear regression 
coefficient computed to compare NIR to the other techniques resulted in values close to 
unity with MRS having the narrowest confidence interval (CI) (r = 0.935, 95% CI: 
[0.860–1.009]) demonstrating highly correlating results between NIR and MRS. 
Conclusions: NIR spectroscopy measurements from a needle-like probe with 
integrated optical fibers for sensing at the tip of the needle can quickly and accurately 
determine hepatic fat content during an interventional procedure and might therefore be a 
promising novel diagnosing tool in the clinic. 
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1. Introduction 
Hepatic steatosis as the most prevalent liver disorder is found in a broad spectrum 
of disease. It is characterized by an excessive accumulation of triglycerides in the 
cytoplasm of the hepatocytes, being the key histological feature. Besides alcoholic liver 
disease, the intrahepatic accumulation of lipids may also be associated with non-alcoholic 
fatty liver disease (NAFLD), a feature not only encompassing the rather benign 
hepatosteatosis, but also the more severe non-alcoholic steatohepatitis, which may lead to 
irreversible liver cirrhosis and hepatic failure. NAFLD is strongly associated with obesity, 
insulin resistance and hyperlipidemia, features of the metabolic syndrome.
1
 As obesity 
and the metabolic syndrome are globally gaining prevalence in pandemic proportions, 
NAFLD may become a major disorder and should be detected in the early reversible 
stage.  
Currently, the golden standard to determine intrahepatic fat is histological analysis 
of samples obtained from a liver biopsy, which might be prone to inter-observer variance
2
 
and to sampling errors.
3
 Though, the invasiveness is its major drawback. Ultrasound (US) 
is a non-invasive technique that is the most widely used to detect fatty infiltration in liver 
by comparing the echogenicity in the liver and fat free organs such as the kidney cortex or 
spleen.
4
 However, this technique is not quantitative, prone to inter-observer variance and 
not optimal in presence of morbid obesity. Another method is based on computer 
tomography (CT) imaging where the Hounsfield attenuation values in liver and spleen are 
compared knowing that fat has a lower X-ray absorption than water and blood.
5
 Similarly 
to US, it is difficult to obtain accurate quantification of fat from CT images especially in 
the less severe cases of steatosis. Moreover, its ionizing radiation limits its use, 
particularly in children. Magnetic Resonance Imaging (MRI) is a widely used technique 
to estimate fat in liver by using commercially available algorithms such as in-
phase/opposed-phase, the Dixon method
6
 and its additional refinements
7
 to quantify fat 
fractions in liver. However, these techniques are sensitive to field inhomogeneity which 
potentially yield large errors on the estimation of fat.
8
 Nevertheless, a recent study 
conducted by Kühn et al. demonstrated that T2
*
-corrected Dixon MRI for estimating 
hepatic fat content showed excellent correlation with liver biopsy without being limited 
by liver iron content and fibrosis or cirrhosis.
9
 Magnetic resonance spectroscopy (MRS) 
enables measurements of water and fat proton signals and is generally considered as the 
most accurate non-invasive technique for hepatic fat quantification.
10
 Still, MRS remains 
a research tool for clinical studies and is not yet used in daily routine liver examinations. 
Optical spectroscopy measurements acquired with needle-like optical probes is a 
relatively new technique that is being developed over the last decade to estimate blood 
volume fractions and saturation in oxygen in the tissue by analyzing the spectra in the 
visible and near infra-red wavelengths range between 400 and 900 nm.
11-13
 We recently 
developed an optical setup and needles with integrated optical fibers that allows spectral 
measurements in the infra-red wavelengths range up to 1600 nm where fat and water 
absorption bands exist that enable accurate fraction estimation of these substances in 
addition to blood.
14
 The advantage of using such a broad wavelength range is that the 
error on the estimated fat fractions is below 3%.
15
 A thorough study was performed in 
order to evaluate the accuracy and the reliability of the fat fraction estimation in phantoms 
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with a wide range of known fat content.
14
 In addition to light absorption caused by the 
various biological chromophores, the light scattering in tissue correlated to the cellular 
structure and morphology is estimated as well. Recently, we have published a study 
discriminating tumors from healthy human liver tissue based on the difference in light 
scattering and the amount of bile in the liver estimated using a similar model as in the 
present study.
16
 Compared to our previous studies
14-16
, we extended the infra-red 
wavelength range of measurement from 1600 to 1800 nm where additional fat and water 
absorption bands exist; enabling higher accuracy in quantification of these biological 
chromophores.  
Fatty liver disease requires diagnostic tools that can accurately estimate hepatic fat 
given the fact that it is positively diagnosed by histopathology for lipid accumulation as 
low as 5%.
17
 Therefore, the goal of the study is to perform a validation of the NIR 
technique with MRS by estimating fat in the liver of two groups of mice under different 
dietary conditions. One group of mice was subjected to a regular chow diet, considered as 
healthy controls, whereas the second was subjected to a high fat diet inducing obesity and 
hepatosteatosis. Besides, ex vivo histopathology, the clinical golden standard, was 
performed for comparison as well as two other ex vivo techniques being magic angle 
spinning nuclear magnetic resonance (MAS-NMR)
18-22
 and high performance thin layer 
chromatography (HPTLC). 
 
2. Materials and methods 
2.1. Animal model and measurement protocol 
Ten male heterozygous APOE*3Leiden.CETP (cholesteryl ester transfer protein) 
transgenic mice,
23
 8-10 weeks of age, were matched on their body weight into a healthy 
control group, which received a regular chow diet (n = 5) or to a diet induced obese group 
(n = 5), supplemented a high fat diet containing 32% (w/w) lard (60 %kcal fat, D12492 
Research Diets, NJ, USA). The mice remained on the dedicated diets for 16 weeks, 
resulting in obesity in the high fat fed group (body weight of 46.9 ± 2.2 g versus 29.0 ± 
1.0 g in the chow group). The animals received food and water ad libitum. Body weight 
and food intake were monitored bi-weekly during the study. 
The mice were anesthetized using a mixture of isoflurane (1-3%) and medical air. 
Liver fat was measured in the left and right lobe non-invasively by MRS. Subsequently, 
the mice were euthanizaed by CO2 suffocation and livers were resected and immediately 
measured with NIR spectroscopy. After the NIR spectroscopy measurements, the livers 
were dissected, divided into several pieces and stored for further ex vivo analyses.  
Animals were obtained from the SPF breeding stock at TNO Metabolic Health 
Research (Leiden the Netherlands). Animal experiments were approved by the 
Institutional Animal Care and Use Committee of The Netherlands Organization for 
Applied Research (TNO).     
 
2.2. Near Infra-Red spectroscopy 
We have recently built an optical setup that allows optical spectroscopy 
measurements of tissue to estimate physiological and morphological information such as 
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chromophores volume fractions (e.g. blood, water, lipid, bile, etc.), blood saturation in 
oxygen and light scattering due to tissue density using an optical tissue model.
14-16
 
Briefly, the setup comprises a light source (Ocean Optics, Duiven, The 
Netherlands) and two optical spectrometers (Ocean Optics, Duiven, The Netherlands) that 
resolve light from 400 to 1200 nm and 900 to 2100 nm, respectively. A custom-made 
needle-like optical probe is connected to the light source and to both spectrometers via 
200 micrometer diameter optical fibers. 
The light that travels through the liver from the emitting to the collecting fibers is 
subject to optical absorption and scattering, properties that are related to the physiological 
and morphological properties of tissue. This tissue-light interaction is described by a 
model deriving from the diffusion theory and allows extraction of parameter of interest 
i.e. the fat fraction within the probed volume at the tip of the needle.
14-16
 A non-linear 
least squares inversion of the model is applied to fit the measurement curves with the set 
of parameters that best describes the tissue optical properties. The absorption coefficients 
of light by the various chromophores in their pure state in liver tissue (i.e. oxygenated 
hemoglobin, deoxygenated hemoglobin, bile, water and lipid) are used as a priori 
knowledge in the model to estimate the corresponding volume fractions in the total 
volume probed with the needle.
14-16 
Figure 1 depicts the absorption of light by water and lipid from 400 to 2200 nm 
that we measured as described elsewhere.
14
 Briefly, pure water and fat were inserted in 
separate cuvettes of different thickness and their optical transmission were measured with 
a 1 nm resolution high-end laboratory spectrophotograph (Perkin Elmer, Waltham, MA). 
From the transmission measurements, the absorption coefficients are computed and used 
as references for the analysis. These two chromophores have high absorption coefficients 
compared to other absorbers for wavelengths above 900 nm. Water has higher absorption 
coefficients than fat. However the fat absorption peaks at 930, 1211, 1720 and 1760 nm 
are of the same order of magnitude as the water absorption values altering the spectral 
shape of the measured spectra in case of presence of fat in the liver. The penetration depth 
depends on the optical properties of the probed tissue i.e. the absorption and reduced 
scattering coefficients. In average, it is roughly half the distance that separates the source 
and detection optical fibers. In our case the fiber separation distance is 2.5 mm yielding a 
penetration depth of approximately 1.25 mm. 
NIR spectroscopy measurements were performed on the fresh excised livers 
immediately after sacrificing the mice. The optical probe was gently put in contact with 
the surface of the liver without pricking. In principle the needle can be inserted inside the 
liver, however, surface measurements were preferred to avoid damaging of the tissue that 
can hamper ex vivo analysis for HPTLC, MAS-NMR and histopathology. In total 30 NIR 
spectra were measured at 6 different positions: in the upper-left, lower-left, central-left, 
upper-right, lower-right and central-right of the liver. 
The measurement acquisition time per spectrum is 500 ms and the analytical 
model was used to fit the measurement between 450 and 1800 nm to extract the fat 
volume fraction.
16
 The percentage of fat is calculated as percentage over water and fat 
similarly to MRS and MAS-NMR. Per mouse, the hepatic fat content was the calculated 
average of all fat fractions derived from the 30 NIR measurements of the liver.  
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Figure 1: Optical absorption coefficient of water and fat. 
 
2.3. Magnetic Resonance Imaging  
After 16 weeks of dietary intervention (either chow or high fat diet), the mice 
were anaesthetized by isoflurane inhalation and placed in a dedicated small animal setup. 
Core body temperature and respiration rate were controlled and recorded during the 
measurements. The MRI experiments were performed using a 3T Philips Achieva MR 
scanner (Philips Healthcare, Best, the Netherlands) with a Quasar dual gradient system 
(amplitude 80mT/m, slew rate 200mT/m/ms). All experiments were performed under 
software release 2.5.3. For imaging the liver and acquiring the MRS spectra, a dedicated 
whole body mouse coil (solenoid receive only, Philips Research, Hamburg, Germany) 
was used. This solenoid coil was placed perpendicular to the main magnetic field of the 
MR scanner. To position the mouse inside the MR coil, a dedicated mouse cradle 
(Equipement Vétérinaire MINERVE, Esternay, France) equipped with an anesthesia 
breathing mask and heating pad (using air) for maintaining the body temperature of the 
anesthetized mouse. The cradle with the mouse was positioned in such a way that the 
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liver of the mouse is positioned at the center of the MR coil. Figure 2 depicts from left to 
right the sagittal, transversal and coronal planes from a mouse MR image. Based on 
anatomical landmarks, a ROI of 27 mm
3
 was placed at the left and the right lobes of the 
liver for MRS measurements. 
 
 
Figure 2: Sagittal, transversal, and coronal planes from a mouse MRI image. Based on 
anatomical landmarks, a ROI of 27 mm
3
 was placed at the left and the right (shown) 
lobes of the liver for measuring a spectrum. 
 
2.4. Magnetic Resonance Spectroscopy 
All spectroscopy data were recorded with a Point RESsolved Spectroscopy 
(PRESS) sequence
24
 which is a volume selective MRS sequence based on 3 orthogonal 
selection gradients in combination with 3 RF pulses. Spoiler gradients were used to 
suppress unwanted signals. This sequence results in a spectrum from the volume defined 
by the intersection of the three slice selective profiles. 
Extra care was taken in planning of the volume in order to avoid chemical shift 
displacement errors as much as possible.  Chemical shift displacement is caused by the 
difference in chemical shift in combination with a selection gradient. As a consequence, 
the actual physical volume from which the -CH2 signals of the fat originate, will be 
different from the water volume. During planning both volumes were always shown on 
the image. Care was taken that both volumes were planned within the liver, avoiding 
major blood vessels. 
After optimization of gradient shimming, three consecutive spectra were acquired: 
(a) TR/TE = 4000 ms/31 ms, voxel size of 5x5x5 mm
3
 and without water suppression; (b) 
TR/TE = 4000 ms/31 ms, voxel size of 3x3x3 mm
3
 and without water suppression; (c) 
TR/TE = 4000 ms/31 ms, voxel size of 3x3x3 mm
3
 and with water suppression. Long TR 
was chosen for complete relaxation to ensure accurate quantifications. In principle, a 
single spectrum takes a couple of minutes however the combination of shimming and 
acquiring three consecutive spectra makes the total MRS scan time of 20 minutes. For all 
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three spectra, acquisition parameters included as well a number of signal averages of 32 
with a readout of 1024 data points over 2000 Hz spectral bandwidth. The first acquisition 
was mainly used for the shim optimization; the second acquisition was used to estimate 
the fat fractions whereas the third acquisition was used to have an improved fit of the 
CH2-signal for a more accurate quantification. 
The data were processed using jMRUI v3.0 software. After phase correction of the 
spectra, quantitative analysis was performed using the Advanced Magnetic Resonance 
(AMARES) algorithm within jMRUI.
25
 The amount of triglycerides can be quantified by 
integrating the triglyceride C(H2)n signal (1.1 - 1.3 ppm) against H2O signal. These values 
are T2-corrected since both signals have a different T2 relaxation time and thus undergo a 
different amount of signal decay at a chosen echo time. The corrected signal A0 can be 
calculated as A0=ATE/exp(-TE/T2) where ATE is the integral at the measured echo time 
and T2 is the spin-spin relation time of the H2O or the triglyceride C(H2)n signal. The T2 
values used in this study are 34 ms for H2O and 68 ms for C(H2)n taken from literature.
26
 
The lipid-percentage FMRS is calculated as FMRS=100.A0-triglyceride/( A0-triglyceride+A0-water) 
with A0-triglyceride and A0-water corresponding to the corrected integral of the C(H2)n and H2O 
signals, respectively.
27 
 
2.5. HR-MAS 1H-NMR spectroscopy description to estimate fat in liver 
After isolation of the whole liver, a piece of the left lobe was snap frozen in liquid 
nitrogen and stored below -70°C until the measurements by HR-MAS NMR. Shortly 
before the measurements, approximately 6 mg of frozen tissue was excised from the liver 
near the site that was previously selected for the in-vivo localized magnetic-resonance 
spectroscopy. The frozen tissue was rapidly transferred into a cooled zirconia 12 L HR-
MAS NMR rotor (CortecNet, product code HZ05537). Subsequently, 8 L of cooled 
99.95% D2O was added to the tissue, a Kel-F spherical spacer (CortecNet, product code 
H8548) was inserted to restrict the sample volume to 12 L,21 the excess of D2O was 
removed, and the rotor was sealed with a Kel-F cap (CortecNet, product code H6304). 
HR-MAS 
1
H-NMR spectra were acquired on a Bruker AVANCE 600MHz NMR 
(Rheinstetten, Germany) spectrometer equipped with a Bruker 4mm 
1
H/
13
C HR-MAS 
probe at a spinning speed of 6000 Hz. The magnetic-field homogeneity was optimized by 
minimizing the line width of the H2O resonance. The Free Induction Decay (FDI) 
sequence had the following parameters: number of averages is 64; spectral bandwidth of 
24 kHz; number of data points is 64k; and a repetition time of 5 s. After apodization with 
a 0.1 Hz exponential window function and Fourier transform, the NMR signals of H2O 
and the fatty-acid CH3 group were manually selected and quantified using the Bruker 
TOPSPIN NMR software package. 
 
2.6. HPTLC measurements to determine hepatic fat 
After isolation of the whole liver, a piece of the left and right lobe were snap 
frozen in liquid nitrogen and stored below -70°C until the measurements of lipids by 
HPTLC as described previously.
28
 In short the liver pieces were homogenized in PBS 
(phosphate-buffered saline). Protein content of all samples was determined and 
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subsequently lipids were extracted. Briefly, a solution of 200 μg protein in 800 μL of 
MilliQ was mixed with 3 ml Methanol/Chloroform (2:1), after which 500 μL Chloroform, 
100 μL Internal Standard and 1 mL MilliQ water was added. All were mixed and 
centrifuged for 10 min at 300 rpm. After the centrifugation the chloroform layer was 
collected and dried under nitrogen. The pellets were dissolved in 50 μL chloroform and 
transferred to a HPTLC plate for separation of triacylglycerols (TG), free cholesterol (FC) 
and cholesterol esters (CE). The lipids were separated using HPTLC on silica gel plates 
and subsequent analysis was performed by TINA 2.09 software (Rayest Isotopen 
Meβgeräte GmbH, Straubenhardt, Germany). The hepatic fat content was calculated as 
mg TG/ mg protein from two samples per mouse. 
 
2.7. Histopathology to determine hepatosteatosis 
After isolation of the whole liver, a piece of the left lobe was formalin fixed and 
embedded in paraffin. Microscopic sections (5 μm thick) were used for histological 
analysis. Sections were stained with haematoxylin-phloxine-saffron. Hepatosteatosis was 
determined by the amount of hepatocellular microvacuolisation around the central vene 
(centrilobular). The severity was defined by estimating the percentage of affected cells: 1- 
Very slight (<5%), 2- Slight (5-50%) and 3- Moderate (>50%). The livers from the chow 
diet group were considered as the healthy reference and therefore this method might be 
considered semi-quantitative. For statistical analyses the estimated percentages of 
affected cells were used. All analyses were performed by one toxicological pathologist. 
 
2.8. Statistical analysis 
All the data obtained by each technique can be described by a normal distribution 
according to the Jarque-Bera test for normality.
29
 Therefore, the estimated fat fractions 
are described as mean ± SD. 
A one-way analysis of variance combined with a post hoc Tukey‟s procedure for 
multiple comparison correction was applied to evaluate whether a technique gives 
significant differences from the others.  
Pairwise comparisons of the determined fat fraction by NIR with the different 
techniques were assessed using Pearson‟s correlation analysis. The Pearson‟s correlation 
coefficient provides an indication on the linearity of the estimated fat with NIR with 
respect to the values estimated by another technique. 
Pairwise robust linear regression fits were performed to evaluate the relation in fat 
estimation between NIR and each of the other techniques. For each mouse, a mean and a 
standard deviation fat fraction value are computed from all the estimated fat fractions 
measured at the different positions within a single mouse. The SD values were taken as 
weighting factor in the robust linear regression fit. A linear regression coefficient close to 
unity would mean that NIR gives similar values than the technique for which it is 
compared. For each linear regression coefficient, a 95% CI was computed. The data are 
displayed as scatter plots including bars that represent SDs within each mouse along with 
their linear fits and corresponding 95% confidence bounds. 
Histopathological results may be considered rather qualitative than quantitative as 
the chow group was defined as the healthy reference, with a disease score of „0‟. 
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Therefore these are slightly different from each of the other techniques results and thus 
not included neither in the one-way analysis of variance test for the comparisons of means 
nor in the pairwise robust linear regression computational procedure. 
 
3. Results 
Sixteen weeks of high fat feeding clearly induced hepatosteatosis as compared to 
the chow diet as determined by NIR, MRS, MAS-NMR and HPTLC and as confirmed by 
histopathologic analysis. Indeed, for each of the methods, applying a one-way analysis of 
variance test to the determined fat fraction values showed that there is a significant 
difference between both groups of mice (P < 0.002). 
 
 
Figure 3: Representative spectra from (A) NIR, (B) MRS, and (C) MAS-NMR 
measurements of a mouse liver under chow diet (left) and high fat diet (right) conditions. 
The arrows indicate wavelengths and frequencies corresponding to fat signatures in the 
spectra. 
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Figure 3A depicts NIR spectra of a liver from a chow diet and a high fat diet 
mouse, respectively. Light absorption below 900 nm is mainly due to the presence of 
blood-derived chromophores such as oxygenated hemoglobin and deoxygenated 
hemoglobin, and bile;
16
 whereas absorption above 900 nm is mainly due to water and fat 
in the tissue.
14
 Besides, examples of MRS (Figure 3B) and MAS-NMR (Figure 3C) 
spectra acquired in a mouse under chow diet and a mouse under high fat diet are 
displayed, respectively. The peaks at a chemical shift of 4.7 ppm correspond to presence 
of water whereas the peaks at a chemical shift of 1.3 ppm to triglycerides fatty acids. The 
arrows in Figure 3 indicate the wavelengths and frequencies for which fat signature exist. 
Representative histologic pictures from a liver from the chow diet group and from the 
high fat diet group are presented in Figure 4. 
 
 
Figure 4: Representative histologic pictures from mouse livers after chow diet (top) and 
high fat diet (bottom) at different magnifications (left 40x and right panel 400x). As 
compared to the chow diet, livers from the high fat diet show histolofical features of 
hepatosteatosis, evidenced by lipid accumulation in the hepatocytes. Asterisk denotes 
adipose cells. 
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Quantitative fat estimation in the liver using the various techniques were 
statistically compared and found not different (Table 1). The P-value for the chow diet 
and high fat diet category are 0.072 and 0.627, respectively; therefore none of the 
methods showed significant difference from another method for hepatic fat quantification 
for any of the mice groups. With respect to the chow diet group, NIR and MRS showed 
the same average fat fraction within a difference of 0.4 percent point whereas a difference 
of 2.7 and 1.1 percent point was observed with MAS-NMR and HPTLC, respectively. 
However, no statistically significant difference was obtained according to Tukey‟s post 
hoc test. The different techniques to measure hepatic fat in the high fat group were very 
similar. 
 
TABLE 1. Mean and standard deviation of the estimated fat in each mice group by the 
different techniques 
  
Fat (%) estimated by the various techniques 
(mean ± SD) 
  
Group  NIR MRS 
MAS-
NMR 
HPTLC  P -value
* 
Chow diet  4.5 ± 2.2 4.1 ± 1.4 7.2 ± 1.8 5.6 ± 1.0  0.072 
High fat diet  23.6 ± 7.3 25.6 ± 9.3 20.2 ± 4.0 26.5 ± 7.3  0.627 
*
Computed with a multiple group one-way analysis of variance test. No significant 
differences observed between any pairwise comparison of the techniques after Tukey‟s 
post hoc multiple comparison tests. 
 
After comparing the results on group level of the various methods, we calculated 
the correlations between the results obtained with the NIR technique and each of the other 
techniques. Table 2 summarizes the Pearson‟s correlation coefficients with corresponding 
CI applied to the data from NIR spectroscopy and the other techniques. NIR showed very 
high correlation with Pearson‟s coefficient P above 0.990 (P < 0.001) with all other 
techniques. Histopathology as semi-quantitative analysis demonstrated a lower value (P = 
0.925, P < 0.001). All compared techniques showed high Pearson‟s correlation 
coefficients meaning that a strong linearity exists between NIR and the different methods 
in determining the fat fraction in liver. Additionally, Table 2 summarizes the linear 
regression coefficient and corresponding 95% confidence intervals when comparing the 
estimated fat with NIR with another method. NIR and MRS showed the linear regression 
coefficient with the narrowest CI comprising unity (r = 0.935, 95% CI: 0.860-1.009). 
Therefore NIR showed to be the most comparable to MRS for fat fractions quantification. 
Comparison with HPTLC showed as well a linear regression coefficient lower than unity 
whereas it was above unity when comparing with MAS-NMR. All the regression 
coefficients have CI comprising unity besides for HPTLC that has an upper bound of 
0.993.  
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TABLE 2. Pearson’s correlation P and linear regression r coefficients computed when 
comparing estimated fat fractions from NIR with respect to MRS, MAS-NMR, and 
HPTLC and to histopathological scores. 
 MRS MAS-NMR HPTLC Histopathology
*
 
P coefficient 
0.993 
[0.970-0.998] 
0.990 
 [0.955-0.998] 
0.993 
[0.969-0.998] 
0.925 
[0.845-0.991] 
r coefficient 
0.935 
[0.860-1.009] 
1.030 
[0.781-1.279] 
0.896 
 [0.799-0.993] 
- 
*
Computed by comparing fat fractions determined with NIR versus the hepateastosis 
scores from histopathology. All P coefficients have P < 0.001. CI with P < 0.05 
displayed between brackets. 
 
Figure 5 depicts the average fat fractions and SD determined by NIR versus MRS 
(Figure 5A), MAS-NMR (Figure 5B) and HPTLC (Figure 5C), respectively. 
Additionally, Figure 5 depicts the linear regression fits and the 95% confidence bounds. 
MRS, HPTLC, and MAS-NMR are the techniques with narrowest to widest confidence 
bounds. The SD of estimated fat fraction with NIR within each mouse is similar to the 
one of HPTLC but larger than MRS. As only a single MAS-NMR spectrum was acquired 
per mouse, no SDs are available for this method. Given the fact that histopathology is a 
semi-quantitative method, no linear regression was applied to compute the regression 
coefficient between NIR and this method. 
 
 
Figure 5: Mean and SD of fat fraction in each mouse determined by (A) NIR versus MRS, 
(B) MAS-NMR, (C) HPTLC. The dashed line corresponds to the linear regression and the 
dotted lines correspond to the 95% confidence bound. 
 
4. Discussion 
In the present study we evaluated the NIR based optical spectroscopy 
measurements of hepatic fat content using a minimally invasive needle-like probe as 
compared to in vivo MRS measurements as validation, to histopathology being the 
clinical golden standard, to MAS-NMR spectroscopy, and to HPTLC measurements. 
 96 
 
Chapter 4 
NIR spectroscopy showed very good agreement in fat quantification as compared 
to MRS with a very high Pearson‟s correlation coefficient and a linear regression 
coefficient of 0.935 making NIR underestimating the fat in liver of 6.5% compared to 
MRS. Whereas the average fat determined in the chow diet mice category is similar for 
both techniques (difference of 0.4 percent point), it is in average 2% lower in the case of 
high fat diet mice liver measurements yielding to a regression coefficient lower than unity 
when comparing NIR to MRS. We have performed two previous studies where we 
investigated the necessity to measure above 1000 nm and the accuracy of fat estimation 
with NIR from phantom measurements with fat content ranging from 0 to 83% of the 
total volume yielding a regression coefficient of 1.02 (R
2 
= 0.999).
14-15
 These studies 
showed the importance of extending the commonly-used wavelength ranges (between 400 
and 1000 nm) up to 1600 nm for a more accurate fat quantification. In this present study, 
we extended the wavelength range up to 1800 nm, where additional fat and water 
absorption bands exist. The local maxima of fat absorption at 1720 and 1760 nm are the 
only wavelength for which these maxima coincide with a local minimum of water 
absorption; adding more accuracy for fat quantification in comparison to what has already 
been published so far in literature. Bernard et al.
30
 performed MRS measurements in 
phantoms with fat content ranging from 0% to 100% and the analysis yielded a regression 
of 1.06 (R
2
 = 0.993). Consequently, based on the results from published phantoms study, 
MRS seems to be slightly overestimating fat fractions compared to NIR which can 
explain the regression coefficient of 0.935 when comparing NIR with MRS in this study. 
From Figure 5A, one can notice that the SD per mouse if smaller when the hepatic fat is 
estimated with MRS compared to NIR. This is due to the fact that only a single 
measurement per lobe is performed whereas three measurements per lobe are performed 
with NIR showing differences in fat content between the measurements performed close 
to the center of the liver compared to the other locations. 
Computing a linear regression coefficient to compare the estimated fat fractions 
between NIR and histopathology is not applicable. This is mainly due to the fact that 
histopathology is a rather semi-quantitative method. Moreover, the chow group was 
defined as the healthy reference with measured fat fractions below 5%, hence the „null‟ 
score for hepatosteatosis. Nevertheless, the correlation with NIR is still very high 
suggesting strong linearity. 
MAS-NMR and HPTLC are two techniques enabling ex vivo fat quantification 
and were used for comparison with NIR. Good agreements are observed between NIR 
and each of both methods with roughly similar Pearson‟s correlation coefficient values. 
However, the linear regression coefficient comparing NIR to MAS-NMR is the only one 
to be above unity. Moreover, only a single measurement per liver was performed with 
MAS-NMR and therefore no standard deviations are available for enhanced comparisons. 
Fat fractions estimated with HPTLC showed slightly higher values than NIR however the 
standard deviations are comparable. A potential explanation for this difference is the fact 
that the determined fat fractions with NIR correspond to the percentage of fat over water 
and fat whereas the fat fractions derived from HPTLC corresponds to percentage of fat 
over protein in liver and not water. 
 97 
 
Validation of interventional fiber optic spectroscopy with MR spectroscopy, MAS-NMR 
spectroscopy, high performance thin layer chromatography, and histopathology for 
accurate hepatic fat quantification 
Chapter 4 
NIR spectroscopy has been used so far to quantify hemoglobin derivatives, and 
few studies investigated fat quantification in breast by measuring the spectra up to 1000 
nm only.
31-32
 Kitai et al.
33
 measured the optical properties such as the absorption and 
reduced scattering coefficients with time-resolved NIR spectroscopy on graft livers and 
showed correlation between the hepatic fat quantification and the ratio of reduced 
scattering to absorption however no quantitative fat is derived. The present study is the 
first to use a wavelength range up to 1800 for a very quick and a more accurate fat 
quantification. 
As fatty liver disease is considered to be positively diagnosed by histopathology 
for lipid accumulation as low as 5%,
17
 NIR seems to be a suitable technique for this 
purpose as demonstrated in this study. This suggests that NIR spectroscopy is a tool that 
performs as good as the other techniques that exists for hepatic fat quantification. NIR 
spectroscopy has the advantage of being very quick in acquiring and analyzing the spectra 
for fat quantification enabling real-time feedback for clinician compared to other 
techniques by only tipping the liver tissue. However optical fibers integrated in needles 
makes this technique invasive causing potential discomfort to patients. 
With NIR measurements at the tip of a needle, only local fat distributions can be 
estimated and therefore mapping of fat accumulations in the liver is only possible along 
the needle path. Existing NIR based imaging tools for fat mapping exist for breast 
however the breast is compressed in order to minimize the thickness of the organ and be 
able to have light penetrating through the whole breast.
32 
Quantifying fat with NIR is a relatively new technique that has only been used so 
far in investigational studies whereas MRS is already a well-established technique that is 
used in the clinics. A number of NIR studies in the oncology field were performed which 
demonstrated that fat content appeared to be a reliable discriminator between tumors and 
the surrounding healthy tissue.
16, 34
 Ongoing human in vivo studies carried out in the 
clinic will provide a better picture of the potential of this technique. With NIR sensing, it 
should be in principle possible to differentiate between microvesicular and 
macrovesicular fat content of liver cells. As a matter of fact, we have demonstrated that it 
is possible to distinguish with NIR between different sizes of lipid vesicles emulsified 
with water.
14
 Phantoms with known fat content where measured before and after 
shrinking of the vesicles sizes in order to investigate the effect of the particles size on the 
NIR spectra. The results showed that the fat content could be accurately determined 
independently from the particles size and that one can correlate the particles size with the 
slope of the estimated reduced scattering. The smaller the particles size, the higher the 
scattering slope. It appeared from this study that the chow diet mice group has a 
statistically higher reduced scattering slope (1.27±0.28) in comparison to the high fat diet 
mice group (0.98±0.23) suggesting larger particles size in the liver of mice under high fat 
diet as compared as the mice under chow diet. This corroborates with what can be seen on 
the histopathology slices in Figure 4 where the high fat diet liver slice shows larger 
adipose cells as compared to the chow diet liver slice. Therefore NIR can be an 
interesting tool to assess the suitability of a donor liver since one of the exclusion criteria 
is the extent of macrovesicular hepatic fat content.
35 
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Table 3 summarizes the characteristics of the different methods. NIR 
spectroscopy has the advantage of being a fast method to measure and estimate the 
hepatic fat. The acquisition time of 20 minutes for MRS is higher than the average values 
reported in literature. This is mainly due to the fact that we added higher order shims to 
our shim procedure to obtain the most optimal results possible. In standard clinical 
settings, higher order shims are not used. In comparison to MRS, high accuracy of fat 
estimation is reached with NIR however it has the disadvantage of being invasive 
whereas MRS is non-invasive. Nevertheless, the measurements can be performed in the 
body and therefore no additional chemical processing of the tissue is required after its 
resection as compared to MAS-NMR and HPTLC. 
 
TABLE 3. Characteristics of different methods for hepatic fat quantification  
  
Measure 
 time 
Invasiveness Accuracy Practice 
Main  
disadvantage 
NIR 
Sub-
second 
Minimally High Research Invasive 
MRS 
20 
minutes 
Non High Common 
Time 
consuming 
MAS-NMR 
10 
minutes 
Resection Average Rare 
Tissue 
excised 
HPTLC Days Resection Average Rare 
Tissue 
excised 
Histopathology Days Biopsy Qualitative 
Very 
Common 
Tissue 
excised 
Histopathology is considered as golden standard in the clinic. 
 
5. Conclusion 
This study investigated the potential of NIR spectroscopy for hepatic fat 
quantification by validating this method with the most commonly-used techniques such as 
MRS and histopathology, as well as HPTLC and MAS-NMR. A paucity of NIR studies 
for fat determination in a wide wavelength range from 450 to 1800 nm makes this study 
the first to be benchmarked with state of the art methods. We hypothesize that optical 
fibers integrated in needles could have the potential of providing instantly relevant 
feedback on hepatic fat quantification during interventional procedures in relevant parts 
of the liver.  
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Abstract 
We investigated differences between healthy tissue and metastatic tumor from ex 
vivo human partial liver resections using diffuse optical spectroscopy with a fiber optic 
probe. We extracted various physiological and morphological parameters from the 
spectra. During evaluation of the residual between the measurements and a fit model 
based on diffusion theory, we found that bile is an additional chromophore absorbing in 
the visible wavelength range that was missing in our model. Consistency of the residual 
with the absorption spectrum of bile was noticed. An accurate measurement of the 
absorption coefficient of bile from various human bile samples was performed and 
implemented into the fit model. Having the absorption coefficient of bile as a priori 
knowledge in the model showed a clear improvement in terms of reducing the fitting 
discrepancies. The addition of this chromophore yields significantly different estimates of 
the amount of blood. Furthermore, the estimated bile volume fraction and reduced 
scattering amplitude turned out to be two main relevant discriminators between normal 
and metastatic liver tissues. 
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1. Introduction 
Incidence and mortality rates of primary and secondary liver cancer have 
progressively increased worldwide over the last two decades [1]. In the western world, 
malignant lesions of the liver are generally metastases from other organs. Tumors of the 
gastro-intestinal tract, such as primary colorectal cancer, preferentially metastasize to the 
liver. 
For liver metastases of colorectal origin, resection is the only accepted treatment 
with curative intent. However, radiofrequency ablation (RFA) is an increasingly practiced 
treatment modality for patients with liver malignancy that are not suitable for surgery [2-
4]. 
The main negative prognostic factor for survival after liver surgery is a positive surgical 
margin [5, 6]. Histological analysis to determine the surgical margin is still considered to 
be the golden standard. However, intra-operative margin analysis would allow direct 
surgical intervention of a positive surgical margin, therefore reducing the chance of post-
operative loco-regional recurrence. 
Patients treated with RFA have demonstrated prolonged survival compared to 
patients treated with chemotherapy alone [7, 8]. Nevertheless, localization of the ablative 
needle and monitoring of the ablation process are important steps for optimal treatment of 
liver malignancies with RFA, since incidence of loco-regional disease recurrence due to 
ineffective ablation ranges from 3.6% to 60% [9]. Therefore, real-time intra-operative 
needle localization and ablation monitoring could improve ablation efficacy and disease-
free survival.     
Diffuse optical spectroscopy with fiber optic probes is a widely used technique to 
estimate the optical properties of tissue [10-15]. Concomitantly, several models have been 
developed to extract the absorption and reduced scattering coefficients from the measured 
spectra which are subsequently converted into physiological parameters. Such parameters 
are very useful to discriminate between healthy tissue and tumors in different organs. 
Indeed, several ex vivo and in vivo clinical studies were performed in the last decade 
showing the potential of optical spectroscopy to discriminate between healthy and tumor 
samples. However, only a few studies have focused on estimating tissue optical properties 
from spectroscopy measurements in liver [26-28] compared to other organs such as breast 
[11, 16-18], cervix [19, 20], lung [10, 21, 22] and skin [23-25]. 
In the present paper, we report on an ex vivo clinical study of healthy and 
metastatic human liver tissue where we measured the diffuse optical spectra in the 500-
1600 nm wavelength range. From the acquired spectra, several physiological and 
morphological parameters of clinical relevance were extracted, using a widely accepted 
analytical model developed by Farrell et al. based on the diffusion theory [29]. Recently, 
we have shown the applicability of the model to wavelength ranges extended to 1600 nm 
where additional absorption features of water and lipids appear [30, 31]. Parameters that 
were also obtained by fitting the model to the measurements are blood, water, lipid 
volume fractions, average vessel radius, oxygen saturation level in blood and tissue 
scattering properties. Accurate analysis of the measured spectra suggested that bile is an 
important chromophore in the liver because it significantly absorbs in the visible 
wavelength range. This chromophore should therefore be included in the fitting model. 
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The difference between healthy and tumor ex vivo human liver tissue was investigated 
based upon the parameters extracted from these measurements. 
 
2. Materials and methods 
2.1 Patients and liver tissue handling 
The presented pilot study on ex vivo liver was conducted at the Netherlands 
Cancer Institute in Amsterdam (NKI-AVL) under approval from the internal review 
board committee. Spectra were collected from liver surgical specimens after partial liver 
hepatectomy. Before resection of the specimen, the hepatic vessels that provide the blood 
supply to the part of the liver containing the tumor were clamped up to one hour before 
the resection started. Directly after resection, tissue was transported to the pathology 
department for further processing. After gross inspection by the pathologist, the optical 
spectra were collected from macroscopic normal and malignant tissue samples. 
Spectroscopy measurements were performed on freshly excised tissue before formalin 
fixation within two hours after the resection. In order to ensure that the measurements 
were at the tumor location, the samples were cut by the pathologist such that the tumor 
would be exposed in the most optimal way for measurements. All tumors were colorectal 
metastases and none were primary tumors. At the measurement sites, tissue was collected 
for conventional histopathology and the slides were analyzed at the pathology 
department. The pathological findings were correlated with the optical measurements. 
Several spectra were measured on liver tissues from 14 enrolled patients. In 
average, 15 spectra at different sites were taken from each of the fourteen healthy and 
metastatic tumor samples, respectively. All the measurements taken from the 14 samples 
were included in the study and compiled with the results from the pathological report. All 
measurements were performed by the same operator and care was taken to ensure the 
same measuring conditions on all the samples. 
 
2.2 Instrumentation and calibration 
The spectra were collected from the different samples with an instrument which 
was used in our previous study [31]. The setup consists of a halogen broadband light 
source with an embedded shutter, an optical probe with three fibers and two 
spectrometers that can resolve light from 400 to 1100 nm (silicon detector) and 800 to 
1700 nm (InGaAs detector), respectively. A filter that rejects light for wavelengths below 
465 nm was mounted in front of the spectrometers to reject second order light at the 
detectors. The 1.3 mm diameter probe has a fiber connected to the light source and two 
other fibers each connected to a spectrometer. The center-to-center distance between the 
emitting and collecting fibers is 2.48 mm, where the tip of the probe has an angled bevel. 
All optical fibers are low-OH fibers of 200 microns core diameter. The spectrometers are 
controlled by custom-made software to acquire the data. Figure 1 depicts a schematic of 
the full setup. 
The system was calibrated prior to each measurement on the tissue samples. The 
calibration consisted of several steps. First, the detectors were cooled down to -40ºC. 
Once the temperature was stable, a wavelength calibration was performed to assign a 
wavelength value to each pixel of both detectors, fitting a second order polynomial to a 
 107 
 
Effect of bile absorption coefficients on the estimation of liver tissue optical properties 
and related implications in discriminating healthy and tumorous samples 
Chapter 5 
set of atomic lines from argon and mercury light sources with peaks at known 
wavelengths. The second steps consisted of calibrating the system with a white 
reflectance standard measurement to compensate for the spectral shape of the light 
emitted by the lamp and the wavelength-dependent sensitivity of the detectors. 
Subsequently, a background measurement was carried out. Each spectrum was acquired 
by measuring simultaneously with both spectrometers. The analyzed spectra 
corresponded to tissue measurements corrected for the spectral shape of the light source, 
and the spectral response of the detectors measured on a white standard reference 
measurement as described in detail in our previous studies [30, 31].  
The simultaneously acquired spectra in the 400-1100 nm range and in the near-
infrared 800-1700 nm range were combined to a single spectrum, using the 950-1000 nm 
range to scale the near-infrared spectrum to the visible spectrum. For the spectral analyses 
we have used the 500-1600 nm spectral range, where the 500 to 1000 nm and 1000 to 
1600 nm correspond to the data collected with the silicon and InGaAs detectors, 
respectively [31].  
 
 
Figure 1. Schematic of the optical setup and the design of the optical probe. 
 
2.3 Mathematical modeling of the diffuse optical spectra 
The measured diffuse optical spectra were fitted, using the method of Farrell et al. 
[29] where the reduced scattering coefficient  ,s  , the absorption coefficient  a  and 
the center-to-center distance between the emitting and collecting fibers at the tip of the 
probe are input arguments for the model. The spectra were fitted over the wavelength 
range of 500-1600 nm, using a non-constrained linear least squares fitting algorithm. The 
validation of this method with the setup and optical probe described in section 2.2 was 
performed in our previous work based on an extensive phantom and in vivo animal 
studies [30-31]. Briefly, we demonstrated that the fiber distance separation that is used is 
large enough in order not to infringe the diffusion theory assumptions. An extensive 
phantom study with different absorption and reduced scattering properties was performed 
to investigate the robustness of the fit. It was also shown that the model is suitable to 
properly estimate chromophore concentrations independently from the reduced scattering 
profile which was varied by changing the particle size distribution in the phantoms. The 
confidence intervals of the estimated parameters that derive from the covariance matrix 
were also used to investigate the reliability of the fits from the phantom measurements.  
The wavelength dependant reduced scattering coefficient is expressed by a double power 
law 
Light source 
Visible spectrometer 
Infrared spectrometer 
 
 
 
1.3 mm 
2.48 
mm 
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where the wavelength   is expressed in nm and is normalized to a wavelength value of 
0λ = 800 nm. The reduced scattering coefficient is expressed as the sum of a Mie and a 
Rayleigh scattering where MRρ  is the Mie-to-total reduced scattering fraction and  b  
corresponds to the slope of the Mie reduced scattering. The total reduced scattering 
amplitude at 0λ  is denoted by a . 
We adopted the formulation of the absorption coefficient that is described in our 
previous study [31] where the absorption, due to chromophores present in the measured 
tissue, is expressed as 
 
     Tissue Blood WL -1a a aμ λ =μ λ +μ λ    [cm ]      (2) 
 
where  Bloodaμ λ  corresponds to the absorption by blood and  
WL
aμ λ  corresponds to 
absorption by water and lipid in the probed tissue. The blood related absorption 
coefficient is given by 
 
         2HbOBlood Hb -1a Blood t 2 a t 2 aμ λ =C λ ν S O μ λ + 1-S O μ λ    [cm ]        (3) 
 
where 2
HbO
aμ  and 
Hb
aμ  are the absorption coefficient of oxygenated hemoglobin 2HbO  
and deoxygenated hemoglobin Hb , respectively. The parameter Bloodν  corresponds to the 
blood volume fraction for a concentration of hemoglobin in whole blood of 150 mg/ml 
and t 2S O  corresponds to the oxygen saturation of the blood in the probed volume. The 
factor C  is a wavelength dependant correction factor known as a pigment packaging 
factor [32] and is given by 
 
 
      
     
2
2
HbO Hb
t 2 a t 2 a
HbO Hb
t 2 a t 2 a
1-exp -2R S O μ λ + 1-S O μ λ
C λ =
2R S O μ λ + 1-S O μ λ
  
  
     (4) 
 
with R  the average vessel radius expressed in cm; note however that its value is reported 
in microns throughout this paper. The absorption due to the presence of water and lipid in 
the measured tissue is defined as 
 
       2H OWL Lipid -1a WL Lipid a Lipid aμ λ =ν f μ λ + 1-f μ λ    [cm ]        (5) 
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with 2
H O
aμ  and 
Lipid
aμ  being the absorption coefficient of water and lipid (density of 0.86 
g/ml [31]) , respectively. The parameters WLν  and Lipidf  correspond to the total volume 
fraction of water and lipid in the tissue and the lipid fraction within this volume, 
respectively. Describing the absorption due to water and lipid as in equation (5) has the 
advantage that the covariance between WLν  and Lipidf  is smaller compared to the sum of 
the absorption of water and lipid separately weighted by corresponding volume fractions 
[31]. However, throughout this paper WLν  and Lipidf  are converted to water and lipid 
fractions and reported as such because of their clinical relevance for interpretation. 
 When inspecting the measured spectra, it was observed that there was a missing 
absorber in the visible wavelength range i.e. between 500 and 750 nm. The assumption 
was that bile would be the missing absorber in the fit model, since it is an endogenous 
compound which is abundant in liver [33]. Absorption by bile was included by 
incorporating it into equation (2) so that the total absorption is expressed as 
 
     Total Tissue Bile -1a a Bile aμ λ =μ λ +ν μ λ    [cm ]      (6) 
 
where Bileν  and 
Bile
aμ  are the volume fraction and absorption coefficient of bile, 
respectively.  The absorption coefficient was determined by measuring bile freshly 
obtained from the gallbladder of two patients who underwent a cholecystectomy as part 
of the liver resection operation. The bile was poured in cuvettes of different thickness (1, 
2, 5 and 10 mm) and the optical transmission was measured in a spectrophotograph 
(Lambda 900 Spectrometer, Perkin Elmer) with a resolution of 1 nm. The bile absorption 
is depicted in figure 2 (circle-marked curve) and it corresponds to the measured 
absorption coefficients from 300 to 1600 nm. In the near-infrared, the bile absorption is 
similar to the water absorption coefficient [33]. This is due to the fact that bile is mainly 
composed of water. In the visible, bile has a local maximum at 409 nm, a local minimum 
at 350 nm and a large absorption peak centered at 605 nm. Additionally, figure 2 shows 
the absorption coefficient in a logarithmic scale of fully oxygenated hemoglobin [34], 
deoxygenated hemoglobin [34], lipid [30] and water [30] from 400 to 1600 nm. 
In the model, we have used the bile absorption coefficient as the measured bile 
absorption coefficient from which the water absorption coefficient was retrieved. Figure 3 
depicts the normalized absorption coefficients of bile, oxygenated and deoxygenated 
hemoglobin starting from 500 nm (starting wavelength of the fit). Bile has a large 
absorption peak at 605 nm of 5.4 cm
-1
 and its value does not change more than 5% 
between 550 and 650 nm. This large absorption peak can significantly change the spectral 
shape in the visible range of a measurement where bile is present in the tissue. 
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Figure 2. Absorption coefficients of deoxygenated hemoglobin (solid line), oxygenated 
hemoglobin (dashed line), lipid (dashed-dotted line) and water (dotted line) from 400 to 
1600 nm .Absorption coefficient of bile (circle-marked line) from 300 to 1600 nm. The 
absorption coefficient axis is in a logarithmic scale. 
 
From the acquired spectra the following parameters a , b , MRρ , R , Bloodν , 2StO , 
WLν , Lipidf  and Bileν  are determined. For each of these fit parameters, the confidence 
intervals were computed from the square root of the diagonal of the covariance matrix for 
a critical value of 0.05 [35]. A statistical F-test was performed to evaluate the 
improvement when bile is added to the model. The F-test is based on analyzing the 
difference between the sum-of-squares of the model with and without the bile absorption 
component. From the number of data points within the wavelength range where the fit 
was performed and the number of fit parameters for the models with and without the bile 
component, an F-ratio is computed from which a p-value can be extracted. If the p-value 
is smaller than the specific significance level chosen to be 0.05, the model with the bile 
component leads to a better description of the measured spectra. Statistical comparison of 
the parameters estimated from the healthy and metastatic tumor measurements was 
performed, using the Kruskal-Wallis non-parametric test with significance determined by 
computed p-values [36]. 
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Figure 3. Normalized absorption coefficients of deoxygenated hemoglobin (dashed line), 
oxygenated hemoglobin (dotted line), and bile (solid line) between 500 and 1000 nm. 
 
3. Results and discussion 
3.1 Mathematical model applied to the healthy liver tissue measurements 
Figure 4 shows a measured spectrum from 500 to 1600 nm of a healthy liver 
sample (dotted line), the corresponding fit curve without the bile component added into 
the model (solid line) and the 95% confidence bounds (dashed lines) [37]. For the 
measurement shown in figure 4, the parameters and the corresponding confidence 
intervals obtained from the fit are Bloodν =4.4±0.3%, t 2S O =22±8%, R =76±13μm, WLν
=91±2%, Lipidf =17±2%, and a reduced scattering amplitude of 14.2±0.3 cm
-1 
at 800 nm 
with a Mie-to-total reduced scattering fraction of 19±4%. When investigating the residual 
(χ2=0.238) and the confidence bounds, a large deviation between the measurement and 
the fit curves was observed around the deoxygenated hemoglobin peak at 758 nm. 
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Figure 4. Reflectance measurement (dotted line) from a normal ex vivo tissue sample and 
its fit (solid line) without bile absorption coefficient implemented in the model and the 
corresponding 95% confidence bound (dashed lines). The vertical dotted lines at 605, 
757, 972 and 1211 nm correspond to the absorption peaks location of bile, deoxygenated 
hemoglobin, water and lipid, respectively. 
 
By adding the absorption coefficient of bile to the model, the large deviation 
around 758 nm significantly reduced while the confidence bounds narrowed towards the 
fit curve. The measurement curve in figure 5 is the same than the one depicted in figure 4 
with a fit including the bile absorption coefficient in the model. For the measurement 
shown in figure 5, the estimated values and the corresponding confidence intervals are 
Bileν =3.9±0.7%, Bloodν =3.5±0.3%, t 2S O =37±8%, R =56±13μm, WLν =93±2%, Lipidf
=19±1%, and a reduced scattering amplitude of 14.5±0.3 cm
-1 
at 800 nm with a Mie-to-
total reduced scattering fraction of 25±7% were found. The residual decreased to a value 
of χ2=0.206. In comparison to the outcome of the model without bile, the oxygen 
saturation level is higher, indicating that the bile absorption was compensated by 
deoxygenated hemoglobin. Similar results can be seen in table 1 which shows comparison 
of the mean and standard deviation of the parameters obtained from all the spectra 
measured on the 14 normal human liver tissue samples. Based on the confidence 
intervals, the model with bile showed for each sample that the parameters were estimated 
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more reliably compared to the model without bile. Another observation in figure 5 is that 
the 95% confidence bound is closer to the fit curve, especially in the wavelength range 
between 500 and 800 nm where a bile absorption peak is present. 
 
 
Figure 5. Reflectance measurement (dotted line) from a normal ex vivo tissue sample and 
its fit (solid line) with bile absorption implemented in the model and the corresponding 
95% confidence bound (dashed line). The vertical dotted lines at 605, 757, 972 and 1211 
nm correspond to absorption peaks location of bile, deoxygenated hemoglobin, water and 
lipid, respectively. 
 
In order to depict the imprint of bile absorption on the measured spectra, a 
forward calculation of the spectrum with the estimated parameters can be computed by 
setting the bile volume fraction to 0%. Figure 6 shows another example of a healthy liver 
spectrum and the corresponding fits where the estimated bile volume fraction is 10.4%. 
Additionally, the forward computation of the spectrum by using the estimated parameters 
as input arguments and setting the bile volume fraction to 0% is plotted and the area 
comprised between the generated curves and the fitted curves is illustrated and highlights 
the spectral changes that result from bile absorption. 
 
 
 114 
 
Chapter 5 
Table 1. Mean and standard deviation of the estimated values of the physiological and 
morphological parameters of healthy liver tissues obtained from the fitting model without 
and with bile absorption coefficient. 
Parameters Fit without bile Fit with bile 
Bile (%) - 6.6±4.5 
Blood volume fraction (%) 4.8±0.3 3.4±2.0 
Blood oxygenation level (%) 6±8 8±14 
Average vessel radius (microns) 67±28 50±22 
Water volume fraction (%) 77±7 76±7 
Lipid volume fraction (%) 17±11 19±11 
Reduced scattering at 800 nm (cm
-1
) 17±2 17±3 
Mie Slope 0.5±0.3 1.0±0.5 
Mie-to-total scattering fraction (%) 19±10 37±19 
According to a statistical F-test with p<0.05, 95% of the data showed improvement 
on the fitting when bile is added to the model. 
 
In order to mathematically evaluate whether bile is the missing absorber in the 
model, a statistical F-test was applied to all the data acquired at healthy sites in the liver 
[37]. P-values were computed from the F-ratios to evaluate if the model with bile 
absorption improved the fits. In total, 95% of the data have shown that the model 
including bile described best the measured spectra with a p-value below 0.05.  
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Figure 6. Tissue measurement from a normal tissue sample (dotted line) with an 
estimated bile volume fraction estimated from the fit (red solid line) of 10.4%. The 
colored area indicates the imprint of bile absorption obtained by comparison with a 
forward computation of the diffuse reflectance spectrum where the bile volume fraction is 
set to 0% (black solid line). 
 
3.2 Comparison of healthy and metastatic tumor liver tissue 
Figure 7 shows a typical spectrum (dotted line) from both healthy and metastatic 
tumor liver tissues with the corresponding fit curves (solid line) including bile. Major 
differences between the two typical spectra correlated with a difference in the estimated 
parameters. 
From the typical metastatic tissue measurement depicted in figure 7, the estimated 
parameters and the corresponding confidence intervals are Bileν =0±0%, Bloodν =1.5±0.1%, 
t 2S O =3±5%, R =31±3μm, WL =101±2%, Lipidf =10±1%, and a reduced scattering 
amplitude of 9.8±0.3 cm
-1 
at 800 nm with a Mie-to-total reduced scattering fraction of 
76±4%. 
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Figure 7. Reflectance measurement of healthy and metastatic tumor liver tissues (dotted 
line) and their corresponding fits (solid line). 
 
Table 2 summarizes all the median and standard deviations derived from the 
interquartiles of the various fit parameters for all the measurements performed in the 
fourteen samples of healthy and metastatic liver tissues. The advantage of reporting the 
median and the standard deviation derived from interquartiles instead of the mean and 
standard deviation is that the data cannot be described by a parametric distribution, hence 
we used a non-parametric statistical Kruskal-Wallis test instead of a t-test to find which 
parameters show significant difference between the two types of tissue, as was also done 
in previous studies [10, 12, 13, 16, 17, 19, 21, 22]. The blood oxygenation was not 
reported, due to the fact that the study was conducted on ex vivo samples. Therefore this 
parameter does not reflect the actual oxygenation level as it would be in vivo. According 
to the Kruskal-Wallis statistical test, the values that showed most significant differences 
between healthy and metastatic tissues with p < 0.01 were bile, the reduced scattering 
amplitude and the water volume fraction. 
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Table 2. Median and standard deviation of the various morphological parameters 
estimated from ex vivo measurements performed on normal and metastatic tumor tissues 
in liver. 
Parameters 
Normal liver 
(14 samples) 
Metastatic Tumor 
(14 samples) 
Bile (%)
a 
5.5±2.3 1.0±1.1 
Blood volume fraction (%) 3.2±1.6 0.8±2.4 
Blood oxygenation level (%) 8±14 45±44 
Average vessel radius (microns) 53±20 67±82 
Water volume fraction (%)
a
 76±4 93±17 
Lipid volume fraction (%) 16±3 12±6 
Reduced scattering at 800 nm (cm
-1
)
 
a
 
17±3 10±3 
Mie Slope 1.2±0.7 0.5±0.5 
Mie-to-total scattering fraction (%) 44±25 57±15 
a
Indicates significant differences with p<0.01 for the Kruskal-Wallis test. 
 
Figure 8 shows a picture of a tumor and the surrounding healthy liver tissue. It is 
visually clear that the tumor is less rich in blood than the healthy liver tissue. All the 
measured tumors were at least a centimeter in diameter and rather white in appearance. 
 
 
Figure.8. Picture of a tumor surrounded by healthy liver tissue. The optical probe is 
directed towards the tumor site. 
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4. Discussion 
A paucity of studies has investigated the absorption coefficient of bile. Maitland et 
al. [33] measured the absorption coefficient of bile from 350 to 2450 nm and stated that 
bile has its main absorption peaks at 400, 1450 and 1900 nm. The latter two most likely 
correspond to absorption due to the presence of water in bile, whereas the peak at 400 nm 
corresponds to an actual absorption peak of bile. After measuring the absorption 
coefficient of bile, we observed a broad absorption peak between 550 and 650 nm with a 
local maximum of 5.4 cm
-1
 at 605 nm. Our measurement also suggests that there is a 
higher absorption peak at 409 nm, whereas the maximum reported by Maitland et al. is at 
400 nm [33]. The presented bile absorption coefficients in this paper can therefore be 
considered as an updated measurement of the one reported by Maitland et al. [33]. 
This study demonstrated the necessity to incorporate the bile absorption 
coefficient into the model when fitting spectroscopic measurements in liver tissue. In 
95% of the measured healthy tissue data, including bile in the fitting model provided a 
better fit according to a statistical F-test. The fit parameters that were mainly altered when 
the bile was not added to the model were the blood volume fraction and the average 
vessel radius. For the 14 measured normal samples, the blood volume fraction decreased 
on average from 4.8±1.7% to 3.4±2.0%, whereas no significant changes were observed 
for the oxygenation level of blood. Figure 2 and 3 illustrates a higher absorption for 
deoxygenated hemoglobin than for oxygenated hemoglobin between 550 and 750 nm. 
The main absorption of bile is between these wavelengths. The resulting fit model 
without bile compensates for the residual by overestimating the deoxygenated 
hemoglobin yielding higher blood volumes with unchanged oxygen saturation levels. 
Moreover, this discrepancy is observed between the measurement and the fit curves 
depicted at 758 nm in figure 4 where no bile was taken into account in the model. It is 
important to note that deoxygenated-hemoglobin has a distinct spectral absorption peak at 
758 nm (cf. figure 2) resulting in an inflection point in the fits that is not present in the 
measured liver spectra. Furthermore, changes are observed in the Mie slope and Mie-to-
total reduced scattering fractions, whereas the reduced scattering amplitude remains 
unchanged. Finally, no effects on the estimation of water and lipid fractions is seen when 
bile is not present in the model. This is expected since there are no overlapping absorption 
features between these two biological parameters. 
It is important to note that the bile that was used to measure its absorption 
coefficients comes from patients suffering from metastatic colorectal cancer. Therefore 
the pigmentation concentration in the bile can vary from one person to another, resulting 
in slightly different absorption coefficients; hence the presence of a significant residual 
around 800 nm when bile is added in the model (cf. figure 5). However, this is not the 
case in all patients. Another remark with respect to the residual is the small deviation 
between the measurement and the fits around 1211 nm which is most probably due to 
changes in water absorption coefficients with temperature. Indeed, the tissue 
measurements were performed ex vivo after resection, and hence the temperature of the 
samples decreased from body temperature down to the room ambient temperature when 
brought to the pathology department. We have shown elsewhere [30] that water 
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absorption coefficient is temperature dependant and that it is prone to significant variation 
in absorption in the vicinity of 1200 nm, hence the small residual around this wavelength.  
The analysis of the diffuse optical spectra showed significant differences 
according to the Kruskal-Wallis non-parametric test with a critical value of 0.01 for bile 
and water volume fractions, as well as the reduced scattering amplitude and the 
oxygenation saturation of blood. 
The study by Kitai et al. [26] measured the optical properties before and after 
clamping the left branches of the hepatic pedicle, including the portal vein and hepatic 
artery, during 60 minutes. Their study showed that the oxygenation level in blood equals 
75% just before clamping the vessels and drops down to 8% one hour after clamping. The 
median oxygenation values in the healthy tissues and tumors presented in table 2 are 8% 
and 45%, respectively. In our study, the blood vessels of the resected specimens were 
clamped up to one hour before the resection was completed and the samples were 
transported within a time frame of two hours after resection to the pathology department. 
Therefore, there was no more blood flow and perfusion to the liver tissue in the ex vivo 
samples yielding to a decrease in oxygenation levels when the samples were delivered for 
measurements. It is therefore difficult to draw any conclusions by comparing the 
estimated oxygenation levels in healthy tissues and the tumors measured ex vivo. 
The reduced scattering amplitude and the bile volume fraction showed the most 
significant differences (p<0.0001) between healthy and metastatic liver tissues. As shown 
in table 2, healthy tissue has more than five times more bile than tumors whereas the 
reduced scattering amplitude is almost twice as high. Healthy liver tissue is mainly 
constituted of hepatocytes which are cells that are arranged as very thin plates separated 
by fine vascular sinusoids where blood flows; allowing perfusion of the bile throughout 
the liver [38]. In the tumor, this structure is lost, causing a different perfusion of the bile 
and an alteration of the cell structures yielding to a different light scattering. This 
observation is consistent with the fact that the tumors in liver are metastases of colorectal 
cancer with different structural composition. The tumor consists therefore of abnormal 
colorectal tissue cells embedded in collagenous cellular stroma induced by the epithelial 
tumor cells. Such tumors are almost completely devoid of stroma. Therefore, hardly any 
bile is expected in the tumor cells from colorectal origin. 
The reduced scattering amplitude is 1.7 times higher in healthy tissue than in 
tumors. Germer et al. measured the absorption coefficient, scattering and anisotropy of 
human liver tissues and colorectal liver metastases in vitro at 850, 980 and 1064 nm [39]. 
They found that scattering in human liver tissues is in average 1.7 times higher than in the 
metastases tissues. However, the large difference in anisotropy yields to reduced 
scattering of 9.5 and 11 cm
-1
 at 800 nm (extrapolated values) for normal and metastatic 
liver tissue, respectively [39]. Therefore, the reduced scattering amplitude of the 
metastatic tumor reported in table 2 is very comparable to the value reported in ref. [39] 
whereas the value in healthy liver tissue is much higher. 
The water volume fraction showed significant difference between both types of 
tissue with higher water content in tumor. There is a multitude of factors that could 
explain this observation. In particular, the fact that water is attracted to necrotic tissue 
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which is also abundantly present in most colorectal liver metastases, the high water 
content of collagenous stroma in general, and tumor induced stroma could play a role. 
From Table 2, one can observe a low Mie scattering contribution in liver 
compared to other organs. The reported Mie-to-total scattering fraction in healthy tissue 
and tumors are 44% and 57%, respectively. Optical properties such as the absorption 
coefficient, scattering coefficient and anisotropy of porcine liver were measured with a 
double integrating sphere setup by Fritz et al. [40] where it is clearly shown that the 
anisotropy of liver tissue steeply increases from 0.75 to 0.9 between 400 and 600 nm and 
is constant at a value of 0.93 beyond 600 nm up to 1600 nm. By applying the double 
power law for reduced scattering as expressed in Eq. (1) to the data of Fritz et al. up to 
1600 nm, the Mie-to-total reduced scattering contribution is as low as 59% which is 
comparable to the values reported in table 2. This is a result of the high gradient of the 
anisotropy below 600 nm. Rayleigh scattering occurs due to the interaction of light with 
sub-micron structures, such as thin fibers, in tissue and it was proven that it is necessary 
to include a Rayleigh term in the reduced scattering model beyond 500 nm [41]. Liver is 
very rich in sub-micron reticular fibers in the perisinusoidal space separating hepatocytes 
from sinusoids, likely yielding high Rayleigh scattering [38].  
Table 2 reports a median value of blood volume fraction in healthy and metastatic 
tissue of 3.2% and 0.8%, respectively. However, despite this large difference, there is 
statistically no significant difference (p < 0.05) between the two types of tissue because 
the standard deviation for tumor tissue is very large. The reason is that in two of the 
fourteen tumor samples, which were large necrotic samples, high amounts of blood were 
present. Indeed it is known that most tumors have a vascular network of higher density 
than most normal tissues. However, the opposite is true for colorectal liver metastases, as 
normal liver tissue is extremely well vascularized to fulfill its many functions related to 
metabolism, detoxification, bile production, etc. The absorption coefficient of the human 
liver measurements in ref. [39] was found to be higher in the liver than in the metastases 
for the wavelengths of interest which in fact means that more blood is present in healthy 
liver tissue than in metastatic tumors which corroborates with the estimated blood volume 
fraction in table 2. 
Given the distance between the emitting and collecting fibers, the amount of light 
that is collected below 600 nm is in some cases close to the noise level because of the 
high blood amount (above roughly 5%) in the liver. The high amount of blood causes a 
decrease in the amount of light that is collected. In order to enhance the reliability of the 
estimated parameters of the blood and bile, one could measure below 500 nm where 
additional absorption peaks of these chromophores exist (cf. figure 2) by using a smaller 
distance separation between the emitting and collecting fibers.  
 
5. Conclusion 
In conclusion, this paper presents the first study in which bile, water and lipid are 
included in addition to oxygenated and deoxygenated hemoglobin in the discrimination 
between healthy and metastatic tumors tissues in human liver with diffuse optical 
spectroscopy. The absorption spectrum of bile was accurately measured and integrated in 
the model in order to estimate the concentration of this chromophore in the liver. We have 
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demonstrated that bile should be included when analyzing diffuse optical spectroscopy 
data, because of its presence in the liver bile ducts. Our results illustrate that 
discrimination between healthy and metastatic liver cancer tissues seems possible based 
on the estimated bile volume fraction and reduced scattering amplitude obtained from 
diffuse optical spectra measured on both types of tissue. Compared to healthy tissue, 
tumors have around five and two times lower bile and reduced scattering amplitude 
values, respectively. This method can also be applied during real-time intra-operative 
needle localization and ablation monitoring to improve ablation efficacy and hence 
disease-free survival. 
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Abstract 
Introduction. There is an increasing trend for optical guidance techniques in 
surgery. Optical imaging using Diffuse Reflectance Spectroscopy (DRS) can distinguish 
different tissue types through a specific “optical fingerprint”. We aim to evaluate whether 
DRS could discriminate metastatic tumor tissue from normal liver tissue and in this way 
would be a potential technology for further implementation into surgical or radiological 
intervention tools.    
 Methods. A miniaturized optical needle was developed able to collect DRS spectra 
between 500 and 1600 nm. Liver specimen of 24 patients operated for colorectal liver 
metastases were analyzed with DRS immediately after resection. Multiple measurements 
were performed and DRS results were compared to the histology analysis of the 
measurement locations. In addition, normal liver tissue was scored for the presence or 
absence of steatosis. 
 Results. A total of 780 out of the 828 optical measurements were correctly 
classified into either normal or tumor tissue. The resulting sensitivity and specificity were 
both 94%. The results of the analysis for each patient individually showed an accuracy of 
100%. The Spearman‟s rank correlation of DRS estimated percentages of hepatic 
steatosis in normal liver tissue compared to that of the pathologist was 0.86. 
 Conclusion. DRS demonstrates a high accuracy in discriminating normal liver 
tissue from colorectal liver metastases. DRS can also predict the degree of hepatic 
steatosis with high accuracy.  The technique, here demonstrated in a needle like probe, 
may as such be incorporated into surgical tools for optical guided surgery or percutaneous 
needles for radiological interventions. 
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1. Introduction 
In the last decade, optical sensing by means of diffuse reflectance spectroscopy 
(DRS) has developed into a promising technique that could make a significant 
contribution to the diagnosis and treatment monitoring of cancer [1, 2]. DRS is an optical 
measurement technique that records changes in the spectral distribution of light after its 
interaction with the molecules of the tissue. Main changes in the reflected spectra are a 
result of a combination of absorption and scattering of light. By illuminating tissue with a 
selected spectral band of light and subsequent analysis of the characteristic scattering and 
absorption patterns, it is possible to obtain an „optical fingerprint‟ of the tissue. Such an 
optical fingerprint represents specific quantitative biochemical en morphological 
information from the examined tissue and may depend on metabolic rate, vascularity, 
intra-vascular oxygenation and alterations in tissue morphology. By allowing specific 
differentiation between tissues, this technique has the potential to be incorporated into 
optical tools for cancer diagnosis and therapy. As such, DRS is progressively being 
explored for sole use as well as for combined use with conventional imaging techniques. 
It has been performed for tissue surface analysis during endoscopical procedures but also 
for analysis of tissue abnormalities in solid organs [3-8]. Within breast cancer, several 
groups have investigated the improvement of tissue biopsy and surgical margin analysis 
with DRS, demonstrating promising results in the discrimination of malignant lesions 
from normal breast tissue [9-11]. 
 Also in patients with primary liver malignancy or metastatic disease to the liver, 
DRS could contribute to daily clinical care. For example, DRS can be incorporated into 
surgical tools or percutaneous intervention needles enabling direct optical guidance by 
real time tissue information at the tip of the instrument.  Such an approach would result in 
guided surgery by optical sensing and could improve surgical outcome by predicting 
resection planes, especially in deep seated smaller tumors or those lesions that are 
difficult assessable. In addition, DRS has shown to identify irreversible cell damage 
during RFA procedures in animal experiments, opening the potential to monitor the 
efficacy during percutaneous RFA ablations in liver tumors [12]. Finally, DRS could be 
of additional value by predicting severe steatosis hepatis and therefore preventing too 
extensive resections in these high risk patients [13-16].  
Despite the potential application of DRS in patients with liver malignancies, 
studies on the use of DRS in human liver tissue are scarce [12, 17-20].  Recently, we 
described bile to be an important liver tissue chromophore, enabling DRS analysis to 
overall discriminate normal liver tissue from metastatic tumor tissue [21]. However, in 
that study a method for tissue prediction in individual patients was still missing. To 
proceed to further clinical implementation we now aim to investigate whether DRS is 
able to discriminate tumor tissue from normal liver tissue in individual patients. 
Moreover, we are interested whether the technique could judge the presence of hepatic 
steatosis, an important limiting factor for extensive liver resections after prolonged 
chemotherapy.  
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2. Materials and methods 
2.1 Clinical study design 
This study was conducted at The Netherlands Cancer Institute (NKI-AVL) under 
approval of the internal review board. Liver tissue was obtained from 24 patients 
undergoing partial liver resection for metastatic colorectal cancer. Shortly after resection, 
tissue was transported to the pathology department for optical spectroscopy analysis. 
After gross inspection by the pathologist, the optical spectra were collected from 
macroscopic normal liver tissue and tumor tissue. From both tissue classes, multiple 
measurements were performed, in total 393 DRS measurements in normal liver 
parenchyma and 435 in metastatic liver lesions. After data acquisition, the measurement 
sites were marked and specimens were fixed in formalin. After fixation, the marked tissue 
measurement locations were selected for cutting and processed for standard Hematoxylin 
and Eosin (H&E) staining. An experienced pathologist, who was blinded for the outcome 
of the spectroscopy analysis, examined the histological slides and visually determined if 
the measurements location was either tumor or normal liver tissue. In addition, for normal 
liver tissue the degree of steatosis was determined. The quantitative assessment of 
steatosis was determined by estimating the percentage of hepatocytes containing lipid 
droplets (both micro- and macrosteatotic droplets). The pathologic degree of steatosis was 
estimated with 5% steps.     
 
2.2 Instrumentation 
The instrumentation and calibration procedure of our optical spectroscopy system 
has recently been described elsewhere by Nachabé et al. [21-24] 
 The system consists of a console comprising a Tungsten/Halogen broadband light 
source, two spectrometers and an optical probe with three optical fibers. The two 
spectrometers resolve light in the visible wavelength range between 400 nm and 1100 nm 
(Andor Technology, DU420A-BRDD) and in the near infrared wavelength range from 
800 up to 1700 nm (Andor Technology, DU492A-1.7), respectively. The developed 
miniaturized optical probe contains three optical fibers: one fiber is connected to the light 
source, while the other two fibers are connected to the spectrometers to capture the 
diffusely scattered light from the tissue (Figure 1). The average tissue volume that is 
illuminated is roughly 5 mm
3
. The acquisition time of each spectrum was on average one 
second.  
 129 
 
Optical sensing for tumor detection in the liver Chapter 6 
 
Figure 1. Schematic overview of the diffuse reflectance spectroscopy system. 
 
2.3 Spectral data processing 
 The light delivered by the illumination optical fiber is subject to optical absorption 
and scattering. Each biological substance in the probed tissue has its intrinsic optical 
absorption property as a function of wavelength.  In the wavelength range between 500 and 
900 nm the dominant chromophores are hemoglobin (oxygenated and deoxygenated) [25], 
bile [21] and β-carotene [9]. In the wavelength range between 900 and 1600 nm, the 
dominant chromophores are water, fat and collagen [24]. Each of these chromophores has a 
well determined optical absorption spectrum available in literature [22]. The total 
absorption coefficient corresponds to the sum of each of these chromophore-specific 
absorption coefficient weighted by the respective volume fraction that it occupies within 
the total probed volume. In addition to absorption, light is also subject to optical scattering 
in tissue due to its morphological irregularity. Optical scattering is defined by a reduced 
scattering amplitude at an arbitrarily given wavelength (e.g. at 800 nm) and a slope. The 
scattering characteristics are dependent on the cellular structure of the target tissue and are 
sensitive to size and density of cellular and subcellular structures. Total scattering is 
composed of Mie scattering (scattering of cellular particles which have a diameter of the 
same or higher order of magnitude than the wavelength) and Rayleigh scattering (scattering 
of cellular particles which have a diameter smaller than the wavelength). 
An analytical model was used to estimate the various chromophore volume 
fractions and scattering coefficients from all the acquired spectroscopy measurements. This 
model was first described by Farrell et al. [26] The measurements are fitted with the 
analytical model by applying a non-linear Levenberg-Marquardt inversion algorithm. 
Diffuse reflectance spectra acquired from the tissue were fitted and analyzed over the 
wavelength range from 500 to 1600 nm. Spectral characteristics analysis was performed 
with a Matlab software package (MathWorks Inc., Natick, MA). Quantified mean values 
for each tissue parameter were calculated and displayed in boxplots.  
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2.4 Tissue classification analysis 
A Classification And Regression Tree (CART) algorithm was used to 
automatically classify each collected tissue into either of the two defined tissue types 
based on the parameters (i.e. volume fractions of the various chromophores and the 
reduced scattering properties) derived from the measurements [25].  With the CART 
algorithm, a decision tree is created based on the five most significantly different tissue 
chromophores and scattering parameters using a leave-one-out (LOO) cross validation 
scheme. Each spectrum is separately classified as either normal or tumor tissue based on 
the calculated thresholds in the decision tree and subsequently compared to the histology 
analysis and presented in terms of sensitivity and specificity. An advantage of the CART 
method is that the results can easily be interpreted and correlated to clinical details, since 
the input parameters are thresholds of the calculated values of the main tissue parameters. 
The CART analysis was performed for all acquired data collectively and also for each 
included patient individually. For the individual analysis, all measurements in each 
defined tissue class were analyzed and compared to the corresponding histological 
diagnosis. We chose an arbitrary threshold of an 80% agreement between all DRS 
measurements at a marked tissue site and the histopathological diagnosis of that site to 
either determine the DRS measurements as correct (≥80%) or define the measurements as 
uncertain (<80%).  
 
2.5 Statistical analysis 
 The DRS-estimated quantification of each parameter in the liver tissues cannot be 
described by a parametric distribution such as the Gaussian distribution. The statistical 
differences between normal liver tissue and tumor tissue were therefore determined using 
the non-parametric Kruskal-Wallis test [27].  P-levels smaller than 0.05 were considered 
statistically significant. 
 The lipid fraction scored by the pathologist was the area fraction (Larea) of the 
slide containing lipid, while with the DRS method we determine the volume of lipid 
fraction. Assuming a homogeneous volume distribution this area fraction can be 
translated in a volume lipid fraction (Lvolume) according to Lvolume = (Larea)
3/2
. For the 
correlation between the DRS and pathologists quantification of steatosis, we used 
Spearman‟s rank correlation test. Analysis was performed using SPSS (Statistical 
Package for the Social Sciences, version 16.0). 
 
3. Results 
The characteristics of all 24 patients who were included in this study are displayed 
in Table 1. 
Figure 2 shows the typical tissue spectra of both normal liver parenchyma and 
incised liver tumor tissue (colorectal liver metastases) from one of these patients. Notable 
spectral differences between the two tissue types are apparent. Photos of the 
corresponding tissue measurements and H&E stained tissue samples of the measurement 
locations are displayed on the right. 
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Table 1. Patient and tumor characteristics of all included patients. 
Number of patients 
Male 
Female 
14 
10 
Median age 
Year 
Range 
64 
41-83 
Tumor Origin 
Colon 
Rectum 
17 
7 
 
 
Figure 2. Comparison of two tissue spectra of normal liver tissue (green) and metastatic 
liver tumor (red). The optical spectra indicate the intensity of light received by the optical 
needle as a function of the wavelength for both tissue types (A). Displayed on the right is 
an incised resection specimen showing the typical white metastasis in the middle and the 
different positions of the optical probe in normal liver tissue (B) and tumor tissue (C) and 
the corresponding pathology slides of normal and tumor tissue (H&E staining). 
 
3.1 Tissue classification analysis 
Figure 3 displays boxplots of the five most significant tissue parameters as 
determined by spectral analysis. All of these parameters displayed P-values < 0.0001 when 
distinguishing normal liver tissue from liver tumor tissue. The most significant tissue 
chromophores were total hemoglobin, fat and bile content. The most significant scattering 
parameters were the scattering at 800 nm and the ratio between the Mie scattering and the 
total scattering. 
 
A
B
C
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Figure 2. Boxplots of relevant tissue parameters derived from the spectral analysis. N=828 
optical measurements. All P-values are below 0.0001. 
 
 Based on these five tissue parameters a decision tree was created using the CART 
algorithm. Table 2 displays the classification accuracy of this decision tree for all optical 
DRS measurements when compared to the histology analysis. A total of 780 out of the 828 
optical measurements were correctly classified in either normal liver tissue or liver tumor. 
This resulted in a sensitivity and specificity of both 94%. 
 
Table 2. Comparison of each optical spectrum classified by CART analysis into either 
normal liver tissue or tumor with the pathological diagnosis. 
Pathology\Model based analysis Tumor tissue Normal liver tissue 
Tumor tissue (N = 435) 410 25 
Normal liver tissue (N = 393) 23 370 
 
 The result of the analysis for each patient individually is displayed in Table 3. For 
each patient, the ratio of the number of correctly classified tissue measurements for both 
normal liver tissue and liver tumor tissue is illustrated. The data shows that for each 
individual patient the defined tissue class on the basis of DRS measurements corresponds 
to the ultimate histological diagnosis. Therefore, the accuracy of DRS to predict either 
tissue class (normal tissue or tumor tissue) was 100%. 
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Table 3. Analysis of all performed optical measurements per patient. Fraction of the 
amount of measurements correctly classified out of the total number of measurements 
performed in either normal liver tissue of liver tumor. 
Patient 
number 
Neoadjuvant 
chemotherapy 
Fraction of correctly 
classified measurements 
in normal tissue 
Fraction of correctly 
classified 
measurements in 
tumor tissue 
1 Yes 5/5 5/5 
2 No 23/24 33/35 
3 Yes 19/19 18/18 
4 Yes 20/20 23/24 
5 Yes 10/10 10/10 
6 No 10/10 15/15 
7 No 10/10 15/15 
8 No 10/10 15/15 
9 Yes 9/9 23/23 
10 Yes 16/16 18/18 
11 Yes 20/21 20/20 
12 Yes 15/15 4/4 
13 Yes 16/16 15/15 
14 No 27/27 12/13 
15 Yes 15/15 20/20 
16 Yes 15/15 20/20 
17 No 15/15 15/15 
18 No 15/15 19/19 
19 Yes 14/15 9/10 
20 Yes 19/20 39/40 
21 Yes 15/15 15/15 
22 Yes 25/26 24/25 
23 No 20/20 21/21 
24 No 25/25 20/20 
 
3.2 Hepatic steatosis 
Figure 4a represents the correlation of the estimated percentage of steatosis in 
normal liver tissue as scored by the pathologist to the quantification of fat by the DRS 
analysis. The Spearman‟s rank correlation coefficient is 0.86. Figures 4b, c and d display 
examples of the optical spectra and corresponding histology specimen of three patients 
 134 
 
Chapter 6 
with different levels of steatosis in the normal liver parenchyma. The spectrum at the 
vicinity of 1211 nm is mainly dominated by absorption of light by lipid cells. Alteration of 
the spectra in this wavelength band is observed with increasing lipid content [27]. 
 
 
Figure 4. Comparison of the quantification of the total steatosis by DRS compared to the 
histological analysis (A). Example of optical spectra taken in healthy tissue and the 
corresponding histological slides (B, C, and D). The dashed lines correspond to the 
wavelength bad for which the spectra are altered by the presence of lipid in the probed 
volume. 
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4. Discussion 
DRS has been demonstrated to be a promising new optical technique for tumor 
diagnosis by multiple studies for over a decade [3, 6, 28-35].  For several human tissue 
types, such as breast and oral cavity, an accuracy of up to 90% and 100% respectively 
were described for discrimination between normal tissue and tumor tissue. A limited 
number of studies investigated the application of DRS in human liver tissue, mainly 
focussing on spectroscopic assessment of thermal ablation [16-20]. In a recent paper, 
however, we demonstrated that the quantification of bile by DRS analysis offers the 
opportunity for more specific tissue discrimination in liver, such as between normal liver 
tissue and metastatic tumor tissue [21]. In continuation on these results we hypothesized 
that also in liver DRS is able to reach a high accuracy for the detection of tumor tissue. In 
the collective analysis of 828 optical measurements of 24 liver specimens, we indeed 
observed a sensitivity and specificity of the DRS of 94% when compared to the pathology 
analysis.  
The performance of this tissue discrimination was based on the estimated 
hemoglobin, lipid and bile content as well as the reduced scattering amplitude and the 
Mie to total scattering ratio. From these derived parameters, it can be seen that normal 
tissue contains more blood, bile and fat than the tumor tissues. The finding with respect to 
blood correlates with the macroscopic observations (cf. Figure 2B and 2C) as normal liver 
is much more abundant in red blood cells compared to metastatic tumor tissue. An 
interesting observation compared to previous studies in other organs is the decreased total 
haemoglobin content in liver tumor compared to normal liver parenchyma. Previous 
studies have all detected higher total haemoglobin content in cancer lesions compared to 
normal tissue [6, 8, 9, 32, 36]. An explanation for this difference could be that previous 
papers all studied primary tumors, while in this paper all tumors were colorectal 
metastases that typically show a solid less vascularised whitish appearance.  As notable in 
figure 2 these metastatic lesions do not all consist of vital tumor cells, but also show 
significant necrotic areas due to poor vascularity. Bile was less present in tumors as it 
concerns metastases from colorectal cancer and therefore very little bile is expected at 
these tumor sites. Another finding is that hardly any fat is present in tumors according to 
the derived fat content from the optical measurements. In general, hepatic metastases do 
not contain fat although rare cases with foci of fat in the metastases exist. Furthermore, 
normal tissue is found to have higher reduced scattering amplitude with a lower Mie 
scattering contribution as compared to tumor. This suggests that normal tissue has a larger 
density of small particles than tumors. This observation collaborates with the fact that 
healthy liver tissue is very rich in small hepatic cells compared to the metastases as can be 
seen in the histological slides in Figure 2. It must be noted that the present study was 
conducted in ex-vivo liver tissue. It remains to be determined whether specific tissue 
parameters, such as total haemoglobin count and bile content that contributed to the tissue 
discrimination in this study, will be of comparable significance in human tissue in-vivo. 
The effect of small haemorrhages, which could occur during in vivo measurements, 
remains to be seen. Oxygenation of tissue could significantly change after resection. For 
this reason we excluded this parameter form the analysis. The scattering and fat content 
parameters are unlikely to change significantly after resection since they are strongly 
 136 
 
Chapter 6 
linked to the morphology of the tissue. Also for bile a significant differences between ex 
vivo and in vivo measurements are unlikely.  
The presented figures of 94% accuracy for tissue discrimination are promising, 
but with regards to the diagnostic accuracy of any medical instrument used in clinical 
practice, the main interest will be the discriminative accuracy within any individual 
patient. In Table 3 we presented an overview of the discriminative accuracy of the DRS 
measurements for all patients individually. DRS measurements predicted the correct 
diagnosis for both normal and tumor tissue for each patient, indicating the potential of 
this technology for image guided surgery.  The fact that the optical probe we used in this 
study is already needle sized shows that further development of specific surgical or 
interventional tools is within technical reach. Such a tools would be feasible for open and 
laparoscopic surgical procedures as well as for interventional procedures in the radiology 
department. It should be stressed that the results of DRS measurements including the 
analysis are available almost real time. The present measurement and analysis time at one 
tissue location is of the order of a few hundred milliseconds but can be further reduced in 
future.  
In addtion, we have demonstrated a high correlation between the estimated fat 
content of the liver by DRS and the presence of steathosis in the histopathological 
specimen.  
This would be most relevant when major liver surgery is considered, especially in 
those patients treated extensivly with pre-operative chemotherapy. In these patients 
steatosis is often induced by prolonged chemotherapy and has been releated to higher 
morbidity scores [37-40]. The presented results suggest that DRS could play a role in 
intra-operative decision-making concerning the extent of liver resection in these patients.  
Although our results are promising towards the use of DRS in the clinical setting, 
several steps remain to be taken. First, our conclusions are based on ex-vivo data. The 
next step would be to reconfirm these conclusions in an in-vivo analysis. Furthermore, no 
primary liver malignancy was included in this study and the feasibility of DRS in primary 
liver cancer remains to be studied. This is stressed by the fact that bile is demonstrated to 
be an important discriminative chromophore between normal liver tissue and metastatic 
liver disease. In contrast to metastatic disease to the liver, primary liver cancer cells can 
produce bile. Therefore, the discrimination with DRS based on bile concentration might 
not be as significant for this tumor type as the results for colorectal liver metastases 
presented in this paper. Further studies are needed to investigate these possible 
differences. 
 
5. Conclusion  
In conclusion, we have demonstrated that DRS discriminates metastatic liver 
tissue from normal liver tissue with a high accuracy. Moreover, DRS proves able to 
determine the extent of steatosis, identifying those patients at risk for extented resections. 
These features illustrate the potential of DRS to be incorporated into image guided 
surgery tools. A prospective in-vivo analysis of DRS in liver and tumor tissue is 
underway to confirm the clinical application of this new technology for real time imaging 
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of surgical procedures as well as for minimally invasive procedures in the radiology 
department. 
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Abstract 
Background. A significant number of percutaneous intra-thoracic biopsy 
procedures result in indeterminate cytological or histological diagnosis in clinical 
practice. Diffuse Reflectance Spectroscopy (DRS) is an imaging technique that can 
distinguish different tissue types on a microscopic level. DRS may improve needle 
localization accuracy during biopsy procedures. The objective of this study was to assess 
the ability of DRS to enhance diagnosis of malignant lung disease in human lung tissue. 
Methods. Ex-vivo analysis with a DRS system was performed on lung tissue from 
10 patients after pulmonary resection for malignant disease. Tissue spectra measured 
from 500 to 1600 nm were analyzed using two analysis methods; a model-based analysis 
that derives clinical and optical properties from the measurements and a partial least 
squares discriminant analysis (PLS-DA) which classifies measured spectra with respect to 
the histological nature of the measured tissue. 
Results. Sensitivity and specificity for discrimination of tumor from normal lung 
tissue were 89% and 79% respectively based on the model-based analysis. Overall 
accuracy was 84%.  The PLS-DA analysis yielded a sensitivity of 78%, a specificity of 
86% and an overall accuracy of 81%. 
Conclusions. The presented results demonstrate that DRS has the potential to enhance 
diagnostic accuracy in minimal invasive biopsy procedures of the lungs in combination 
with conventional imaging techniques. 
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1. Introduction 
Essential first steps in the diagnostic work-up after detection of a suspected lung 
mass include describing the anatomical extent as well as the cellular origin of the tumor. 
Biopsy or fine needle aspiration of the lesion for further analysis is a crucial step in this 
process. For intra-thoracic lesions, this is often performed percutaneously. Correct 
localization of the biopsy needle within the target lesion is essential for success of this 
procedure and is frequently performed under image-guidance of computed tomography 
(CT).  
Recent studies have reported varying figures of overall accuracy for thoracic 
biopsies, which respectively range between 67% and 96% 
1-5
. Main factors influencing 
the biopsy accuracy are location and size of the intra-thoracic lesions as well as 
respiratory motion during the biopsy procedure. Moreover, even correct localization of 
the biopsy needle within the target lesion can still result in indefinite pathology diagnosis 
when the biopsy only consists of necrotic cell debris. Hence, a considerable number of 
patients undergoing percutaneous biopsies will subsequently require a repeated biopsy or 
even surgical intervention to obtain tissue material for diagnosis before an individualized 
treatment plan can be initiated.  
In recent years, promising achievements in specific tissue discrimination have 
been made in the field of diffuse reflectance spectroscopy (DRS) that may allow 
improved accuracy in cancer diagnostics 
6-8
.
  
With this optical technique changes in the 
spectral distribution of light, as a result of either absorption or scattering of light, are 
recorded after the light has interacted with molecules in tissue.  Subsequently, the 
collected spectral information is translated into morphological and physiological 
information. Changes in human tissue associated with malignant transformation include 
alterations in cellular composition, metabolic rate, vascularity, intra-vascular oxygenation 
and tissue morphology. DRS is sensitive to such changes in tissue, enabling 
discrimination between normal tissue and tumor. Ultimately, incorporation of this 
technology into biopsy needles may improve tip localization of the biopsy needle within 
the tissue compared to image-guided localization.  
Many human tissue types have been subjected to optical spectroscopy with 
promising results for clinical application of this technique. Only a few studies involving 
optical spectroscopy have focused on the characterization of human lung tissue. Those 
published mainly involved the incorporation of DRS or Fluorescence spectroscopy (FS) 
into bronchoscopy tools 
9-13
. Detection of superficial abnormalities during bronchoscopy 
procedures was proven to be enhanced with use of spectroscopy techniques within this 
setting. Sensitivity of DRS and FS ranged between 70 and 86%, specificity ranged 
between 68 and 82%. 
Recently, we have developed and validated a novel DRS system combining 
detection of visual (VIS) and near-infrared light (NIR) spectrum 
14-17
.
 
Contrary to most 
previous studies with DRS that focus on the VIS part of the spectrum, we included the 
NIR (1000-1600 nm) spectrum.  
The aim of this report is to assess the discrimination accuracy of our DRS system 
between normal lung tissue and tumor in an ex-vivo analysis.  
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2. Materials and methods 
2.1 Clinical study design 
This study was conducted at The Netherlands Cancer Institute (NKI-AVL) under 
approval of the internal review board committee. Lung tissue was obtained from 10 
patients who had undergone a pulmonary resection (lobectomy or segmental resection) 
for primary non-small cell lung cancer or pulmonary metastases.  
Directly after resection, tissue was transported to the pathology department for 
optical spectroscopy analysis. After gross inspection by the pathologist, the optical 
spectra were collected from macroscopic normal tissue and tumor samples. Spectroscopy 
measurements were performed on freshly excised tissue within two hours after the 
resection. Each specific measurement location was digitally photographed during the 
procedure. Figure 1(A) depicts a photograph of a resected lung sample with a cut through 
the tumor. A total of 330 optical measurements were performed on 67 tissue locations of 
both normal lung tissue and tumor. Resection specimens were then fixed in formalin. The 
measurement locations were subsequently selected and excised according to the 
measurement locations on the photos. These tissue samples were paraffin-embedded, cut 
in 2- to 3-μm-thick sections and stained with standard hematoxylin/eosin staining. An 
experienced pathologist, who was blinded for the outcome of the spectroscopy analysis, 
examined the histological slides. Examples of a pathology slide of normal lung tissue as 
well as tumor lung tissue are shown in Figure 1.  
 
 
Figure 1. Photograph of a resected lung sample showing a cut through the tumor. An 
example of a pathology slide of normal lung tissue with pink appearance (B) and dark 
appearance (C) as well as lung tumor (D). 
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2.2 Instrumentation 
The instrumentation and calibration procedure of our optical spectroscopy model 
have been described recently by Nachabé et al 
14-17
. 
In short, ex-vivo diffuse reflectance spectra were measured with a portable 
spectroscopic system as described earlier 
17
. The system consists of a console comprising 
a Tungsten/Halogen broadband light source and two spectrometers. The spectrometers 
resolve light either between 400 nm and 1100 nm (Andor Technology, DU420A-BRDD) 
or from 800 up to 1700 nm (Andor Technology, DU492A-1.7). An optical probe 
containing three optical fibers was connected to the optical setup. As depicted in Figure 2, 
one fiber is connected to the light source and the two other fibers are connected to the 
spectrometers to collect diffusely scattered light from the tissue. The optical probe has a 
diameter of 1.3 mm and its distal end is polished at an angle of 20 degrees. The 
illumination optical fiber is located at a distance of 2.48 mm from the two side-by-side 
optical fibers that are used to collect the diffused light (Figure 2). Such a setup enables 
spectral acquisition in the range between 500 to 1600 nm via an optical fiber with its 
distal end placed against the samples.  
 
 
Figure 2. Schematic of the DRS optical setup. 
 
2.3 Light-tissue interaction and optical spectroscopy 
The light delivered by the illumination optical fiber is subject to optical absorption 
and scattering. Each biological substance in the probed tissue has its intrinsic optical 
absorption property as a function of wavelength. The most common biological substances 
that absorb light are blood-derived chromophores such as oxygenated and deoxygenated 
hemoglobin, water and lipid 
15
. Oxygenated and deoxygenated hemoglobin have the most 
dominant absorption coefficients in the wavelength range below 900 nm whereas water 
and lipid have the most dominant absorption coefficient above 900 nm 
15
. Each of these 
chromophores has a well determined optical absorption spectrum available in literature 
15
. 
The total absorption coefficient corresponds to the sum of each of these chromophore-
specific absorption coefficient weighted by the respective volume fraction that it occupies 
within the total probed volume. This is known as the Beer-Lambert law that applies in 
non-turbid media. However, in addition to absorption, light is also subject to optical 
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scattering in tissue due to its morphological irregularities at a structural level yielding 
deflection of the light rays after interaction with the different substances present in tissue. 
The optical scattering is mathematically defined as a monotonic decreasing power-law 
function over wavelength. Therefore the optical scattering is defined by a reduced 
scattering amplitude at an arbitrarily given wavelength (e.g. at 800 nm) and a slope. The 
diffused light that is collected at the detection optical fibers correspond to a non-linear 
mathematical relation of the wavelength-dependent absorption and scattering properties 
18
. The volume of the probed diffused light in tissue is mainly dependent on the 
absorption and scattering properties as well as the distance between the illumination and 
collection fibers. Given the specification of the optical probe that was used in this study 
and the range of tissue absorption and scattering properties over the wavelength range of 
interest (i.e. 500 to 1600 nm), the average probed volume is roughly 5 mm
3
. 
 
2.4 Spectral data processing 
Two different lung tissue types were classified in the spectral data processing: 
normal lung tissue and tumor. Furthermore, measured spectra from all included 
measurement locations were separated into either the training data set (N = 171 optical 
measurements from 35 tissue locations) or the validation data set (N = 159 optical 
measurements from 32 tissue locations). This was accomplished by randomly dividing 
measurement sets from different tissue locations of both normal lung tissue and tumor from 
each included patient between the two data sets. The histological breakdown of the optical 
measurements performed in these patients is displayed in table 1.  
 
Table 1. Histological breakdown of tissue samples used for data analysis. N = 10 
patients. 
Measured tissue 
types 
Optical 
measurement 
locations 
(training and 
validation 
sets) N= 67 
Optical 
measurements 
(training and 
validation sets) 
N= 330 
Optical 
measurement 
locations 
(and 
validation 
set) N= 32 
Optical 
measurements 
(validation set) 
N= 159 
Normal lung tissue 30 145 14 66 
Tumor 37 185 18 93 
 
Finally, all acquired spectra were analyzed in two ways: First, an analytical model 
derived from the diffusion theory was used to estimate the various chromophore volume 
fractions and scattering coefficients 
18
. Second, a statistical classification of the tissue 
spectra was performed using partial least squares discriminant analysis (PLS-DA) 
19
. 
Model-based analysis. Validation of the analytical model that was used to recover 
the chromophore volume fractions and scattering coefficients from the measurements has 
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recently been described 
14-17
. Diffuse reflectance spectra measured from the tissue were 
fitted over the wavelength range from 500 to 1600 nm. A non-linear Levenberg-
Marquardt inversion algorithm was used to estimate the various unknown chromophores 
volume fractions from the spectra within the analysis wavelength range. This inversion 
consists of determining the optimum volume fractions of the four chromophores of 
interest as well as the reduced scattering amplitude (which we arbitrarily defined at 800 
nm) and slope which minimizes best the residual between the model and the measurement 
15
. A total blood volume fraction is computed as the sum of the estimated oxygenated and 
deoxygenated haemoglobin volume fraction by considering a total haemoglobin 
concentration of 150 mg per ml of blood; oxygenation level in tissue computed as the 
ratio of oxygenated hemoglobin to the total blood volume fraction, water volume fraction 
and adipose tissue volume fraction. The absorption coefficient of each of these 
chromophores in its pure state is used as a priori knowledge during the fitting procedure. 
An example of a spectral measurement on a normal lung sample and a tumor with the 
corresponding fitting curve are shown in Figure 3. The spectral characteristics analysis 
was performed with Matlab software package (MathWorks Inc., Natick, MA). Quantified 
mean values for tissue parameters were calculated based on all tissue measurements and 
were displayed in boxplots.  
Subsequently, we used the data from the training data set to design a decision tree 
for automated discrimination between normal lung tissue and tumor. This was performed 
using the Gini index maximisation and has recently been described by Nachabé et al 
17
. 
By applying this evaluation method, thresholds of the most significantly discriminating 
tissue parameters are yielded from which all included tissue measurements could be 
differentiated into either tissue class with the least number of evaluation steps. The 
calculated thresholds were depicted as a decision tree.  
PLS-DA analysis. Partial least squares (PLS) analysis is a regression method to 
find a linear relationship between a response variable Y (tissue type class) and the 
independent variables X (spectra). The method is based on finding a number of principal 
components (PC) that represent as much of the variance in X as possible and are relevant 
to the response variable Y. The PLS model is generated using part of the data, the training 
data set. A discriminant analysis (DA) method is subsequently performed to obtain 
thresholds for discriminating the different responses (tissue classes). Prediction of class 
(tissue type) on the remaining data (the validation data set) is obtained by comparing the 
predicted PLS scores with the DA thresholds. The measured tissue type is assigned to one 
of the two predefined tissue classes depending on the PLS scores. The PLS-DA algorithm 
scripts were implemented in MATLAB 7.2 using PLS Toolbox 5.8.  
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Figure 3. Example of spectral measurements in normal (point-marked curve) and 
tumor tissue (circle-marked curve) as well as the corresponding fit (solid line curve). 
 
2.5 Statistical analysis 
The DRS-estimated quantification of each parameter in the lung tissue cannot be 
described by a parametric distribution such as the Gaussian distribution. The statistical 
differences between the two distinguished lung tissues were therefore determined using a 
non-parametric Kruskal-Wallis test 
20
. P-values smaller than 0.05 were considered 
statistically significant. 
Discriminative accuracy for both the model-based and PLS-DA analysis were 
determined by comparing the means of all tissue spectra from each measurement location 
of the validation data set to the yielded thresholds from each analysis method and 
assigning each collected tissue spectrum to either defined tissue class. These results were 
then compared to the histology analysis and were subsequently presented in terms of 
sensitivity, specificity and overall accuracy.  
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3. Results 
3.1 Study characteristics 
Five of the included patients were male and five were female. All patients were 
smokers and the average age was 61 years old (range 38 to 74 years). Six of the patients 
had undergone neo-adjuvant treatment. Eight of the measured tumors were primary lung 
tumors and the remaining two measured tumors were metastases from the colon and from a 
melanoma. 
 
3.2 Tissue parameter analysis 
Tissue parameter quantification was performed as part of the model-based data 
analysis using all of the 330 collected optical spectra. Quantification was primarily 
performed on all relevant tissue parameters as well as on the reduced scattering coefficient 
at three different wavelengths. The tissue parameters with the most discriminative 
relevance were total hemoglobin volume fraction, water volume fraction, adipose tissue 
volume fraction and reduced scattering coefficient at 800 nm (Figure 4). Significant 
statistical differences were demonstrated for hemoglobin volume fraction (P < 0.001) and 
reduced scattering coefficient at 800 nm (P < 0.01).  
 
 
Figure 4. Boxplots of diagnostically relevant tissue parameters. N= 330 tissue 
measurements from 67 measurement locations. Hb+HbO2 = total hemoglobin volume 
fraction, H2O = water volume fraction; Fat = adipose tissue volume fraction; μs` = 
reduced scattering coefficient at 800 nm. 
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3.3 Classification accuracy 
Model-based analysis. The computed decision tree based on tissue parameter 
thresholds is demonstrated in Figure 5.  The means of all collected tissue spectra from each 
measurement location could be assigned to either tissue class based on thresholds yielded 
from hemoglobin volume fraction and reduced scattering coefficient in a two-step analysis. 
Results from the tissue parameter quantification of the validation data set were analysed 
according to the defined thresholds. Compared to the histology analysis overall 
discriminative accuracy of the model-based analysis was 84% (Table 2). 
 
 
Figure 5. Discriminative thresholds for automated discrimination between normal lung 
tissue and tumor depicted in a decision tree. Thresholds were calculated based on 
quantification of tissue spectra from the training data set. N = 37 measurements locations.  
 
Table 2. Model based classification accuracy of DRS measurements of lung tissue divided 
into 2 classes compared to the pathology analysis. N = 32 measurement locations. 
Pathology\Model based analysis Tumor tissue Normal lung tissue 
Tumor (N = 18) 16 2 
Normal lung tissue (N = 14) 3 11 
Sensitivity = 89%; Specificity = 79%; Overall accuracy = 84%. 
µs’ < 23.5 
cm-1 
 
Hemoglobin volume 
fraction ≥ 3.9 % 
 
µs’ ≥ 23.5 cm
-1 
 
NORMAL TUMOR 
Hemoglobin volume 
fraction < 3.9 % 
µs’ < 31 cm
-1 
 
µs’ ≥ 31 cm
-1 
 
NORMAL TUMOR 
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PLS-DA analysis. Results from the PLS-DA classification analysis of the spectra 
are displayed in Figure 6. For several measurements difficulty discriminating between 
normal lung tissue and tumor was apparent. Overall discriminative accuracy of the PLS-
DA analysis was 81% (Table 3). 
 
 
Figure 6. PLS-DA classification of the spectra of DRS measurements comparing benign to 
malignant tissue. Each square represents a tissue measurement from which the spectrum is 
compared to the spectral thresholds acquired from the training data set analysis. N= 32 
measurement locations. Red circles represent the histological diagnosis tumor and green 
squares normal lung tissue. 
 
Table 3. PLS-DA classification accuracy of DRS measurements of lung tissue divided into 
two classes compared to the pathology analysis. N = 32 measurement locations. 
Pathology\PLS-DA Tumor tissue Normal lung tissue 
Tumor tissue (N = 18) 14 4 
Normal lung tissue (N = 14) 2 12 
Sensitivity = 78%; Specificity = 86%; Overall accuracy = 81%. 
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4. Discussion 
This report demonstrates first published results of a novel Diffuse Reflectance 
Spectroscopy system, combining the analysis of spectral results after ex-vivo lung tissue 
illumination with both visual and near infra-red light. Research with DRS on other human 
tissue has proven the potential of this technique for tissue discrimination. As yet, this was 
never performed including near-infrared spectra beyond 1000 nm 
21-25
. The advantage of 
having an additional spectrometer that resolves light above 900 nm is the possibility to 
measure spectra in a range where water and lipid have high absorption coefficients 
14
. 
Therefore accurate volume fractions of these biological substances can be determined and 
used for classification on top of the commonly used blood derived chromophores and 
scattering parameters 
9-10
. Although no significant differences was observed between 
normal and tumor in water, Figure 4 shows that estimated water distribution is skewed to 
higher values in tumor than normal lung tissue. We expected that the water volume 
fraction would be higher in tumor tissue compared to normal because normal tissue 
consists of air filled alveoli compared to more solid, no air containing, tumor tissue. 
Probably due to the resection these alveoli are partly collapsed resulting in a more dark 
appearance of the normal lung tissue. This is supported by pathology findings showing 
collapsed alveoli in the normal lung tissue with darker appearance (Figure 1(C)).  These 
results indicate that accurate determination of the water volume fraction might play a role 
in discriminating normal and tumor an in vivo setting where the above effect is not 
expected. As a result having a spectrometer to resolve light for wavelengths beyond 900 
nm, being able to determine accurately the water volume fraction, might then turn out to 
be useful. From the boxplots, one can further notice that normal lung samples have 
significantly higher blood volume fraction than in tumors. This can be seen in Figure 
1(A) with the tumor being the white part surrounded by the pink normal lung tissue. The 
scattering of tissue in normal is higher in normal than in tumor samples according to the 
boxplots. This is due to the fact that normal lung tissue has a multitude of alveolus filled 
with air that yields to greater light scattering (related to refractive index changes in tissue) 
as opposed to the solid tumors.  
Using two different data analysis methods our DRS system yielded a promising 
overall discriminative accuracy of 84% for the model-based data analysis and 81% for the 
PLS-DA analysis compared to the pathology analysis. These results indicate that DRS has 
the potential to enhance diagnostic accuracy during minimal invasive thoracic procedures 
in combination with conventional imaging techniques.   
In clinical practice, the main objective for correct localization of the needle within 
the target lesion is accurate identification of the tumor itself. High specificity of an 
imaging modality is therefore the most important parameter. Hence, the higher the 
specificity, the lesser indeterminate results can be expected. In previously published 
papers specificity for thoracic biopsies mainly with CT guidance ranges from 83 to 97%, 
resulting in indeterminate biopsies in 3 to 17% of the patients  
1-5
. An indeterminate 
biopsy is defined as a biopsy which was thought to be taken from the target lesion, but 
cannot be characterized as malignant tissue by the pathologist. The best specificity result 
displayed in the current paper was 86% with the PLS-DA data analysis. This would result 
in an expected indeterminate test results of 14% of patients. Because the two diagnostic 
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tests can be considered independent when performed together, the test accuracy from both 
tests may be multiplied to calculate the suspected combined discriminative accuracy. A 
combination of biopsy with CT imaging and displayed DRS incorporated in a biopsy 
needle could in theory therefore improve biopsy specificity to 98%. It can be concluded 
that DRS has the potential to enhance diagnostic accuracy during minimal invasive 
thoracic procedures in comparison with conventional imaging techniques. This hypothesis 
will have to be proven in future in-vivo experiments. 
Additional arguments can be given towards the expected feasibility of DRS in an 
in-vivo analysis. First; we would expect tissue scattering to have a more significant 
discriminative effect in an in-vivo analysis. Hence, in the in-vivo setting the alveoli will 
be air-filled. The expected scattering will therefore be higher compared to the ex-vivo 
collapsed alveoli due to the larger refraction index mismatch between air and human 
tissue. Thus, the expected difference in the scattering coefficient compared to solid tumor 
will be larger. Second; we expect the water volume fraction to show more difference 
between the normal and tumor tissue due to the air filled alveoli. Third; we expect a 
greater number of significant discriminative tissue parameters in in-vivo measurements. 
The main discriminative tissue parameters in this study were total hemoglobin volume 
fraction and the reduced scattering coefficient at 800 nm. Fawzy et al. and Bard et al. 
both demonstrated similar results with these tissue parameters in their in-vivo analysis of 
bronchial mucosa 
9, 12
. Another important distinguishing parameter in their studies was 
tissue oxygen saturation. Both studies demonstrated tissue oxygen saturation to be 
diminished in cancerous lesions in comparison to normal lung tissue. In our DRS 
analysis, no significant differences in tissue saturation were displayed between normal 
lung tissue and tumor. Overall fitting results of our optical measurements revealed an 
average oxygenation in normal lung tissue of 31% (SD ±22%) compared to 24% (SD 
±22%) in measured tumor tissue (data not displayed). This is most likely due to the nature 
of this analysis and the ex-vivo optical measurements. Moreover, during the operation the 
target tissue specimen is progressively impaired from blood circulation before final 
resection is performed.  
Furthermore, for future analysis we plan to combine DRS with Fluorescence 
spectroscopy. Discriminative accuracy of such a combined spectroscopy system has been 
proven to be superior to each spectroscopy technique alone in two recent studies of 
human breast tissue 
26, 27
. Thus, an overall improvement of our discriminative accuracy is 
to be expected in future in-vivo experiments of lung tissue.  
Although our results are promising, a critical assessment must be noted. First, 
although analyses were performed on a significant number of measured spectra which are 
comparable to quantities in previously published studies, a restricted number of patients 
(N=10) and tissue specimens were utilized. Heterogeneity between patients could have a 
negative effect on the discriminative accuracy. Second, total hemoglobin volume fraction 
was demonstrated to be the main discriminative parameter. It is unclear what the 
discriminative value of a comparable analysis of lung tissue in an in-vivo setting would be 
in case of local hemorrhage caused by the optical needle. Hence, located hemorrhage 
during minimal invasive spectroscopy measurement could have a negative effect on 
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optical measurement due to the absorption properties of hemoglobin in the visual 
spectrum.  
In conclusion, a novel Diffuse Reflectance Spectroscopy system was presented for 
analysis of human lung tissue. Overall discriminative accuracy of the DRS system 
compared to the pathology analysis was 84% and 81% for model-based and PLS-DA 
analysis, respectively. Based on the presented results, we conclude that DRS has the 
potential to enhance diagnostic accuracy in minimal invasive procedures of the lungs. In-
vivo experiments are currently being performed by our group to confirm these results as a 
next step towards before clinical application. 
 
5. Acknowledgments 
The authors would like to thank the pathology department staff at the Netherlands 
Cancer Institute (NKI-AVL) and Philips Research project members for their contribution 
in the optical data collection and assessment. In particular, we thank W. Bierhoff for the 
probe development and J. Horikx for the optical console development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 155 
 
Diffuse reflectance spectroscopy: a new guidance tool for improvement of biopsy 
procedures in lung malignancies 
Chapter 7 
References 
1. Gong Y, Sneige N, Guo M, Hicks M, Moran C. Transthoracic fine-needle aspiration vs 
concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective 
comparison of diagnostic accuracy.  Am J Clin Pathol 2006; 125:438-444. 
2. Rivera M, Detterbeck F, Mehta A. Diagnosis of lung cancer: the guidelines. Chest 
2003; 123:129S-136S. 
3. Priola A, Priola S, Cataldi A, Di Franco M, Pazè F, Marci V, et al. Diagnostic accuracy 
and complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study 
based on the experience of the cytopathologist. Acta Radiol. 2010; 51(5):527-533. 
4. Kothary N, Lock L, Sze D, Hofmann L. Computed tomography-guided percutaneous 
needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin 
Lung Cancer 2009; 10(5):360-363. 
5. Aviram G, Greif J, Man A, Schwarz Y, Marmor S, Graif M, et al. Diagnosis of 
intrathoracic lesions: are sequential fine-needle aspiration (FNA) and core needle biopsy 
(CNB) combined better than either investigation alone? Clin Radiol. 2007; 62(3): 221-
226. 
6. Sćepanović O, Volynskaya Z, Kong C, Galindo L, Dasari R, Feld M. A multimodal 
spectroscopy system for real-time disease diagnosis.  Rev Sci Instrum 2009; 80(4):043103. 
7. Frangioni J. New technologies for human cancer imaging.  J Clin Oncol 2008; 
26(24):4012-4021. 
8. Brown J, Vishwanath K, Palmer G, Ramanujam N. Advances in quantitative UV-
visible spectroscopy for clinical and pre-clinical application in cancer.  Curr Opin 
Biotechnol 2009; 20: 119-131. 
9. Bard M, Amelink A, Hegt V, Graveland W, Sterenborg HJ, Hoogsteden H, et al. 
Measurement of hypoxia-related parameters in bronchial mucosa by use of optical 
spectroscopy.  Am J Respir Crit Care Med 2005; 171: 1178-1184. 
10. Bard M, Amelink A, Skurichina M, Noordhoek Hegt V, Duin R, Sterenborg H, et al. 
Optical spectroscopy for the classification of malignant lesions of the bronchial tree.  
Chest 2006; 129:995-1001. 
11. Fawzy Y, Zeng H. Intrinsic fluorescence spectroscopy for endoscopic detection and 
localization of the endobronchial cancerous lesions.  J Biomed Opt 2008; 13(6): 064022. 
12. Fawzy Y, Petek M, Tercelj M, Zeng H. In vivo assessment and evaluation of lung 
tissue morphologic and physiological changes from non-contact endoscopic reflectance 
spectroscopy for improving lung cancer detection.  J Biomed Opt 2006; 11(4):044003. 
13. Hirsch F, Prindiville S, Miller Y, Franklin W, Dempsey E, Murphy J, et al. 
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a 
randomized study.  J Natl Cancer Inst 2001; 93(18):1385-1391. 
14. Nachabé R, Hendriks BH, Desjardins A, van der Voort M, van der Mark M, 
Sterenborg HJ. Estimation of lipid and water concentrations in scattering media with 
diffuse optical spectroscopy from 900 to 1,600 nm.  J Biomed Opt 2010; 15(3):037015. 
15. Nachabé R, Hendriks BH, van der Voort M, Desjardins A, Sterenborg HJ. Estimation 
of bilogical chromophores using diffuse optical spectroscopy - benefit of extending the 
UV-VIS wavelength range to include 1000 to 1600nm. Optics Express 2010; 18(24): 
1432-1442. 
 156 
 
Chapter 7 
16. Nachabé R, Evers DJ, Hendriks BH, Lucassen G, van der Voort M, Wesseling J, et al. 
Effect of bile absorption coefficients on the estimation of liver tissue optical properties 
and related complications in discriminating healthy and tumorous samples. Optics 
Express 2011; 2(3): 600-614. 
17. Nachabé R, Evers DJ, Hendriks BH, Lucassen G, van der Voort M, Rutgers EJ, et al. 
Diagnosis of breast cancer using diffuse optical spectroscopy from 500 to 1600 nm: a 
comparison of classification methods. J Biomed Opt 2011; 16(8): 087010. 
18. Farrell T, Patterson M, Wilson B. A diffusion theory model of spatially resolved, 
steady-state diffuse reflectance for the noninvasive determination of tissue optical 
properties in vivo. Med Phys. 1992; 19(4):879-888. 
19. Barker M, Rayens W. Partial least squares of discrimination. J Chemometrics 2003; 
17(3):166-173. 
20. Kruskal W, Wallis W. Use of Ranks in One-Criterion Variance Analysis. J American 
Statistical Association 1952; 47(260): 583-621. 
21. Bigio I, Bown S, Briggs G, Kelley C, Lakhani S, Pickard D, et al. Diagnosis of breast 
cancer using elastic-scattering spectroscopy: preliminary clinical results.  J Biomed Opt. 
2000; 5(2):221-228. 
22. Zhu C, Palmer G, Breslin T, Harter J, Ramanujam N. Diagnosis of breast cancer using 
diffuse reflectance spectroscopy: Comparison of a Monte Carlo versus partial least 
squares analysis based feature extraction technique.  Lasers Surg Med. 2006; 38:714-724. 
23. Brown J, Wilke L, Geradts J, Kennedy S, Palmer G, Ramanujam N. Quantitative 
optical spectroscopy: a robust tool for direct measurement of breast cancer vascular 
oxygenation and total hemoglobin content in vivo.  Cancer Res. 2009; 69(7):2919-2926. 
24. Chang V, Cartwright P, Bean S, Palmer G, Bentley R, Ramanujam N. Quantitative 
physiology of the precancerous cervix in vivo through optical spectroscopy.  Neoplasia 
2009; 11(4):325-332. 
25. Wang H, Jiang J, Lin C, Lin J, Huang G, Yu J. Diffuse reflectance spectroscopy 
detects increased hemoglobin concentration and decreased oxygenation during colon 
carcinogenesis from normal to malignant tumors.  Opt Express 2009; 17(4):2805-2817. 
26. Volynskaya Z, Haka A, Bechtel K, Fitzmaurice M, Shenk R, Wang N, et al. 
Diagnosing breast cancer using diffuse reflectance spectroscopy and intrinsic 
fluorescence spectroscopy.  J Biomed Opt 2008; 13(2):024012. 
27. Majumder S, Keller M, Boulos F, Kelley M, Mahadevan-Jansen A. Comparison of 
autofluorescence, diffuse reflectance, and Raman spectroscopy for breast tissue 
discrimination.  J Biomed Opt 2008; 13(5):054009. 
  
 
Chapter 8 
Diagnosis of breast cancer using optical 
spectroscopy from 500 to 1600 nm: a comparison 
of classification methods 
 
 
 
 
 
 
Rami Nachabé 
Daniel J. Evers 
Benno H. W. Hendriks 
Gerald W. Lucassen 
Marjolein van der Voort 
Emiel J. Rutgers 
Marie-Jeanne Vrancken Peeters 
Jos A. van der Hage 
Hesters S. Oldenburg 
Jelle Wesseling 
Theo J. M. Ruers 
 
J. Biomed. Opt.2011 August, 16: 087010 
 158 
 
Chapter 8 
Abstract 
We report on the use of diffuse optical spectroscopy analysis of breast spectra 
acquired in the wavelength range from 500 to 1600 nm with a fiber optic probe. A total of 
102 ex vivo samples of five different breast tissue types, namely adipose, glandular, 
fibroadenoma, invasive carcinoma and ductal carcinoma in situ from 52 patients were 
measured. A model deriving from the diffusion theory was applied to the measured 
spectra in order to extract clinically relevant parameters such as blood, water, lipid, and 
collagen volume fractions, β-carotene concentration, average vessels radius, reduced 
scattering amplitude, Mie slope and Mie-to-total scattering fraction. Based on a 
classification and regression tree algorithm applied to the derived parameters, a 
sensitivity-specificity of 98%-99%, 84%-95%, 81%-98%, 91%-95%, and 83%-99% were 
obtained for discrimination of adipose, glandular, fibroadenoma, invasive carcinoma, and 
ductal carcinoma in situ, respectively; and a multiple classes overall diagnostic 
performance of 94%. Sensitivity-specificity values obtained for discriminating malignant 
from non-malignant tissue were compared to existing reported studies by applying the 
different classification methods that were used in each of these studies. Furthermore, in 
these reported studies, either lipid or β-carotene was considered as adipose tissue 
precursors. We estimate both chromophore concentrations and demonstrate that lipid is a 
better discriminator for adipose tissue than β-carotene. 
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1. Introduction 
Within present-day strategy of human breast cancer treatment, diagnostic biopsy 
and surgical margin assessment are two elements in which procedural accuracy could 
significantly be enhanced. 
Missed diagnoses of cancer by false-negative biopsies have been reported ranging 
from 4.3 to 17.9%, despite ongoing advance in imaging technologies. Moreover, 
indeterminate pathology analysis will result in need of repeat biopsies in between 4 to 
32% of patients [1-6].
 
 
Breast conservative therapy aimed at conserving as much breast tissue as possible, 
is the treatment of choice in patients with T1-T2 breast tumors. However, the rate of 
irradical resection and the need for a secondary surgical procedure is often over 10%, 
depending on the specific definition [7, 8]. 
 Over the last decade, new tools have been developed to classify breast tissue and 
assess breast tissue margins based on optical spectroscopy techniques [9-22]. Bigio et al. 
performed in vivo elastic scattering spectroscopy measurements between 350 and 750 nm 
to discriminate between 13 malignant and 59 non-malignant breast tissue samples by 
applying artificial neural network (ANN) and hierarchical cluster analysis (HCA) on the 
spectra yielding sensitivity-specificity of 69%-85% and 67%-79%, respectively [9]. This 
study also showed that the spectral features between 400 and 500 nm in adipose tissue are 
mainly dominated by β-carotene light absorption, however optical properties were not 
derived from the measured spectra. The biomedical group at Duke University has 
performed several studies where optical properties were derived from measurements 
performed between 350 and 600 nm by using an inverse Monte-Carlo technique to extract 
hemoglobin and β-carotene concentrations as well as hemoglobin saturation and the 
reduced scattering amplitude [10-13]. Classification based on linear support vector 
machine (SVM) learning was performed to classify malignant (35 samples) from non-
malignant samples (50 samples including adipose and fibrous tissue types) with a 
sensitivity-specificity of 83%-80% [10]. A more recent study from the same group 
showed that it is possible to discriminate 54 malignant samples from 70 non-malignant 
samples with a sensitivity-specificity of 83%-87% based on the extracted parameters 
from diffuse reflectance measurements [11]. Volynskaya et al. conducted an ex vivo 
breast (104 samples) study where a classification between four types of breast tissue was 
performed from diffuse reflectance spectra acquired from 350 to 750 nm [14]. 
Classification of 31 normal, 55 fibrocystic change, 9 fibroadenoma, and 9 infiltrating 
ductal carcinoma was achieved with a sensitivity-specificity of 100%-100% by using a 
logistic regression algorithm (LR). An ex vivo breast study by Majumder et al. showed 
that sparse multinomial logistic regression classification of 134 normal (adipose and 
glandular), 86 invasive ductal carcinoma, 18 ductal carcinoma in situ and 55 
fibroadenoma spectra can be achieved with sensitivity-specificity ranging from 28%-86% 
to 86%-97% when only analyzing diffuse reflectance spectra acquired between 400 and 
800 nm [15]. A more recent study showed sensitivity-specificity of 85%-96% when 
discriminating 145 normal from 34 tumor (invasive ductal carcinoma and ductal 
carcinoma in situ) samples [16]. Laughney et al. presented ex vivo non-contact optical 
properties estimations from spectra acquired between 510 and 785 nm from 29 breast 
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samples and a k-nearest neighbor (KNN) classification method was used to discriminate 
between different tissue types [17]. They have shown an interesting comparison of 
classifying the different types of tissue according to their pathology identity and by 
grouping them into subgroups such as adipose (7021 spectra), non-malignant (533 
inflammation, 4110 benign epithelia, and 31226 normal epithelia spectra), and malignant 
(194 ductal carcinoma in situ, 479 invasive lobular carcinoma, and 22547 invasive ductal 
carcinoma spectra). Their results showed sensitivity-specificity of 87%-99%, 90%-82%, 
and 77%-90% for adipose, non-malignant and malignant, respectively. However, a 
sensitivity-specificity of 87%-99%, 74%-74%, 9%-91%, 0%-100%, 77%-90%, 0%-
100%, and 0%-100% was reached for adipose, normal epithelia, benign, inflammation, 
invasive ductal carcinoma, ductal carcinoma in situ, and invasive lobular carcinoma, 
respectively. 
 Other studies [18-21] investigated wavelength ranges between 600 and 1100 nm 
where water and lipid were estimated in addition to hemoglobin. Therefore adipose tissue 
could be discriminated based on the amount of estimated lipid and not β-carotene, since 
this chromophore has negligible absorption above 600 nm. However these investigators 
did not perform classification on their data. 
In our study, we have conducted an ex vivo trial to estimate optical properties 
from 102 samples of five different types of breast tissue: adipose, glandular, invasive 
carcinoma (IC), fibroadenoma (FA), and ductal carcinoma in situ (DCIS) measured in 52 
patients. Optical spectra were taken with a setup that can resolve light from 500 nm up to 
1600 nm and a model based on diffusion theory was applied to the measurements to 
estimate the optical properties by determining several parameters such as blood, water, 
and lipid volume fractions, reduced scattering amplitude, Mie slope, Mie scattering 
fraction, and pigment packaging factor [23, 24]. Besides, β-carotene was also included in 
our model since it has significant absorption up to 500 nm as demonstrated by other 
groups [9-11, 14]. Recent findings by Taroni et al. showed that collagen is an important 
absorber to include in the model for fitting the measured spectra as it has distinct 
absorption features above 900 nm [19-21]. Therefore, we measured the absorption 
coefficient of collagen up to 1600 nm and included it in our model. 
We present the first study using DRS measurements on a 500-1600 nm 
wavelength range to estimate physiological, morphological and optical properties 
parameters of ex vivo breast tissue. The classification and regression tree (CART) 
algorithm, a probabilistic discriminative classification method, was applied to the derived 
parameters to evaluate the performance of diagnosis of the five measured types of tissues. 
Sensitivity-specificity computation and receiver operating characteristic (ROC) curves 
analysis were performed to quantify the overall performance of the diagnosis by using the 
Provost and Domingos measure (PDM) [25].   
In addition, several classification methods that were used in literature to 
discriminate malignant from non-malignant tissues were applied to our data in order to 
compare our results with those reported in existing literature studies. Additional 
classification methods were also applied for comparison. 
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Finally, classification of adipose tissue based on either β-carotene or lipid only 
was compared as no existing breast studies in literature made a comparison on classifying 
adipose tissue based on only one of these two adipose tissue precursors. 
 
2. Materials and methods 
2.1.Ex vivo breast sample collection 
      The human breast samples were obtained under approval by the internal 
review board committee of the Dutch Cancer Institute in Amsterdam, The Netherlands 
(NKI-AVL) where this study was conducted. The breast samples that were measured 
corresponded to resection specimens of either to mastectomies or lumpectomies. Breast 
samples of patients subject to mastectomy were sliced with a thickness of roughly 0.5 to 1 
cm whereas the sample sizes of the patients who were subject to lumpectomy (e.g. 
fibroadenoma) corresponded to the size of the excised tissue which was in average 
several millimeters in diameter. After surgical resection, resection samples were 
transferred to the pathology department within 2 hours where they were inked at the 
surface before slicing them for histological processing. All optical measurements were 
performed before formalin fixation and tissue preparations by the pathologists in order to 
limit as much as possible changes in the optical properties from the tissue conditions 
when excised. Five different types of tissue were measured based on the macroscopical 
indication by the pathologist: adipose, glandular, fibroadenoma (FA), invasive carcinoma 
(IC) and ductal carcinoma in situ (DCIS). A total number of 102 samples from 52 patients 
were investigated from which a total number of 980 spectra were acquired and co-
registered with the pathological findings. The pathological diagnosis performance was 
very high for all the cases that we have tested. The cancerous cases were all 
macroscopically clear cut carcinomas; and in case of doubt we were reluctant to include 
such cases in this study. Table 1 summarizes the histological breakdown of the breast 
tissue samples including the amount of acquired spectra in this study. 
 
Table 1. Histological description of breast tissue types and the corresponding amount of 
samples and spectra that were measured. 
Type of breast tissue (abbreviation) Number of samples Number of spectra 
Non-Malignant 73 643 
   Adipose 43 327 
   Glandular 23 189 
   Fibroadenoma (FA) 7 127 
Malignant 29 337 
   Invasive Carcinoma (IC) 21 241 
   Ductal Carcinoma In Situ (DCIS) 8 96 
Total 102 980 
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2.2.Instrumentation and spectral calibration 
      Ex vivo diffuse reflectance spectra were taken using a portable spectroscopic 
system as illustrated in Fig. 1 and used in previous studies [23, 24, 26]. A tungsten 
halogen broadband light source with an integrated shutter (Ocean Optics, HL-2000-HP) 
was used to deliver light into tissue. Delivery of light to the tissue and its collection were 
achieved with a 1.3 mm diameter fiber-optic probe with a distal end polished at an angle 
of 20 degrees. The probe comprises three 200-μm core diameter optical fibers with one 
fiber connected to the light source that is located 2.48 mm from the two side-by-side 
optical fibers that are used to collect the diffused light. The optical fibers used for the 
collection of light are connected to a spectrometer with a silicon detector (Andor 
Technology, DU420A-BRDD) and a spectrometer with an InGaAs detector (Andor 
Technology, DU492A-1.7), respectively. After thermoelectrically cooling the detectors to 
-40˚C, wavelength values were assigned to each pixel of the detector by fitting a second-
order polynomial to a set of atomic lines from an argon source with peaks at known 
wavelength. Subsequently, the spectral response of a white reflectance standard 
(Spectralon) with known reflectivity was measured by placing the distal end of the probe 
at a fixed distance of roughly 2 mm and followed by a background measurement in order 
to minimize the impact of ambient light. This step is necessary as it allows correcting for 
the system response (e.g. spectral shape of the light source and wavelength-dependent 
sensitivity in the optics and gratings and the detectors). This white reference measurement 
is used to divide each spectral measurement on the tissue samples for which a background 
measurement is subtracted yielding to the final reflectance measurement. The integration 
time for each measurement is in average 0.5 second. The reflectance spectra obtained 
with both spectra are combined together to form one single reflectance spectrum ranging 
from 500 to 1600 nm and is used in order to apply the mathematical modeling for the data 
analysis. 
 
Figure 1. Schematic of the optical setup and the design of the optical probe. 
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2.3. Spectral data modeling  
       The measured spectra were fitted from 500 to 1600 nm with the model of 
Farrell et al. [27] that is derived from diffusion theory using a Levenberg-Marquardt non-
linear inversion algorithm in order to determine the absorption coefficient       and the 
reduced scattering coefficient   
     expressed in cm-1. The validation of the model based 
on a phantom study, including spectral calibration procedures, and its application to in 
vivo and ex vivo tissues were justified in detail elsewhere [23, 24].  
The model requires the distance between the emitting and collecting fibers as well 
as the wavelength-dependent absorption coefficients of the chromophores of interest as 
input arguments. Additionally, the reduced scattering coefficient was empirically 
modeled as: 
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where     = 800 nm corresponds to a wavelength normalization value,   is the reduced 
scatteringamplitude at   , the Mie scattering slope is  , and   denotes the Mie-to-total 
reduced scattering fraction assuming Mie and Rayleigh scattering as the two types of 
scattering in tissue.  
The absorption coefficient is expressed as a term that corresponds to vascular absorption 
  
        , of the light due to blood-derived chromophores and a second term   
         
due to absorption of light by other chromophores present in breast tissue. The blood 
related absorbers are deoxygenated-hemoglobin (Hb) and oxygenated-Hemoglobin 
(HbO2) and define the absorption coefficient due to blood as: 
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where    
       and   
        correspond to absorption coefficients of pure Hb and HbO2 
given an average hemoglobin concentration in blood of 150 mg/ml, respectively. The 
parameters   and       correspond to the blood volume fraction and the level of 
hemoglobin saturation by oxygen, respectively. The parameter      was used to account 
for inhomogenous distribution of hemoglobin in vessels and is known as pigment 
packaging factor [28] expressed as: 
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where   corresponds to the average vessel radius. Studies that were performed on breast 
tissue [11, 14] showed that it is important to have β-carotene (βc) as an absorber in the 
model when recording spectra in the visible range. Indeed, these studies demonstrated 
that βc is an essential discriminator for adipose tissue in breast. Other studies that 
investigated optical properties of breast in the near infrared range [18, 20] discriminate 
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adipose tissue from other types of tissue based on light absorption by lipids. However, no 
studies so far used both βc and lipid. In our study we included both absorbers in the 
model and investigated the advantage of measuring up to 1600 nm where additional water 
and lipid absorption features exist [23] which enables more accurate estimation of lipid 
volume fraction [24]. 
Taroni et al. showed that collagen is an abundant absorber in several breast tissue 
types when recording optical spectra up to 1100 nm [19-21]. Therefore, we have 
measured collagen Type I (Sigma-Aldrich C9879) absorption coefficients from 500 to 
1600 nm by tightly inserting  the collagen fibers in cuvettes of 0.5, 1 and 2 mm thickness 
and measuring its absorption with a spectrophotograph with a 150 mm diameter 
integrating sphere (Lambda 900 Spectrometer, Perkin Elmer). The absorption 
measurements were separated from the scattering by mounting the cuvettes inside the 
integrating sphere far away from the detector. When a sample is mounted inside the 
sphere, the loss of light is mainly due to absorption by the sample related to the 
absorption coefficient. Because of the turbidity of the sample, scattering occurs. 
Therefore, an additional measurement was performed by allowing the forward transmitted 
light to escape out of an exit port in the back end of the sphere in order to measure 
scattering. The scattered light from the sample mounted inside the sphere is therefore 
measured, and subsequently the absorption coefficient can be determined by subtracting 
the measurement with the opened exit port from the measurement with closed exit port. 
The absorption coefficient due to non-blood derived chromophores is expressed 
as: 
 
  
       *        
         (        )  
      +             
           
                  
 
where   
        ,   
      ,   
            and        correspond to the absorption 
coefficients of lipid, water, collagen and the extinction coefficient (in cm
-1
.M
-1) of β-
carotene, respectively. The parameter   represents the water and lipid volume fraction, 
and        represents the lipid fraction within the volume probed by the light. However, 
          corresponds to the collagen volume fraction in the probed tissue whereas     
corresponds to the molar concentration of β-carotene. The absorption coefficients of the 
various chromophores of interest are depicted in Fig. 2. The absorption coefficient at unit 
concentration of Hb and HbO2 that is used as a priori knowledge for the model are from 
Zijlstra et al. [29] whereas the extinction coefficient of β-carotene in human adipose cells 
is from van de Poll et al. [30]. Water and lipid absorption coefficients that are used in the 
presented study are from previous published work [23]. The collagen absorption 
coefficient presented in this study has a local maximum at 1200 nm of 1.54 cm
-1
 which is 
of the same order of magnitude as the water and lipid absorption coefficient in the 
vicinity of 1200 nm. It is important to note that collagen has a wider maximum than fat 
but narrower than water. Other local maxima at 911, 1030 and 1510 nm are observed with 
absorption coefficients of 0.21, 0.34, and 5.22 cm
-1
. The presented absorption coefficient 
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of collagen is about an order of magnitude higher than the one presented by Taroni et al. 
[20], however it matches very well with the coefficients reported by Tsai et al. [31] and 
by Nunez [32]. The difference in collagen absorption values with Taroni et al. could be 
due to the fact that the density of our measured sample is different from the density used 
by Taroni et al. 
 
 
Figure 2. Normalized absorption coefficients of deoxygenated-hemoglobin (Hb), 
oxygenated-hemoglobin (HbO2), β-carotene, water (H2O), lipid and collagen. 
 
 In few cases, the ink used by the pathologist before cutting was spread into the 
tissue when slicing the breast samples, influencing the measured spectral shapes. In order 
to correct for this, the absorption coefficients of these inks were measured and added to 
the fitting. Given the large number of free parameters, two separate fits on different 
wavelength ranges were performed: the first fit was performed between 500 and 900 nm 
with   
                    and        only in the model and the second fit was 
performed between 900 and 1600 nm with   
                    and        only in the 
model. The extracted values from both fits were used as initial guess for the fit applied 
over the full wavelength range between 500 and 1600 nm in order to ensure stability of 
the fit. 
From fits to the spectra between 500 and 1600 nm, the following fit parameters 
were obtained:  ,     ,  ,  ,       ,          ,    ,  ,   and  . For each estimated value, a 
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confidence interval computed from the covariance matrix was used to assess the 
reliability for each fit parameter [33]. 
 
2.4 Statistical analysis 
A non-parametric Kruskal-Wallis statistical test was conducted to evaluate 
significant differences of the estimated parameters between the various types of breast 
tissue for a significance level of 5% (i.e. p<0.05). The test examines if the medians of the 
various groups are not all equal; meaning that if the p-value is below the significance 
level, at least one type of tissue can be discriminated from the others. Therefore an 
additional post hoc test is required to account for multiple comparisons, as well as for the 
fact that comparisons can be interrelated. In this study, Tukey‟s post hoc test was applied 
at a significance level of 5%. This statistical procedure is a restricted pairwise comparison 
that follows the Kruskal-Wallis test which had indicated the significance of the 
differences [34].  
 
2.5 Classification algorithms 
The classification and regression tree (CART) algorithm was used to classify 
between the five types of tissue. The CART algorithm starts from a central node that 
discriminates the largest class, adipose tissue in our case, based on the best classifier. 
From this root node, a split is performed to discriminate the largest class from the other 
tissue classes. From the split, daughter partial trees are generated and other parameters are 
used for further splits. The purity of each node is assessed with the Gini‟s maximization 
index algorithm which corresponds to unity minus the sum of squares of the proportions 
of target classes at a specific node [35]. The advantage of CART is that it is a non-
parametric method whereas other methods such as (linear discriminant analysis) LDA, 
LR, and KNN assume functional relations between dependent and predictor variables. 
Moreover, one of the advantages of CART is that it is easy to interpret since the input 
parameters for classification are used whereas other methods post-process the parameters 
into scores that might not be intuitively related to the input parameters. The performance 
of the diagnosis was evaluated by carrying out an ROC analysis. From the sensitivity-
specificity values and the area under the ROC curves (AUC), the Provost and Domingos 
measure (PDM) for total AUC is computed to assess the accuracy of the diagnostic 
algorithms [25]. The PDM value corresponds to the sum of AUC of each class weighted 
by the class size fraction. 
Classifications were carried out on the estimated parameters from the fit model 
using a leave-one-out (LOO) cross validation scheme. Additionally, a hold-out (HO) 
cross validation scheme with a 70%-30% training-testing split of the data was carried out. 
The split was performed by random selection of the data before splitting and 
classification. This partition procedure and classification was reproduced 20 times and the 
computed sensitivity-specificity values were averaged.    
Several techniques were used in literature to classify parameters based on diffuse 
reflectance spectroscopy measurements or directly applied to the spectra as mentioned in 
the introduction section. The following classification algorithms were applied to our data: 
ANN [9], linear SVM [11], LR [14-16] and KNN employing Mahalabonis distance to 
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account for parameters intercorrelation [17], in order to evaluate the sensitivity-specificity 
of discriminating malignant and non-malignant types of breast tissue. Besides, other 
classification methods were also tested such as CART, LDA with Mahalanobis distance 
stratified covariance, and non-linear SVM to discriminate malignant from non-malignant 
breast tissues. However, the classification was performed by taking the amount of 
samples that corresponds to the lowest sample size within the malignant and non-
malignant category respectively. This means that within the non-malignant category, 127 
spectra from adipose and from glandular tissues were randomly selected and added to the 
FA spectra to form the non-malignant database whereas 96 spectra from IC were 
randomly selected and added to the DCIS spectra to form the malignant database. The 
purpose of such categorization is to avoid higher representation of one type of tissue over 
the others within the same category. Otherwise, discriminating malignant from non-
malignant tissue would be comparable to classification of adipose versus IC given the fact 
that the total adipose and IC spectra represent 51% and 72% of the non-malignant and 
malignant samples size, respectively. 
Furthermore, this study is the first that estimates both β-carotene and lipid from 
breast tissue measurements. A classification of adipose tissue was performed from all the 
parameters except lipid, water and collagen and another classification without β-carotene 
to evaluate which adipose precursor is the most accurate for adipose breast tissue 
classification using the CART algorithm. 
 
3. Results 
Fig. 3 depicts typical examples of spectra measured on adipose (Fig. 3.a), 
glandular (Fig. 3.b), FA (Fig. 3.c), IC (Fig. 3.d) and DCIS (Fig. 3.e) tissues and their 
corresponding fits. From the measurement of adipose breast tissue, one can notice the 
effect of β-carotene absorption on the spectra below 550 nm and the lipid absorption 
peaks at 930 and 1211 nm. 
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Figure 3. Typical measurement of adipose (a), glandular (b), FA (c), IC (d), and DCIS (e) 
and their corresponding fit curves. 
 
Fig. 4 depicts the histograms of the median and standard deviation for each of the 
parameters derived from the fit per category of tissue type. Complementary to Fig.4, 
Table 2 displays the parameters that show significant differences (p<0.05) for pairwise 
types of tissue comparison according to a Kruskal-Wallis test followed by a post hoc 
multiple comparison Tukey‟s test. 
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Figure 4. Average and standard deviation of the estimated blood volume fraction (ν), 
oxygenation level (StO2), water (H2O), lipid, reduced scattering amplitude (α), scattering 
slope (b), vessel radius (R),  β-carotene, collagen, and the Mie-to-total reduced scattering 
fraction (ρ) for each of the various types of breast tissues: adipose, glandular, FA, IC, 
and DCIS. 
 
It can be seen that adipose and DCIS tissue contains almost twice as much blood 
as the other types of tissue whilst the blood oxygenation level is lower in malignant tissue 
(StO2<40%) compared to non-malignant tissue. Adipose tissue can clearly be 
distinguished from the other tissue types by its high lipid average volume fraction and β-
carotene concentration of 80% and 12 μM, respectively. FA has the lowest β-carotene 
concentration and is significantly different from the other tissue types except for DCIS. 
The reduced scattering amplitude is the lowest for adipose tissue (roughly 5 cm
-1
) and the 
highest for DCIS (roughly 10 cm
-1
), whereas it is rather similar for the other tissues 
(around 7 cm
-1
). A clear distinction can be observed for the Mie slope where it is almost 
2-fold smaller for non-malignant compared to malignant samples. Apart from adipose 
tissue, IC showed significant differences based on the water content with the highest 
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amount among all tissues. Adipose and FA have the lowest collagen volume fraction of 
roughly 14%, whereas glandular and IC are about 18% and DCIS has the highest value 
with 22%. Although adipose and FA have similar collagen volume fractions, this 
parameter showed significant difference between DCIS and adipose tissue and not with 
FA due to the higher standard deviation in collagen in adipose tissue compared to FA. It 
can be seen that the trends in collagen are correlated with the estimated Mie scattering 
fractions: a lower collagen volume fraction corresponds to a higher Rayleigh scattering 
contribution. 
 
Table 2. Parameters that show significant difference for the pairwise comparisons of the 
different tissue types after Kruskal-Wallis statistical test with post hoc Tukey’s multiple 
comparison test (p<0.05). 
 Type of breast tissue 
Type of  
breast 
tissue  
Glandular FA IC DCIS 
Adipose  
ν, StO2, H2O, 
Lipid, α, βC, 
Collagen, ρ 
ν, StO2, H2O, 
Lipid, α, b, R, βC 
ν, StO2, H2O, 
Lipid, α, b, R, 
βC, Collagen, ρ 
H2O, Lipid, α, 
b, 
 βC, Collagen, 
ρ 
Glandular  - 
b, R, βC, 
Collagen, ρ 
StO2, H2O, α, b, 
R 
ν, StO2, α, b 
FA   - 
StO2, H2O, R, 
βC, Collagen, ρ 
ν, StO2, Lipid, 
α, R, ρ 
IC   
- 
 
ν, Lipid, α, R 
 
Multiple class classification was performed with the CART method, on the five 
categories of breast tissue i.e. adipose, glandular, FA, IC, and DCIS in order to evaluate 
the performance of such a diagnosis. Fig. 5 depicts a decision tree that classifies all 
tissues based on a specific threshold value for each parameter. As can be seen, the first 
node allows discrimination of adipose tissue based on the lipid content. If the lipid 
volume fraction is above 40%, an acquired spectrum is considered to be taken in adipose 
tissue otherwise it is another type of tissue. 
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Figure 5. Classification decision tree of the different breast types based on parameter 
threshold values. 
 
Table 3 corresponds to the confusion matrix displaying the diagnostic 
performance by comparing with the pathological diagnosis being the reference standard. 
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Table 3. Confusion matrix displaying classification of breast tissues using the CART 
algorithm for classification. 
 
Table 4 compares the sensitivity-specificity rates for each type of tissue when a 
LOO and HO cross validation were applied. The overall classification accuracy computed 
from the confusion matrix is 90% (879 out of 980). The type of tissue with the lowest 
sensitivity rate is FA whereas adipose tissue has the highest specificity rate. 
 
Table 4. Sensitivity and specificity of CART classification of each type of tissue using 
leave-one-out (LOO) and 20-fold hold-out (HO) cross validation. 
 
 
Sensitivity (%) - Specificity (%) 
Type of breast tissue  
 Leave-one-out cross 
validation 
Hold-out cross 
validation  
Adipose 
 
98 – 99 98±1 – 99±1 
Glandular 
 
84 – 95 80±6 – 95±2 
FA 
 
81 – 98 75±9 – 97±1 
IC  
 
91 – 95 86±6 – 94±2 
DCIS 
 
83 – 99 81±10 – 98±2 
 DRS classification diagnosis 
 Non-Malignant  Malignant 
Type of breast tissue  
(number of samples) 
Adipose Glandular FA IC DCIS 
 
Adipose (327) 319 6 2 0 0 
Glandular (189) 7 158 8 15 1 
FA (127) 0 11 103 11 2 
IC  (241) 0 15 4 219 3 
DCIS (96) 0 5 1 10 80 
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The receiver operating characteristic (ROC) curves for classification of each tissue 
are depicted in Fig. 6 including confidence intervals. 
 
 
Figure 6. ROC curves (solid line) for classification of adipose (a), glandular (b), FA (c), 
IC (d), and DCIS (e) tissues including confidence intervals (dashed line) and 
corresponding AUC. 
 
Corresponding area under curve (AUC) and PDM measures are summarized in 
Table 5. From the AUC values, the performance of the diagnosis can be classified into 
three categories with adipose as the best performance (AUC almost 100%), glandular as 
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the worst performance with AUC of 86% and FA, IC and DCIS as the median 
performance with comparable AUC values of roughly 92%. The PDM multiple classes 
overall performance of the diagnostic is 93.6%. 
 
Table 5. AUC values of ROC curves for the five tissue types and PDM value. 
Type of breast tissue  AUC Confidence Interval 
Adipose 99.8% 99.7%-99.9% 
Glandular 85.9% 81.9%-87.9% 
FA 92.3% 90.4%-94.1% 
IC  92.5% 90.9%-94.0% 
DCIS 91.8% 88.7%-93.4% 
PDM for total AUC 93.6% 91.9%-94.9% 
 
Table 6 summarizes the sensitivity-specificity obtained for classification of 
malignant versus non-malignant tissues by using various algorithms for classification. 
The obtained numbers are compared to what has already been reported by other studies 
from different research groups. The best algorithm performance applied to the data was 
reached with KNN classification whereas the poorest performance was reached with LDA 
classification. 
Classification based on the CART method showed that discriminating adipose 
tissue based on the β-carotene values only yields to a sensitivity-specificity of 68%-92% 
whereas classification based on the lipid parameters yields to a sensitivity-specificity of 
98%-99%. Using both parameters yielded a sensitivity-specificity of 99%-99%.  
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Table 6. Literature overview of diagnostic performance in discriminating malignant from 
non-malignant tissue and comparison of different classification algorithms applied to the 
data in the presented study. 
Classification 
algorithm 
Reference 
Sens. (%)- 
Spec. (%) 
 
Sens.-Spec. 
of 
 this study 
(LOO) 
Sens.-Spec. 
of 
 this study 
(HO) 
Artificial Neural 
Network 
Bigio et al.
 (a)
 69 – 85   89 – 98 91±2 – 96±4 
K-Nearest Neighbor  
Laughney et 
al. 
90 – 77  96 – 99 94±4 – 98±2 
Logistic Regression 
Volynskaya 
et al. 
100 – 100(b)  82 – 94 82±3 – 94±6 
Logistic Regression  Keller et al.
 (a)
 85 – 96(b)  82 – 94 82±3 – 94±6 
Linear Support 
Vector Machine  
Zhu et al. 83 – 87(b)  79 – 93 81±4 – 93±2 
Non-Linear Support 
Vector Machine 
- -  90 – 97 88±4 – 97±2 
Linear Discriminant 
Analysis  
- -  78 – 95 74±6 – 96±2 
Classification And 
Regression Tree 
- -  88 – 93 85±6 – 92±3 
(a)
 Sensitivity and specificity computed after classification of the spectra and not from the 
parameters derived from a fit-model. 
(b)
 Fluorescence was also measured in these studies however the reported sensitivity-
specificity corresponds to classification of parameters derived from diffuse optical 
spectroscopy only except for Keller et al. 
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4. Discussion 
This study corresponds to the first in its kind that evaluates the classification of 
different types of breast tissue based on several parameters derived from spectroscopic 
data acquired from a wide wavelength range from 500 to 1600 nm. From Table 2, it is 
clear that adipose tissue is the easiest tissue that can be discriminated from the other types 
of tissue. More than seven parameters showed significant differences with lipid, water 
and β-carotene as main discriminators, as supported by other studies as well [9-22]. 
Glandular and DCIS tissues have the lowest amount of parameters that showed significant 
differences with other tissues. It is important to note that the use of post hoc Tukey‟s test 
is essential for reliable statistical test for significance of differences. If not used, 
additional parameters become significantly different between types of tissue. For 
example, lipid becomes significantly different between glandular and FA as well as IC if 
no post hoc test is performed. Moreover, glandular tissue has on average 5% lipid 
whereas FA and DCIS have below 0.5% lipid while still no significant differences are 
observed according to Tukey‟s test despite an order of magnitude difference in lipid 
content. Similarly to ex vivo [10, 11, 14] and in vivo [18, 22, 36] existing studies, we also 
observed a lower blood oxygenation level in malignant tissue compared to non-malignant 
tissue with significant differences (cf. Table 2 and Fig. 4). This is expected because 
malignant tissues are known to exhibit regions of hypoxia [36]. Although this observation 
corroborates with other existing ex vivo studies, this should be validated in vivo because 
the oxygenation level of the tissue can significantly change during and after tissue 
excision. Another interesting finding is that we observed comparable amounts of blood 
(0.3%) in malignant and non-malignant tissue similar to reported studies in literature. Yet 
on the contrary, Van Veen et al. [22] have reported a higher blood volume fraction in 
malignant tissue similarly to optical mammography studies that were conducted in vivo 
by Spinelli et al. on 190 patients from which 32 had cancer [37] and by Grosenick et al. 
on 154 patients with 87 carcinoma cases [38] (In Ref. 38, table 4 provides an overview on 
blood volume, oxygenation level, and reduced scattering properties of healthy and 
malignant tissue from various optical mammography studies available in literature). 
Among the malignant types of tissue, only DCIS exhibited larger amount of blood than 
the average value of blood in non-malignant tissues. An increase in blood volume 
fractions is a potential marker for angiogenesis. Yet again, the current study was 
performed ex vivo and an in vivo study is required to confirm this observation as shown 
by Van Veen et al. Furthermore, our data corroborates with the observation from other 
studies with respect to the reduced scattering amplitude. Indeed, the reduced scattering 
amplitude is higher in malignant tissue (8.1 cm
-1
) than in non-malignant tissue (5.6 cm
-1
). 
As expected, we observed that collagen volume fractions correlate with ρ. This is in 
agreements with findings of Saidi et al. [39] that the Rayleigh scattering in tissue is 
mainly due to sub-micron collagen fibers in the connective tissue suggesting a stronger 
Rayleigh contribution in glandular, IC and DCIS that contain the highest collagen volume 
fractions as depicted in Fig 4. Water content is the most prominent in IC and is 
significantly different from the other tissues (cf. Table 2). The lowest water volume 
fraction is obviously observed for adipose tissue since lipid contains almost no water. 
However collagen-rich stroma contains quite a lot of water as collagen fibers are 
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hydrophilic. Thus if a tumor induces a lot of stroma, the water content in the tumor will 
be relatively high as the fibers are loosely arranged leaving a lot of space for water 
molecules to intervene in the tumor. In breast tissue with benign sclerotic changes in 
which collagen gets cross-linked to a great extent, hardly any space is left for water 
molecules. Necrosis can also play a role in water increase but only a very small minority 
of all breast cancer contains necrotic areas in general. When investigating the differences 
in values of the different parameters within each patient instead of comparing tissue types 
from all the patients together, the p-values for discriminating a tissue from another 
becomes even smaller. Results of the spectral differences between different patients are to 
be presented in a future publication. 
Multiple class classification with the CART algorithm demonstrated a very high 
overall diagnostic performance of 94% with the highest AUC value for adipose tissue and 
the lowest for glandular tissue as can be seen in the ROC curves in Fig. 6. In the study by 
Majumder et al., glandular and adipose tissues were both classified as normal and 
discriminated with FA, IC and DCIS and obtained an overall classification performance 
of 88% using sparse multinomial LR on the diffuse reflectance spectra [15]. Our data 
showed better sensitivity-specificity for IC and DCIS (cf. Table 4) whereas FA showed 
similar performance. It is important to note that the amount of DCIS samples by 
Majumder et al. is rather small compared to the other tissues and therefore a low 
performance can be expected. Moreover, DCIS is not a common tissue measured by other 
groups (6, 2, and 1 samples measured by Majumder et al. [15], Zhu et al. [11], and 
Laughney et al. [17], respectively). It is recommended to acquire more spectra from a 
sample and to perform classification on the spectra in order not to bias the diagnosis by 
low numbers compared to other tissues. 
For a better comparison of our results with existing literature studies, we have 
performed classification on our data using the techniques suggested in literature. Table 6 
summarizes the classification algorithm used to discriminate malignant tissue (i.e. IC and 
DCIS) from non-malignant tissue (i.e. adipose, glandular and FA) and the table compares 
the reported sensitivity-specificity values as reported in literature with those obtained in 
our study. The sensitivity-specificity obtained with the same method for all categories of 
breast classification, i.e. the CART method, is 88%-93%. Compared to the results by 
Bigio et al., ANN classification applied to our data showed better sensitivity-specificity. 
However, it is important to note that our classification was performed on the parameters 
derived from the spectra and not by applying the ANN classification to the spectra as 
done by Bigio et al. The KNN classification employing Mahalanobis distance metric to 
account for parameter intercorrelations, as used by Laughney et al., showed the highest 
diagnostic performance. The sensitivity-specificity obtained with this method corresponds 
to a very high performance. One might question the classification method because the 
KNN algorithm can be biased since it is very sensitive to redundant or similar features 
because all features contribute to the similarity principle and thus to the classification. 
Using an LR based classification method showed a sensitivity-specificity of 82%-94% 
which is outperformed by the sensitivity-specificity of 100%-100% obtained by 
Volynskaya et al. However, it is important to note that the study by Volynskaya et al. did 
not include the 6 DCIS samples they measured because they considered it was a very 
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small number compared to the 9 IC, 9 FA, 31 normal and 55 fibrocystic change (FCC) 
samples they had measured. Keller et al. obtained a lower sensitivity but higher 
specificity compared to our result. It should be noted that they classified the spectra and 
not the parameters that were derived from the spectra. Moreover, they included 
fluorescence spectra to their classification scheme. Zhu et al. achieved a sensitivity-
specificity of 83%-87% and 82±5%-89±5% using SVM classification with a LOO and 
HO cross-validation scheme, respectively. In our study, the sensitivity-specificity with 
linear SVM classification is 79%-93% and 81±4%-93±2% with a LOO and HO cross 
validation scheme, respectively. The data used for classification by Zhu et al. correspond 
to 89% of adipose tissue within the non-malignant category and 74% of IC among the 
malignant category. Therefore, the weight of classification is mainly dominated by 
adipose and IC for malignant and non-malignant tissue, respectively. In our study, 51% of 
the non-malignant samples correspond to adipose tissue and 71% of the malignant tissue 
samples correspond to IC. However, we have performed the classification by taking the 
same amount of spectra for each type of tissue within the malignant and non-malignant 
category in order to avoid an overrepresentation of adipose and IC within the non-
malignant and malignant category, respectively. This can explain the fact that we observe 
a lower sensitivity than Zhu et al. However, we obtain a higher specificity suggesting that 
we can classify non-malignant tissue better thanks to the additional parameters derived 
from the fit-model. In case of non-linear SVM, i.e. using a Gaussian radial basis kernel 
function instead of a linear kernel, the performance of discriminating malignant tissue 
increased to a sensitivity-specificity of 82%-94%. As mentioned by Zhu et al. in a 
previous study [10], a classification based on linear algorithms could underperform in the 
diagnosis since the optical properties are non-linearly related in the description of the 
measured spectra, hence the better performance of the non-linear compared to the linear 
SVM algorithm applied to our data. Besides, for comparison with another non-linear 
classification method, a sensitivity-specificity of 78%-95% reached with LDA employing 
Mahalanobis distance yielded the lowest performance among the other classification 
methods with respect to specificity. From the various classification methods, large 
variations in sensitivity-specificity can be achieved and therefore care should be taken 
when comparing one‟s results with existing results in literature. The choice of the 
classification algorithm is very important and the sample sizes, the methods, and the 
linearity of the problem should be carefully taken into consideration. As a matter of fact, 
for classification problems with small sample size LDA is not suitable, as it is a 
parametric method assuming normal distribution of the data in each class. Other methods 
have the advantage of being non-parametric methods. However, KNN is very sensitive to 
redundant and similar features for classification. On the other hand, linear SVM finds 
linear separation of two classes in the training set with a hyperplane that has maximal 
distance from the two classes. If the groups are not linearly separable, non-linear SVM 
can be applied [40]. The LR algorithm is a probabilistic method that has the advantage of 
using few or no statistical assumptions but the drawback is that the complete data is 
needed for each class to calculate the probabilities. Hence large variations in sample sizes 
can bias the classification. 
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Among the studies quoted in Table 6, the study by Keller et al., Majumder et al., 
Zhu et al. and Volynskaya et al. performed fluorescence measurements. The latter two 
derived collagen and NADH concentrations from fitting the fluorescence spectra. Both 
studies showed a significant increase in collagen in malignant tissue compared to non-
malignant tissue which correlates with our finding where we estimated collagen with 
diffuse reflectance spectroscopy measurements. Adding fluorescence to diffuse optical 
spectroscopy did not result in the same conclusions for the different studies. Volynskaya 
et al. showed a decrease in specificity from 100% to 96%, whereas Zhu et al. did not 
observe any differences in performance. Majumder et al. showed a tremendous 
improvement in discriminating the tumor types of tissue when adding fluorescence 
measurements to the classification routine increasing the overall diagnosis performance 
from 88% without fluorescence to 95% with fluorescence. Apart from fluorescence, 
Majumder et al. performed Raman spectroscopy measurements and showed that this 
optical tissue measurement technique yields to the best overall performance (99%). The 
group of biomedical photonics at MIT presented several Raman studies [41-44] showing 
that they can reach sensitivity-specificity of 83%-93% by classifying estimated 
parameters similar to those extracted from the measurements presented in this paper such 
as β-carotene, lipid, collagen as well as additional biological substances such as calcium, 
cholesterol, and cell nucleus. Interestingly, in comparison with the Raman results of the 
study conducted by the MIT group, the average collagen and fat fractions are reasonably 
similar for the different types of tissue except for adipose tissue where we estimate an 
average collagen content of 15%. In the latest study from the MIT group [42] the 20 
spectra acquired from DCIS samples were not classified because this type of tissue was 
not encountered in the calibration data set they used for their diagnostic algorithm 
development. They do discuss nevertheless that applying their algorithm to the DCIS 
samples would result into 5 samples out of 20 to be classified as malignant based on 
classification of their estimated fat and collagen fractions derived from the fitted Raman 
spectra. 
One final point of discussion concerns adipose tissue discrimination. Both lipid 
and β-carotene are adipose tissue precursors and only one of them was used in previous 
studies. In this paper, we estimate both chromophores and from classifying adipose tissue 
based on only one of the chromophores, it turned out that lipid is the best discriminator 
for adipose tissue with sensitivity-specificity of 98%-99% versus 68%-92% for β-
carotene. It is known that β-carotene is significantly lower in smokers than non-smokers 
[45]. Thus, it can bias the discrimination of adipose tissue in breast depending whether a 
patient is a smoker or not, making lipid a more suitable discriminator. 
 
5. Conclusion 
We present the first breast diagnosis study based on estimating morphological, 
physiological and optical parameters derived from diffuse reflectance spectroscopy 
measurements on a 500 to 1600 nm wavelength range. Based on a classification and 
regression tree algorithm applied to the derived parameters, a sensitivity-specificity of 
98%-99%, 84%-95%, 81%-98%, 91%-95%, and 83%-99% was obtained for 
discrimination of adipose, glandular, fibroadenoma, invasive carcinoma, and ductal 
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carcinoma in situ, respectively; and a multiple classes overall diagnostic performance of 
94%. A comparison of different classification techniques to discriminate malignant and 
non-malignant tissue showed varying performance that can highly depend on the 
classification algorithm. Finally, to the best of our knowledge, given the fact this is the 
only study that estimates both β-carotene and lipid as adipose tissue precursor; we show 
that lipid is a much better discriminator with sensitivity–specificity of 98%-99% for lipid 
versus 68%-92% for β-carotene. 
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Abstract 
Background. Optical spectroscopy is increasingly used in breast tissue analysis. 
Despite years of research, final steps towards clinical application of optical spectroscopy 
are yet to be taken. One of the reasons for current inability for clinical application could 
be the continuously executed collective data analysis methods in combination with 
significant inter-patient breast tissue variations. An individualised approach for optical 
spectroscopy analysis in breast tissue could improve discrimination accuracy towards a 
future clinical application of this technique. 
Methods. Breast tissue from 47 patients was included for an ex-vivo analysis with 
Diffuse Reflectance Spectroscopy (DRS). The measured optical spectra from all patients 
collectively and individually were analyzed. 
Results. Collective patient data analysis for discrimination between normal and 
malignant breast tissue yielded sensitivity and specificity of 90% and 88%, respectively 
whereas individual patient data analysis improved discrimination accuracy to 100% for 
31patients. 
Conclusions. Individual patient discrimination of tumor tissue from normal tissue 
displayed improved accuracy between normal and malignant breast tissue. These results 
support further validation on an individual patient analysis and direct towards in-vivo 
application of DRS in clinical practice for diagnostic procedures in breast tissue. 
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1. Introduction 
In the last decade new optical guidance techniques are increasingly being 
implemented into medical practice of cancer, rapidly evolving standard protocol and 
treatment strategies [1, 2]. One of these new optical techniques is Diffuse Reflectance 
Spectroscopy (DRS) [3-5]. DRS has the potential of differentiating biological structures 
and compositions by their intrinsic light absorption characteristics which varies with 
wavelength. It can provide detailed information of the underlying biological composition 
of tissue. DRS consists of recording the spectral response of tissue illuminated with light 
which is partially absorbed by endogenous chromophores as well as scattered by the 
various cells and fibers along its path towards a detection unit. Depending on the tissue 
composition and its structure, a specific spectral pattern is acquired from which the 
biological composition related to light absorption and tissue density related to light 
scattering are both recovered via well-established mathematical model that describes the 
spectral measurement [4]. By allowing specific differentiation between tissues, the 
technique has the potential to be incorporated into optical tools for cancer diagnosis and 
therapy.   
 One considered application for DRS that could improve clinical practice of breast 
cancer in the near future are the optical guided tissue biopsy. Current figures on repeated 
breast tissue biopsies due to indeterminate pathology analysis range from 5 to 30% [6-9].  
 Breast tissue can arguably be considered one of the most challenging human tissue 
types due to the general inhomogeneity of the morphology within both normal and 
malignant breast tissue [10]. Normal breast tissue composition is largely influenced by 
due age and hormonal status of the individual. Therefore, tissue analysis with DRS to 
discriminate tissue types based on the derived parameters from the measurements can be 
expected to be hampered by this diversity of tissue and inter-patient variation. Several 
groups have focussed on breast tissue discrimination with DRS [5, 11-17]. Presented 
results of discriminative accuracy based on analysis between normal and malignant breast 
tissue in these papers ranged between 65% and 90%. These results have not yet resulted 
in the development of optical spectroscopic guided instruments for use in clinical 
practice.  
 We believe that inter-patient variation within breast morphology hampers the 
discriminative accuracy as currently used and an important next step towards the 
application of optical techniques like DRS within clinical cancer is to focus on the 
development and optimization of individual patient analysis methods. Hence, with 
regards to the diagnostic accuracy between different tissues of any medical instrument 
used in clinical practice, the main interest of any physician will be the discriminative 
accuracy within any individual patient. Such an approach is already common practice in 
various imaging modalities like X-ray, CT, MRI or Ultrasound where malignant tissue is 
compared to normal tissue within an individual patient. This should also be considered as 
an important requirement for the introduction of any optical spectroscopy system for 
clinical use.  
 In a previous study, we published results of the development and validation of a 
novel Diffuse Reflectance Spectroscopy system combining detection of visible (VIS) and 
near-infrared (NIR) light spectra that enables DRS measurements on a very wide 
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wavelength range from 500 to 1600 nm [18, 19]. The aim of this present study is to 
confirm the hypothesis that the discriminative value of an individual analysis approach of 
breast tissue using DRS is an important step towards the development of intelligent 
medical tools such as an optical biopsy needle. 
 
2. Materials and methods 
2.1 Clinical study design 
This study was conducted at The Netherlands Cancer Institute (NKI-AVL) under 
approval of the internal review board committee. Breast tissue was obtained from 47 
female patients who had undergone either a local excision or total mastectomy of the 
breast due to the presence of a fibroadenoma or (pre)-malignant disease. Shortly after 
surgical resection, tissue was transported to the pathology department for optical 
spectroscopy analysis. After gross inspection by the pathologist, the spectroscopy 
measurements were performed on freshly excised tissue within two hours after resection. 
The optical spectra were collected from macroscopic normal fat, glandular tissue samples 
and fibroadenoma lesions as well as from (pre)-malignant tissue samples. On average, 
five optical measurements were performed at each measurement location. Subsequently, a 
biopsy of the measured tissue location was performed. These tissue samples were then 
fixated in formalin, paraffin-embedded, cut in 2- to 3-μm-thick sections and stained with 
standard hematoxylin/eosin staining. An experienced pathologist, who was blinded for the 
outcome of the spectroscopy analysis, examined the histological slides. For each 
measurement location, the percentages of adipose, glandular and fibroadenomatous tissue 
as well as ductal carcinoma in-situ (DCIS) and invasive carcinoma were respectively 
scored if present in the two dimensional image of the slide. Within the 47 resected tissue 
specimen, 160 measurements were performed in 11 fibroadenomatous lesions, 121 
measurements in 11 areas of DCIS and 314 measurements in 35 lesions of Invasive 
carcinoma. Five of these lesions were lobular carcinomas and 30 were ductal carcinomas. 
A total of 294 measurements in adipose tissue of the breast specimen and 184 
measurements in glandular tissue were performed. In total, 1073 DRS measurements 
were acquired. 
 
2.2 Instrumentation 
The instrumentation and calibration procedure of our optical spectroscopy system 
has been described in recent papers [18-20].  
The system consists of a console comprising a Tungsten/Halogen broadband light 
source, two spectrometers and an optical probe with three optical fibers. The two 
spectrometers resolve  light in the visible wavelength range between 400 nm and 1100 nm 
(Andor Technology, DU420A-BRDD) and in the near infrared wavelength range from 
800 up to 1700 nm (Andor Technology, DU492A-1.7), respectively. The optical probe 
contains three optical fibers: one fiber is connected to the light source, while the other two 
fibers are connected to the spectrometers to capture the diffusely scattered light from the 
tissue. The average tissue volume that is illuminated is roughly 5 mm
3
. The acquisition 
time of each spectrum was on average one second. 
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2.3 Spectral data processing 
Five different breast tissue classes were distinguished in the spectral data 
processing: adipose tissue, glandular tissue, fibroadenoma, DCIS and invasive carcinoma. 
Additionally, we distinguished normal breast tissue (all tissue locations of adipose, 
glandular and fibroadenomatous tissue) from malignant breast tissue (DCIS and invasive 
carcinoma). An analytical model was used to estimate the various chromophore volume 
fractions and scattering coefficients from all the acquired spectroscopy measurements. 
This model was first described by Farrell et al. [21] The model has been further modified 
and validated to be applicable to human tissue samples [12, 19, 20, 22, 23]. Diffuse 
reflectance spectra acquired from the tissue were fitted and analyzed over the wavelength 
range from 500 to 1600 nm. The measurements are fitted with the analytical model by 
applying a non-linear Levenberg-Marquardt inversion algorithm. By fitting the model to 
the measured spectra, several parameters are derived such as total hemoglobin 
concentration (the sum of oxygenated and deoxygenated hemoglobin), water, lipid, 
collagen volume fractions, and β-carotene as well as the scattering amplitude at 800 nm 
wavelength. Light in the wavelength range between 500 and 1000 nm is mainly subject to 
absorption due to presence of hemoglobin and β-carotene in the probed volume; whereas 
for higher wavelength range it is due to presence of water, lipid and collagen [20]. The 
scattering of light is dependent on the cellular structure of the target tissue and is sensitive 
to the size and the density of cellular and subcellular structures. Spectral characteristics 
analysis was performed with a Matlab software package (MathWorks Inc., Natick, MA). 
The distribution of the quantified values of each tissue parameter was displayed in 
boxplots. 
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Figure 1. Boxplots of most significantly different tissue parameters. DCIS = ductal 
carcinoma in-situ; μs’ = scattering at 800nm. 
 
2.4 Tissue classification analysis 
In the spectral data processing, breast tissue was categorized into the five defined 
tissue classes and also as two groups either as normal liver tissue or as tumor tissue. A 
Classification And Regression Tree (CART) algorithm was used to automatically classify 
each collected tissue into one of the defined breast tissue types based on the parameters 
derived from the measurements [24]. With the CART algorithm, a decision tree is created 
based on the five most significantly different tissue chromophores and scattering 
parameters using a leave-one-out (LOO) cross validation scheme. Each spectrum is 
separately classified based on the calculated thresholds in the decision tree and 
 191 
 
Accurate tissue analysis of the breast with diffuse reflectance spectroscopy through 
an individualized approach 
Chapter 9 
subsequently compared to the histology analysis and presented in terms of sensitivity and 
specificity. The CART analysis was performed for all acquired data collectively and also 
for each included patient individually in which both normal breast tissue and 
(pre)malignant tissue was measured. It must be noted that the classification between 
normal breast tissue and malignant breast tissue was performed taking the amount of 
samples that corresponds to the tissue class with the lowest sample size in both groups. 
This was done to avoid overestimation of the discrimination accuracy due to the higher 
representation of one of the tissue classes over the other within either the normal or 
malignant tissue group.  Within the normal breast tissue group, 160 tissue measurements 
of both adipose and glandular tissue were randomly selected and added to the 
corresponding to the number of fibroadenomatous tissue measurements. For the 
malignant tissue measurements, 120 invasive carcinoma tissue measurements were 
randomly selected.  
Previously, the CART analysis with LOO cross validation scheme was studied by 
Nachabé et al. in the only published comparison to other generally used spectral 
classification algorithms [20]. The main advantage of the CART method is that the results 
can easily be interpreted and correlated to clinical details, since the input parameters are 
thresholds of the calculated values of the main tissue parameters.  
 
2.5 Statistical analysis 
The DRS-estimated quantification of each parameter in the breast tissue classes 
cannot be described by a parametric distribution such as the Gaussian distribution. The 
statistical differences of each parameter in the defined tissue classes were therefore 
determined using the non-parametric Kruskal-Wallis test [25].  P-values smaller than 0.05 
were considered statistically significant. 
 
3. Results 
A total of 47 breast tissue specimens from female patients were included into this 
study. The mean age at time of operation was 52 years (range 20 – 74 years).  
 
3.1 Cohort data analysis 
Chromophore volume fractions and scattering coefficients from each of the tissue 
parameters were calculated from each tissue measurement using the analytical model. The 
distributions of each of the six most significantly different tissue parameters for each of 
the five distinguished tissue classes are depicted in Figure 1. Adipose tissue is best 
distinguished from the other tissue classes by fat,water , and β-carotene content, as well 
as by the scattering coefficient at 800 nm. Fibroadenomatous tissue is best discriminated 
from the other five tissue classes based fat and β-carotene. Each measurement was 
diagnosed using the CART algorithm to predict for each measurement to which of the 
five defined tissue classes it belongs and to classify it either as normal breast tissue or 
malignant breast tissue after comparison with the histology diagnosis. The results of the 
five class distribution of the analysis results are displayed in Table 1. 
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Table 1. Diagnosis for each tissue measurement generated by the DRS analysis compared 
to the histology diagnosis of the measurement location with the calculated sensitivity and 
specificity of all the measurements in each tissue class. 
 
A high specificity (≥90%) for all tissue classes was noted. Adipose tissue is the 
best distinguishable tissue from the rest and there is a notable overlap in diagnosis 
between glandular tissue and DCIS resulting in the lowest sensitivity rates. The result of 
discrimination between normal and malignant breast tissue samples is displayed in Table 
2. After random selection of the tissue classes within both groups to fit the amount of 
measurements of the tissue class with the lowest sample size, the comparison of DRS to 
the pathology diagnosis yielded a sensitivity of 90% and a specificity of 88%. 
 
Table 2. Classification of tissue measurements defined as normal or as malignant breast 
tissue.  
 DRS classification diagnosis 
 Malignant  Non-Malignant 
Type of breast tissue 
(number of samples) 
Invasive 
carcinoma 
DCIS FA 
Glandular 
tissue 
Adipose 
tissue 
 
Invasive carcinoma     (314) 268 17 6 23 0 
 DCIS                         (121) 22 86 1 12 0 
 FA                             (160) 13 5 132 10 0 
 Glandular tissue        (184) 24 12 7 141 0 
 Adipose tissue           (294) 9 6 0 10 269 
Sensitivity(%)-Specificity (%) 85-90 71-95 83-98 77-93 91-100 
Pathology (number of samples) Malignant tissue Normal tissue 
Malignant tissue  (N=242) 219 23 
Normal tissue      (N=480) 59 421 
Sensitivity of  90% and specificity of 88% 
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The microscopic heterogeneity of the various tissue samples is illustrated in 
Figure 2. Three examples of invasive carcinoma are displayed with different percentages 
of malignant tissue within the specimen, respectively classified by the pathologist as 20%, 
50% and >90% invasive carcinoma within the tissue sample. The corresponding 
measured spectrum for each sample displays notable differences when compared. It is to 
be expected that these differences in histology and corresponding spectra will contribute 
to the difficulties distinguishing mainly glandular tissue from DCIS and invasive 
carcinoma, which were noted in Figure 1. We therefore divided all of the 314 
measurements of invasive carcinoma into <50% or >50% malignant cells within the 
tissue specimen based on the individual pathology reports and compared these two groups 
to all measurements of glandular tissue.  
 
 
Figure 2. Example of the pathological heterogeneity within several tissue samples defined 
as 20% (A), 50% (B), and 90% (C) invasive carcinoma, respectively. 
 
The results of the differences in significance of the quantification of most notable 
tissue parameters in the two malignant groups compared to glandular tissue are displayed 
in table 3. Both malignant groups can be discriminated from glandular tissue based on the 
parameters THC and fat. For the parameters scattering at 800nm, β-carotene and collagen 
A B C 
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no significant differences are illustrated when the percentage of invasive carcinoma 
within the tissue specimen is < 50%, but are apparent for ratios of invasive carcinoma > 
50%. 
 
Table 3. Significant differences of the quantification of the most notable tissue parameters 
of all invasive carcinoma measurements with either <50% or >50% malignant cells 
within each tissue specimen compared to glandular tissue measurements.  ~: Tissue 
parameter not significantly different when comparing glandular tissue with invasive 
carcinoma;  ↑ / ↓ : tissue parameter respectively higher and lower in the invasive 
carcinoma compared to glandular tissue with a P-value < 0.05;  ↑↑ / ↓↓ : tissue 
parameter respectively higher and lower in the invasive carcinoma compared to 
glandular tissue with a P-value < 0.0005. 
 
3.2 Individual data analysis 
Discrimination between the classified tissue classes was also performed for each 
patient individually, with emphasis on the discrimination between normal and malignant 
breast tissue. In one of the 47 tissue specimen, all five defined tissue classes were present 
and could be examined. Results of the tissue and spectral analysis are displayed in Figure 
3. 
 
Parameter Invasive carcinoma 0-50% Invasive carcinoma 50-100% 
Total hemoglobin  ↑↑ ↑↑ 
Fat ↓↓ ↓↓ 
β-carotene ~ ↓ 
Collagen ~ ↑↑ 
Scattering amplitude ~ ↑↑ 
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Figure 3. H&E staining of the five different tissue classes within one single patient 
specimen i.e. adipose tissue (A), glandular tissue (B), fibroadenomatous tissue (C), DCIS 
(D), and invasive carcinoma (e) including the corresponding spectra. The distribution of 
all the measurements for each defined tissue class based on the quantification of 
scattering at 800nm and total hemoglobin content is also illustrated (F). 
 
For each tissue sample, a marked heterogeneity of the histology is notable. These 
variations can be expected to contribute to difficulty in the classification when a cohort of 
patients is examined. For each tissue class, the acquired optical spectrum is displayed as 
well as the scattering coefficient at 800nm wavelength versus the total haemoglobin 
content (THC) is plotted. When comparing the five tissue classes for this individual 
patient based on these two parameters (Figure 3F), the five classes can simply be 
discriminated from each other. Results of all performed measurements and the 
A B C 
D E F 
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discriminative accuracy between normal and malignant breast tissue on an individual 
basis are displayed in Table 4.  
 
Table 4. Results of the discriminative accuracy between normal and 
malignant tissue measurements for each patient in which both groups were present. 
Patient Adipose 
tissue 
Glandular 
tissue 
FA DCIS Invasive 
carcinoma 
Sens. 
(%) 
Spec. 
(%) 1 10 - - 5 - 100 100 
2 - - 10 - - - - 
3 5 4 - 10 10 100 96 
4 5 - 20 - - - - 
5 5 9 - - 9 100 100 
6 - 10 - 8 - 86 100 
7 - 4 - - 20 100 100 
8 - 10 - - 5 76 100 
9 5 4 - - 10 100 100 
10 5 - - - 10 100 100 
11 - - 28 - - - - 
12 8 - 25 - - - - 
13 5 - - 21 - 100 100 
14 4 - - - 20 100 100 
15 5 - - - 10 100 100 
16 8 5 - - 19 100 100 
17 10 - - - 7 100 100 
18 5 9 - - 10 100 100 
19 10 - - - 10 100 100 
20 9 - 10 - - - - 
21 - - 24 - - - - 
22 10 - - 14 - 100 100 
23 5 - - - 10 100 100 
24 9 9 - - 19 100 100 
25 10 5 - 14 - 100 100 
26 10 - - 4 10 100 100 
27 10 10 - 20 - 92 100 
28 10 10 - - 10 100 100 
29 10 - - - 10 100 100 
30 4 - 10 - - - - 
31 5 - - - 15 100 100 
32 10 10 - - 10 100 100 
33 5 10 - - 5 100 100 
34 6 5 5 5 5 100 100 
35 4 10 - - 5 100 100 
36 10 10 - 10 10 100 100 
37 5 5 - - - - - 
38 5 - - 10 10 100 100 
39 5 4 8 - - - - 
40 5 - 5 - - - - 
41 5 5 - - 5 100 100 
42 5 5 - - 5 100 100 
43 10 - - - 10 100 100 
44 5 5 - - 10 100 100 
45 10 7 - - 10 90 94 
46 8 9 - - 15 100 100 
47 14 10 15 - - - - 
Total 294 184 160 121 314 - - 
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4. Discussion 
 The implementation of optical technologies within clinical cancer is increasingly 
being explored [1-5]. For the approach to the clinical application of these new 
technologies within the diagnosis and treatment of breast malignancies, the heterogeneity 
of this human tissue must be considered. This heterogeneity is apparent on the 
histological slides of the tissue measurement locations displayed in Figures 2 and 3. 
Moreover, one must keep in mind that with DRS, one is comparing the optical 
characteristics of a tissue volume of several mm
3 
to the histological characteristics of a 
tissue sample of 5 μm thickness typically. In this study of ex-vivo breast tissue we 
examined 47 specimens exploring the hypothesis that an individual approach to breast 
tissue analysis would enhance the discriminative accuracy between normal and malignant 
tissue and could therefore be an important step towards incorporation of DRS within 
clinical practice of breast cancer. 
 The histological heterogeneity depicted in Figures 2 and 3 is also apparent in the 
results of the quantification of several tissue parameters illustrated in Figure 1. When we 
distinguished between five different tissue classes, the boxplots clearly displayed a 
notable distribution range of most of the measurable optical parameters within the 
different tissue classes for measurements in multiple breast tissue locations. Adipose and 
fibroadenomatous tissue can be well differentiated from the other three tissue classes, yet 
the discrimination of glandular tissue from DCIS and invasive carcinoma is not so 
straightforward. The overall discrimination accuracy of DRS distinguishing 5 tissue 
classes was 82%. Sensitivity and specificity for each of the tissue classes ranged between 
71% and 91% and between 90% and 100%, respectively. When we compared the 
combined measurements of normal and benign breast tissue to both malignant breast 
tissue classes the sensitivity was 90% and specificity 88%. These figures are conform best 
published figures in previous papers of DRS analysis in breast tissue [5, 13, 15, 16, 26, 
27].  
 A more detailed analysis of the results in Figure 1 and Table 1 reveals the main 
discriminating difficulty between glandular tissue, DCIS and invasive carcinoma with a 
notable overlap in the quantification of the tissue parameters. This has been reported by 
Volynskaya et al. [12] with no significant differences in collagen and β-carotene in these 
tissue classes and by Zhu et al. [5] with similar concentrations in β-carotene and THC. 
We demonstrated a main discriminative factor to be the scattering at 800nm. Overall 
scattering has been previously published to be an important discriminative factor [5, 10]. 
 These results can be explained when taking into mind that primary malignant 
degeneration in the breast is generally a gradual evolution of glandular tissue to 
carcinoma in-situ to an invasive carcinoma and that an important part of the composition 
of all three tissue classes will be fibro-vascular matrix with possible adipose component, 
it is not surprising that these tissues are not easily discriminated. Moreover, the presence 
of micro-calcifications in carcinoma in-situ areas and irregularly shaped and ordered 
cancerous cells in invasive carcinoma lesions is expected to cause notable scattering 
variations. The differences in composition between various cancerous lesions are 
displayed in Figure 2 and depending on the proportion of malignant cells within the 
measured specimen the different tissue parameters will be more or less significantly 
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different from normal glandular tissue as is demonstrated in Table 3. Finally, the age of 
the patients included into this study ranged from 20 to 74. The differences in menopausal 
status and composition of the normal breast structure between these patients would be 
expected to differ remarkably. 
 Notable improvement in the discrimination accuracy is displayed in the Figure 3 
and Table 4. In one of the tissue specimen included in this study, all five distinguished 
tissue classes could be examined (Figure 3 and patient 34 in Table 4). Within the tissue 
samples of this single patient an inhomogeneous histology is apparent with various 
percentages of normal and malignant tissue types within each sample. From the DRS 
spectrum we selectively extracted the scattering coefficient at 800nm and THC.  We 
subsequently compared the five different tissue classes based on these two tissue 
parameters (Figure 3F) and demonstrated in this analysis that each of the five tissue 
classes can easily be distinguished from the others. Moreover, the figures display a 
notably small variation of the two parameters within each tissue class. The discriminative 
accuracy of this individual analysis was 100% as displayed in Table 4.  For each patient 
in which both normal breast tissue as malignant tissue was measured (N=36 patients), we 
performed a comparable individual discriminative analysis (Table 4). For 31 of these 
patients the discriminative accuracy of this individual analysis was 100%. The analysis of 
two of the patients revealed a sensitivity which was inferior to the collective analysis.  
 When we translate these results on individual analysis to clinical practice of tissue 
biopsy the main objective for correct localisation of the needle within the target lesion is 
accurate identification of malignant tissue from normal tissue. High specificity of the 
optical modality is therefore the most important parameter. Hence, the higher the 
specificity, the lesser indeterminate results can be expected. An indeterminate biopsy is 
defined as a biopsy which was thought to be taken from the target lesion, but cannot be 
characterized as malignant tissue by the pathologist. With an individual patient tissue 
analysis we displayed a specificity which was minimally 94% and in all but two patients 
was 100%. We therefore conclude that individual tissue analysis with DRS is superior to 
a collective data analysis and could enhance the accuracy in breast tissue biopsy when 
included into a biopsy needle. 
 
5. Conclusion 
Diffuse reflectance spectroscopy is considered as an important new optical 
sensing technique that could improve on various aspects of clinical practice in cancer in 
the near future. Based on the results presented in this paper, we conclude that the analysis 
of optical characteristics of different tissue classes within an organ of a single patient is 
superior to an analysis using the results of a cohort data analysis. We argue that for future 
application of DRS into clinical practice such as breast tissue biopsy, emphasis should 
therefore be put on individual tissue analysis. As a next step towards a clinical application 
we aim to confirm these results in an in-vivo setting. 
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Abstract 
This study presents the first in vivo real-time tissue characterization during image-
guided percutaneous intervention with diffuse optical spectroscopy (DOS) sensing at a tip 
of a needle with integrated optical fibers. A total of 9 percutaneous needle insertions in 
three woodchucks with primary hepatocellular carcinoma were performed under 3D 
fluoroscopy and ultrasound; DOS measurements were continuously acquired during 
needle insertion and clinically relevant parameters were extracted from the optical data 
along the needle paths. The derived real-time tissue characterization enabled 
identification of the tissue type at the needle tip during the transition from healthy liver to 
tumor tissue. Statistically significant differences in tissue properties between the tumor 
and the healthy liver enabled discrimination between these two types of tissues. Tissue 
blood content, oxygenation level, lipid content and tissue density were the main 
parameters that showed significant differences when the needle tip was guided from 
healthy tissue to tumor. 
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1. Introduction 
Diffuse optical spectroscopy (DOS) is an emerging technique for real-time tissue 
characterization. This technique consists of studying the spectral light response after 
illuminating tissue with a light source. The collected optical spectra are translated into 
clinically relevant parameters such as blood, water and lipid fractions, tissue oxygenation 
levels and tissue density related to the scattering of light [1]. In recent research, several 
advances have been made in integrating optical fibers into needle-like probes for DOS 
measurements at the distal end of the devices [2-5]. Most of the DOS clinical studies have 
addressed the diagnostic performance of such a tool in discriminating tumors from normal 
tissue. These clinical experiments consisted of performing several point measurements at 
different locations in tumors and healthy tissue. The diagnostic performance of DOS has 
generally been evaluated by comparing the outcome of a statistical classification with 
pathology [3, 5] or with diagnostic medical images used as reference [2,3,6]. A few in 
vivo studies have been conducted to demonstrate that DOS measurements enable tissue 
discrimination [3,4,6]. In most of these cases, image guidance was used to advance the tip 
of the probe into the region of interest [2,3,6]. Point measurements were then performed 
at various positions in tumors and in normal tissues. DOS data collected from various 
patients were gathered together by type of tissue and diagnostic performance in 
discriminating tumor from normal tissue was thereby evaluated. However, no continuous 
DOS measurements were performed during the insertion of the needles in the subjects. 
Continuous measurements are of great relevance during percutaneous procedures, 
because they enable detection of the transition from healthy tissue to tumor based on the 
clinical parameters derived from optical spectroscopy. Additionally, continuous 
measurements provide a profile of the tissue along the needle path yielding data on intra-
subject heterogeneity. 
To this aim, we applied continuous DOS measurements under 3D fluoroscopy and 
ultrasound guidance in woodchucks with hepatocellular carcinoma (HCC) tumor to 
evaluate the added-value of continuous measurements during percutaneous insertions.  
 
2. Materials and methods 
2.1. Animal model and handling 
In this study, we used three woodchucks with HCC tumor induced by the 
woodchuck hepatitis virus infection. Similar to hepatitis B virus, the woodchuck hepatitis 
virus infects the liver, may cause acute and chronic hepatitis and usually leads to 
development of HCC within three years. The woodchucks were ordered from 
Northeastern Wildlife Inc. (Harrison, ID, USA) and weighed an average of 2.5 kg. The 
animals were initially sedated with an intramuscular injection of 5mg/kg of Xylazine 
(Fort Dodge Labaratories, Fort Dodge, Iowa) and 50mg/kg of Ketamine (Fort Dodge 
Labaratories, Fort Dodge, Iowa). For intravenous contrast agent administration, a 20 
gauge angiocatheter was placed into the femoral vein using direct ultrasound guidance. 
All procedures in this study followed the guidelines of the Institutional Animal Care and 
Use Committee of Cincinnati Children Hospital Medical Center and were approved by 
the ethics committee. 
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2.2. Needle with sensing capabilities and optical setup 
A research prototype setup that allows optical spectroscopy measurements of 
tissue via optical fibers integrated in a needle was used in this study [7]. In short, the 
setup includes a light source and two optical spectrometers that enable light detection in 
the visible and near infrared wavelength range. A custom-made needle is connected to the 
light source and to both spectrometers via 200 micrometer diameter optical fibers. The 18 
gauge needle has a polished angle tip of 70 degrees while the fiber ends were cut straight. 
The light emitted at the tip of the needle travels through the tissue before reaching the 
collecting optical fiber and is subject to optical absorption and scattering. The 
measurement acquisition time per spectrum is 300 ms and an analytical model was used 
to derive the various physiological and morphological properties from each spectrum. The 
spectral measurements enable estimation of physiological and morphological information 
such as biological volume fractions (e.g. blood, water, lipid, bile, etc.), oxygenation level 
of blood and light scattering due to tissue density using a mathematical model that 
describes tissue-light interaction [7]. The blood volume fraction corresponds to 
hemoglobin (oxygenated and deoxygenated) assuming a concentration of 150 g of 
hemoglobin per liter of plasma. The lipid volume fraction corresponds to a density of 0.86 
g/ml.  
 
2.3. Image guidance 
The needle insertions were performed under 3D fluoroscopy and ultrasound 
guidance to advance the tip of the needle into the tumor. Whereas ultrasound is a common 
imaging technique used for needle guidance, 3D fluorosocopy is a more recent technique 
that consists of overlaying live X-ray fluoroscopy with cone beam CT (CBCT) [8]. A 3D 
soft tissue CBCT dataset was acquired after injection of contrast agent (Optiray 350, 
Covidien) for better visualization of the tumor and the surrounding healthy tissue. From 
the 3D data set, an optimal CT-like slice with the tumor being clearly visible was selected 
to define a planned needle path. The needle planning was interactively performed by 
drawing a line from the center of the tumor towards the skin surface. Figure 1.A shows a 
CBCT image of the tumor within the liver as well as the planned needle path whereas 
Figure 1.B shows the 3D fluoroscopy with the tip of the needle reaching the target. Live 
fluoroscopy and ultrasound imaging were acquired simultaneously with DOS acquisition 
in order to assure registration of the tissue characterization with the actual location of the 
needle tip. A total of 9 insertions were performed in the animals. At the end of the 
experiment, the liver was excised for gross tissue investigation. A cut-through was 
performed along the needle path in the tumor to observe the tissue structure.  
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Figure 1. (A) Cone beam CT slice depicting a virtual needle path (green line) with entry 
point (magenta marker) defined at the skin surface and the end target in the middle of the 
round tumor. The small and large dash markers along the virtual line correspond to mm 
and cm spacing, respectively. The white arrows indicate the boundaries of the tumors 
along the virtual line (B) Cone beam CT overlayed with live fluoroscopy (i.e. 3D 
fluoroscopy) demonstrating tumor in liver. The green line corresponds to the virtual 
needle trajectory. The needle tip is in the center of the tumor 
 
3. Results 
When comparing the data acquired within the normal liver tissue and within the 
tumor from the 9 insertions, statistical differences (P-value < 0.05) were noted for 
parameters such as blood volume fraction, tissue oxygenation level, lipid volume fraction, 
and scattering amplitude. The set of boxplots in the top row of Figure 2 shows that blood 
and lipid volume fractions and the tissue oxygenation were significantly greater in normal 
liver as opposed to tumors, whereas the scattering amplitude was greater in tumors than in 
normal liver tissue. In all reported in vivo studies in literature, collective data acquired 
from all enrolled subjects were statistically compared [3,4,6]. However, it is interesting to 
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evaluate the statistical differences within one needle insertion. The bottom row of Figure 
2 shows boxplots of the parameters of interest for a single insertion from normal to tumor 
tissue. It can be seen that the trends are similar to the collective data set. What is 
interesting to note is the fact that outliers (cross markers in boxplots) for blood and tissue 
oxygenation values correspond to transition values from one tissue type to another. 
 
 
Figure 2. Boxplot of collective data for normal and tumor tissues (top tow) and for a 
single insertion (bottom row) of blood, lipid volume fractions as well as tissue 
oxygenation and scattering amplitude. 
 
Figure 3 depicts estimated values of the four derived parameters while inserting 
the needle from normal to tumor tissue from which the boxplots in the bottom row of 
Figure 2 were obtained. 
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Figure 3. Histogram of blood volume fraction, tissue oxygenation, lipid volume fraction 
and scattering amplitude derived from DOS measurements when needle being inserted 
from normal to tumor tissue. 
 
4. Discussion 
Several observations can conjointly be drawn from Figure 2 and 3. First, the total 
amount of blood is significantly higher in healthy liver as opposed to tumor tissue. This 
observation correlates with the macroscopic investigations after tissue resection depicted 
in Figure 4. Second, the oxygenation saturation level of blood is lower in the tumor as 
compared to the healthy liver. Furthermore, parts of the tumors are hypoxic with 
oxygenation levels as low as 10%, while regions close to the boundaries have higher 
oxygenation levels. Third, the lipid volume fractions are very low at the boundaries 
between the tumor and the healthy liver tissue. Finally, the scattering amplitude of the 
probed healthy liver tissue is homogeneous whereas it is heterogeneous in the tumor; this 
correlates with the macroscopic observation shown in Figure 4 where the tumor tissue 
has a more granular structure. Additionally, the difference in tissue homogeneity between 
the tumor and the healthy part of the liver is visible macroscopically on the CBCT images 
displayed in Figure 1. These findings were consistent for all insertions except for one 
case in which the blood content in tumor was higher than in normal tissue; this was 
confirmed by ultrasound to be a hemorrhagic part of the tumor. 
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Figure 4. Photograph of the liver with a cut section through the tumor. The thickness of 
the tumor is roughly one centimeter as it can also be seen on Figure 1. 
 
To our knowledge, there have been no previous in vivo liver tumor DOS studies, 
although there have been a few ex vivo studies demonstrating higher blood content in the 
healthy liver as compared to tumor; however, care should be taken in interpreting ex vivo 
human studies because the tissue properties can change very quickly after excision of the 
tissue [9,10]. Moreover, the ex vivo studies were done in liver with colorectal metastases 
whereas the present study addresses primary liver tumors. The comparison of the derived 
parameters is thus not straightforward. Therefore, this present in vivo animal study can be 
considered as a starting point for future investigational works in discriminating HCC from 
healthy liver tissue. The ex vivo studies available in literature showed higher scattering 
amplitude as well as lipid, blood and bile content in healthy liver as opposed to tumor. 
From the results depicted in Figure 2, we also demonstrate that blood and lipid content 
are greater in the healthy part of liver. There was no significant difference in bile content, 
which is most likely due to the fact that the tumors in our animals are primary tumors and 
not metastases from other organs; metastases are made of abnormal cells from the organ 
of origin and therefore no bile is expected in metastases [9]. 
The existing in vivo studies in the literature were mainly performed in breast [3,4] and 
lung [6]; therefore, only comparisons of physiological parameters (e.g., oxygenation 
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levels) in our study to these previous studies are valid, and tissue composition 
comparisons are not. Our results agree with the general reported findings from the in vivo 
human DOS studies that were conducted previously by different research groups [3,4,6]. 
Most of these studies demonstrated lower oxygenation levels in the tumor and higher 
scattering amplitude, as did our study. 
The information provided by DOS, such as mapping of blood oxygenation levels along 
the needle path, can be of great relevance in the case of biopsy procedures. Hypoxic 
tissue is often associated with necrosis and therefore measuring the oxygenation level in 
tumors can allow the operator to avoid performing a biopsy in a necrotic region that 
would not allow conclusive tumor staging by pathologists. Hence, relying on the 
oxygenation level in blood is of great interest in performing biopsies [4]. 
In the HCC tumor, the estimated lipid volume fraction was non-uniformly distributed, 
which is expected because HCC is known to be associated with patchy macroscopic fatty 
change [11]. The scattering amplitude related to tissue density is also heterogeneous in 
the tumor, whereas it is homogenous in healthy liver. This observation is in agreement 
with existing findings on stiffness measurements with ultrasound or MR elastography, 
with tumors being harder than normal liver tissue [12]. Performing continuous 
measurements during a needle insertion as opposed to single point measurements in the 
different types of tissues as done in existing studies has the advantage of providing a full 
overview of the tissue characterization along the needle path to ensure better needle 
placement for biopsies. 
 
5. Conclusion 
In summary, this study shows the potential of real-time tissue characterization by 
diffuse optical spectroscopy measurements at the tip of a needle during percutaneous 
intervention. This first in vivo liver study using diagnostic imaging as a reference 
demonstrates that blood content and tissue oxygenation can be used as the primary 
discriminators for transition from normal tissue to tumor. Lipid content and scattering 
amplitude provide information on the heterogeneity of tumor tissues along the needle 
path, which contrasts to the homogeneity of the surrounding normal liver tissue. 
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General discussion 
Several research groups investigated over the last two decades the potential of 
diffuse optical spectroscopy for specific medical applications such as cancer diagnosis, 
treatment monitoring and surgery support. The recent technical advances in detectors, 
gratings, optical fibers and light sources enabled the possibility to perform quasi real-time 
measurements with miniaturized probes such as needles, endoscopes, catheters and the 
like.  
 
 This dissertation encompasses several research and development works in the 
field of clinical diagnosis with diffuse optical spectroscopy. Needle-like optical probes 
with similar characteristics than conventional medical needles were developed in such a 
way that the optical fibers were integrated in the cannula. Three optical fibers were 
embedded, one from which light is delivered while the two other fibers are connected to 
the detection unit composed of silicon and InGaAs detectors, respectively. The InGaAs 
detectors are relatively new and expensive enabling light detection above a micron 
wavelength. Formerly, PbS detectors were used to detect light with wavelength above a 
micron however the sensitivity of such detectors is poor. Other research groups only use 
silicon detectors due to its low price limiting the light detection to wavelengths below one 
micron. Therefore, most research groups have only evaluated blood-derived 
chromophores in the visible and near infrared wavelengths range because these are the 
man chromophores that have spectral absorption features in wavelength range detectable 
with silicon detectors. In the beginning of the century, researchers have tried to estimate 
water and lipid concentrations by trying to measure up to the limit of silicon detection of 
light roughly around 1100 nm. However, the reliability of the derived water and lipid 
concentrations could well be not very accurate because of the limitations and sensitivity 
of silicon detectors. By measuring simultaneously with silicon and InGaAs detectors, we 
were able to acquire spectra up to 1800 nm with a signal-to-noise ratio above 100:1 
enabling accurate absorption coefficients measurement of biological chromophores such 
as water, lipid and collagen. The determination of absorption coefficients of these 
chromophores enables their use in mathematical models to derive their concentrations in 
tissue after spectral measurements with the optical probe. Therefore, the use of an InGaAs 
detector is relevant for accurate determination of additional biological substances that are 
not commonly used by other research groups.  
 
The model we used to characterize tissue corresponds to an analytical expression 
derived from diffusion theory. In this dissertation the first parameterization of diffuse 
optical spectroscopy measurements over a wavelength range comprising the visible and 
the near infrared up to 1800 nm is presented. Validation of the method and the 
mathematical model to derive parameters relevant to the clinician was performed by 
means of phantoms studies and benchmarking with other existing techniques for 
biological substances concentration estimation. The validation is performed by comparing 
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the derived chromophores concentrations from the mathematical model with the actual 
concentrations in the phantom with known optical properties. The robustness of the 
model is evaluated by changing the average particles size in the phantom without 
modifying its content. Such a procedure enables to verify that the model does extract the 
same concentrations while the scattering properties are being changed. Comparison of 
quantifying concentrations of certain biological substances with other existing methods is 
also considered as a guaranty of the reliability of diffuse optical spectroscopy in 
determining proper values. Validation of the model in deriving the various parameters of 
interest is an essential and crucial step before interpreting the measurements performed in 
the clinic as the outcome should help the physician to make the proper diagnosis or make 
the right decision during a medical procedure. However, using a model derived from the 
diffusion theory has its limitations. In fact, in order to be applicable the scattering length 
of the photons i.e. the average distance between two scattering events should be small 
compared to the source-detector fiber distance. Recently, several studies by various 
research groups were conducted to model diffuse optical spectroscopy for side-by-side 
fibers as well as single fiber backscattering configurations. These models are developed 
based on either phantom measurements or probabilistic-based simulations (e.g., Monte-
Carlo) with a wide range of optical properties corresponding to the one expected in tissue. 
In this dissertation, we have chosen to use probes in which the source-detector fiber 
distance is large compared to the average scattering length of the photons such that 
diffusion theory is applicable across the broad wavelength range of interest. 
 
Most of the presented clinical studies in this dissertation were conducted in ex 
vivo settings and therefore the blood derived chromophores might be questionable 
although measurements were performed immediately after tissue excisions. Nevertheless, 
extending the wavelength range has clear benefits when comparing with results from 
other existing ex vivo clinical studies available in literature. The first in vivo experiments 
that were performed in animals with primary tumors showed the importance of real-time 
measurements and data analysis in order to identify the transition of needle placement in a 
tumor based on the changes in the derived parameters. Additionally, deriving the tissue 
oxygenation level along the needle path is of great relevance to avoid taking biopsies in 
hypoxic locations that potentially could be correlated to necrosis. 
  
In this PhD research, several advances have been made with respect to measuring 
and investigating biological chromophores that are not commonly used in literature. 
Whereas the main focus of most of the research groups are investigating the difference 
between normal and dysplastic tissue in blood content and its oxygenation level, the 
presented preclinical and clinical studies in this dissertation showed that several 
additional chromophores can be relevant for tissue discrimination yielding better 
diagnosis performances. Diffuse optical spectroscopy has been widely used for diagnosis 
in the field of oncology where blood volume fraction, its oxygenation level and the 
reduced scattering amplitude are the main three derived parameters that allows 
discrimination of dysplastic and cancerous tissue from normal tissue. Having a wide 
wavelength range up to 1800 nm showed to be of great relevance for accurate water and 
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lipid volume fractions estimation. It was shown that proper estimation of water and lipid 
concentrations can significantly improves diagnosis performances in breast and liver 
cancer. Therefore, the thorough investigation in understanding which biological 
substances that could potentially play a role in discriminating abnormal from normal 
tissue is very important. For instance, bile showed to be a biological chromophore that is 
significantly higher in healthy liver as opposed to colorectal metastases tumors due to the 
presence of cancer cells originating from a different organ, hence not containing bile. In 
opposition, the in vivo study in animal with primary tumor showed no significant 
differences in bile content between normal and tumor samples measurements. However, it 
was shown that tissue oxygenation is lower in tumors as expected and proven in different 
in vivo studies presented by several research groups.   
 
 The main clinical applications addressed in this dissertation are focused on 
diagnosis but several other clinical applications can be addressed with diffuse optical 
spectroscopy sensing at the distal end of needle-like fiber optic probes. A wide range of 
clinical applications have been investigated by several research groups. Two of the topics 
that have been gaining a lot of interest are chemotherapy monitoring as well as tumor 
margin assessments. The possibility of measuring up to 1800 nm widens further the scope 
of clinical applications as it enables to derive many other biological substances that 
absorb lights in the infrared wavelengths range. In fact, the possibility of accurately 
quantifying lipid and water shows that diffuse reflectance spectroscopy has a great 
potential in steatosis quantification and non-alcoholic fatty liver disease diagnosis. This 
disease is considered to be positively diagnosed if the haptic fat is above 5% only, hence 
the need of accurate tools for reliable hepatic fat quantification. Diffuse reflectance 
spectroscopy can be an interesting alternative for magnetic resonance spectroscopy for 
accurate quantitative fat determination provided that measurements are performed in a 
very wide wavelength range comprising several fat and water absorption features. The 
work presented in this dissertation yielded additional clinical investigations addressing 
specific applications. For example, another clinical application of interest that can be 
addressed due to the lipid quantification from a broad wavelength range corresponds to 
epidural space identification. For instance, an in vivo study in swine showed the potential 
of diffuse optical spectroscopy in identifying the epidural space which is a lipid-rich 
space surrounding the cerebral spine fluid. It was shown that a confirmation of needle 
placement in the epidural space can be ensured based on the amount of lipid and blood 
present in the probed volume. 
  
 Further investigations in the wavelength ranges above a micron are still required. 
It has been demonstrated in this dissertation that absorption coefficients of water and lipid 
are sensitive to temperature and types of triglycerides, respectively. Thus additional 
research is advised to evaluate the possibility of temperature estimation from the spectral 
measurements or discriminating different types of fat in tissue. These topics are of a great 
challenge as the changes are very subtle and thus accurate signal processing is to be 
envisaged. Other chromophores should also be investigated in the infrared wavelengths 
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range as there are probably other biological substances that absorb light in the infrared 
such as for instance collagen as shown in this dissertation. 
 
Ongoing in vivo human clinical studies using the technology and methods 
developed herein should further validate the clinical value in surgical and interventional 
procedures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Summary 
The goal of this dissertation is to present the potential of diffuse optical 
spectroscopy technique to characterize and differentiate types of tissue, including 
dysplastic and cancerous tissues, when measuring the tissue spectra during a surgical or 
an interventional procedure under medical image guidance. 
 
This dissertation begins with a chapter that describes the different mathematical 
modeling of light transport in scattering media such as tissue. Each of the existing models 
used in literature is described including the way to extract the optical properties by 
applying it to the tissue measurements performed with fiber-optic handheld probes. An 
overview of the clinical applications investigated by the research groups is given as well 
as the performance of the diagnosis in discriminating different types of tissue based on 
the derived parameters. 
 
Chapter 2 and 3 corresponds to the validation of the diffusion theory model 
applied to optical spectroscopy measurements performed in a wide wavelength range as 
compared to what has been already presented in literature. In fact, chapter 2 presents the 
very first validation available in literature of the applicability of diffusion theory 
approximation model to measurements performed from 900 to 1600 nm. Water and lipid 
absorption coefficients were measured for different temperatures and used to in the model 
to derive the concentration of these chromophores. The validation was performed by 
recovering the actual water and lipid content in custom made emulsions with known lipid 
content. The validation of the reduced scattering estimation was performed by correlating 
the estimated parameters related to the reduced scattering with the particles size of the 
emulsions after blending and investigating the particle size distribution. Chapter 3 
presents the advantage of extending the commonly-used wavelength range from 400 to 
1000 nm up to 1600 nm. Although water and lipid can be estimated from diffuse optical 
spectroscopy measurements up to 1000 nm, this chapter shows that the extension of the 
wavelength significantly improves the accuracy of the optical properties extraction and 
that the lack of spectral feature of water and lipid when measuring up to 1000 nm can not 
only yield inaccurate water and lipid content but as well influence the estimated blood 
concentrations and reduced scattering parameters. 
 
Chapters 4 through 6 present the application of diffuse optical spectroscopy for 
diagnosis related to liver diseases. Chapter 4 is a benchmarking of optical spectroscopy 
with other techniques such as magnetic resonance spectroscopy (MRS), nuclear magnetic 
resonance spectroscopy (NMR), high performance thin layer chromatography (HPTLC) 
and histopathology for hepatic lipid quantification in mice. The derived hepatic fat 
fractions in the mice liver did not show any significant differences between the various 
techniques. Furthermore, it was shown that it was possible to clearly distinguish the group 
of mice on chow diet from the group of mice on high fat diet. The potential of diffuse 
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optical spectroscopy in quantifying hepatic lipid is of great interest for diagnosis of fatty 
liver disease where it is considered to be positive in patients for hepatic lipid fractions as 
low as 5%. Chapter 5 presents optical spectra acquired ex vivo on metastasis in liver and 
the surrounding healthy liver tissue in 14 patients. This chapter demonstrates the 
importance of including bile absorption coefficients to the model in addition to 
oxygenated-hemoglobin (HbO2), deoxygenated hemoglobin (Hb), water and lipid as 
livers are rich in bile ducts. This study shows that it is possible to discriminate tumors 
from the surrounding healthy liver tissue based on the amount of bile, water and the 
reduced scattering amplitude. Chapter 6 describes the diagnosis performance of diffuse 
optical spectroscopy in discriminating the tumors from the healthy liver samples with two 
different methods: classifying the types of tissues using the derived clinical parameters 
from fitting the diffusion theory mathematical model to the measurements as well as 
applying a statistical method to classify the raw optical measurements. In this chapter, in 
addition to discriminating tumors from healthy tissue, the lipid content estimated with 
diffuse optical spectroscopy showed a strong correlation with hepatic fat estimation from 
the histological slides. These findings ultimately have impact on detecting tumors when 
performing a biopsy as well as defining the steatosis level in liver. 
 
Chapter 7 demonstrates the capability of diffuse optical spectroscopy in 
discriminating tumor sites from the surrounding healthy lung tissues. An ex vivo study 
was conducted in samples excised from 10 patients with lung cancer. This study showed 
that hemoglobin volume fraction and the reduced scattering amplitude showed significant 
difference in both type of tissue by being lower in tumors as compared to the healthy lung 
sites. Additionally, the performance of diagnosis to discriminate the tumors from the 
healthy lung samples was evaluated and yielded sensitivity and specificity up to 86% and 
85%, respectively. 
 
 Chapters 8 and 9 demonstrate the potential of diffuse optical spectroscopy to 
classify several types of breast tissues including malignant types. Chapter 8 corresponds 
to an ex vivo study on 54 excised breast samples that were measured at 5 different sites, 
namely adipose, glandular, fibroadenoma, invasive carcinoma and ductal carcinoma in 
situ. From the various optical parameters that are derived from the measurements and the 
chromophores volume fractions, statistical tests were performed to investigate which 
parameter shows significant difference between pairwise types of tissue. Furthermore, the 
performance of diagnosis in discriminating the 5 types of tissue yielded area under 
receiver operator curve (AUC) ranging from 86% to 100%. Additionally, the performance 
of classifying benign and malignant samples was made with different types of 
classification methods that were already applied by various research groups that 
conducted optical spectroscopy measurements on breast samples. The different 
classification schemes were compared and it was shown that the performance of the 
diagnosis can vary a lot depending on the type of classification that is used. Therefore this 
chapter emphasizes the importance of being very critical when selecting the classification 
scheme. Chapter 9 shows the differences in investigating the difference in optical 
properties and measurements between malignant and non-malignant tissue by comparing 
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intra and inter-patients variations. It was concluded that the diagnosis performance is best 
when comparing the tissues within single patients as compared to when all data from all 
patients are compared. 
  
 Chapter 10 presents the feasibility of real-time tissue characterization during 
needle insertions from healthy liver to hepatocellular carcinoma tumor where medical 
imaging such as 3D fluoroscopy and ultrasound were used as reference. Whereas in 
literature point measurements in healthy and in tumors are compared,  this study shows 
that continuous diffuse reflectance measurements while advancing the needle enables the 
identification of the tumor boundaries based on the derived clinical parameter, namely 
blood oxygenation and volume fraction as well as the scattering amplitude. 
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Samenvatting 
Het onderzoeksdoel van dit proefschrift is vaststellen in hoeverre diffuse optische 
spectroscopie gebruikt kan worden om verschillende weefsels, waaronder displastisch en 
kankerweefsel, van elkaar te onderscheiden tijdens chirurgische of onder beeldgeleiding 
uitgevoerde ingrepen.  
 
In hoofdstuk 1 worden verschillende mathematische modellen uit de literatuur 
besproken die optische verstrooiingsparameters extraheren uit spectra die gemeten zijn 
met handzame op glasvezel gebaseerde meetinstrumenten. Tevens wordt er een overzicht 
gegeven van de klinische toepassingen die door de verschillende onderzoeksgroepen 
hiermee onderzocht zijn, evenals de behaalde nauwkeurigheid in onderscheidend 
vermogen van deze methodes. 
 
In hoofdstuk 2 en 3 van dit proefschrift wordt de validatie van het diffusie theorie 
model onderzocht wanneer deze toegepast wordt op een groter golflengte gebied dan tot 
dus ver beschreven in de literatuur. Hoofdstuk 2 beschrijft voor het eerst de toepassing 
van het diffusie model voor het golflengte gebied van 900 tot 1600 nm. Water en vet 
absorptiecoëfficiënten zijn gemeten voor verschillende temperaturen en vervolgens 
gebruikt als invoerparameters in het model om de concentraties van deze chromoforen uit 
de gemeten spectra te bepalen. Dit model is vervolgens gevalideerd door verschillende 
water en vet emulsies met bekende vet concentraties te meten. De validatie van de 
gereduceerde verstrooiingscoëfficiënt is gebeurd door de voorspelde vetdeeltjesgrootte in 
de emulsies na menging te vergelijken met de gemeten deeltjesgrootte verdeling. 
Hoofdstuk 3 gaat in op het voordeel dat de uitbreiding van het golflengte gebied tot 1600 
nm geeft vergeleken met de steeds gebruikte golflengte gebied van 400 nm tot 1000 nm. 
Hoewel vet en water concentraties ook geschat kunnen worden op basis van het spectrum 
tot 1000 nm laat dit onderzoeksdeel zien dat de uitbreiding van het golflengte gebied leidt 
tot een nauwkeurigere  bepaling van deze parameters. Daarnaast wordt ook aangetoond 
dat de beperkte spectrale karakteristieken van water en vet in het golflengte gebied tot 
1000 nm niet alleen leiden tot een onnauwkeurige schatting van water en vet concentratie 
maar dat ook de verstrooiingsparameters en bloedconcentratie schattingen nadelig 
beïnvloed worden. 
 
In de hoofdstukken 4 tot en met 6 worden de toepassingen van de diffuse optische 
spectroscopie op leverziekten besproken. In hoofdstuk 4 wordt optische spectroscopie 
vergeleken met andere technieken zoals magnetische resonantie spectroscopie (MRS), 
nucleaire magnetische resonantie spectroscopie (NMR), hoge prestatie dunne laag 
chromatografie (HPTLC) en histopathologie op vetgehalte bepaling in muizenlevers. De 
verschillende technieken vertoonde geen significante verschillen tussen de bepaalde lever 
vetfracties. Verder wordt aangetoond dat het mogelijk is de groep muizen op chow 
voeding te onderscheiden van de groep muizen op voeding met hoog vetgehalte. 
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Kwantificeren van levervet met diffuse optische spectroscopie is van groot belang voor de 
diagnose van leververvetting waarbij patiënten met een vetpercentage van meer dan 5% al 
als positief beschouwd worden. In hoofdstuk 5 worden ex vivo spectroscopische meting 
aan uitgezaaide dikke darm tumoren in de lever van 14 patiënten besproken. In dit 
hoofdstuk wordt het belang van het toevoegen van gal aan de lijst van absorberende 
stoffen in de lever, waar galproductie plaatsvindt, naast die van oxyhemoglobine (HbO2), 
desoxyhemoglobine (Hb), water en vet aangetoond. Deze studie laat zien dat het mogelijk 
is om deze uitgezaaide kankergezwellen te onderscheiden van normaal leverweefsel op 
basis van de gemeten hoeveelheid gal, water en de gereduceerde verstrooiingscoëfficiënt. 
Hoofdstuk 6 beschrijft het diagnostische vermogen van diffuse optische spectroscopie om 
lever kankergezwellen van normaal leverweefsel te onderscheiden waarbij twee 
onderzoeksmethoden gebruikt zijn: classificatie op basis van de bepaalde optische 
parameters door het diffusie theorie model te fitten aan de spectra alsook door een 
statistische classificatie methode toe te passen op de ruwe optische metingen. Daarnaast is 
in dit hoofdstuk ook gekeken naar het vetgehalte in de lever bepaalt uit de optische 
metingen en dit vergeleken met de vetgehalte schatting op basis van pathologisch 
gekleurde weefselcoupes, hetgeen een goede correlatie liet zien. Beide bevindingen zijn 
waardevol, daar ze het biopteren van kankergezwellen kunnen verbeteren en tevens de 
risico‟s bij levertransplantaties kunnen verkleinen door snel en nauwkeurig de steatose 
graad van de lever te bepalen. 
 
Hoofdstuk 7 laat de mogelijkheden van diffuse optische spectroscopie zien bij het 
onderscheiden van kankergezwellen in longweefsel. Een ex vivo studie werd uitgevoerd 
aan weefselmonsters van 10 patiënten met longkanker. Dit onderzoek toonde aan dat de 
hemoglobine concentratie en gereduceerde verstrooiingsamplitude significant verschilden 
in het kankerweefsel vergeleken met het omringende normale weefsel. De sensitiviteit en 
specificiteit waarmee longkankergezwellen van normaal longweefsel onderscheiden 
kunnen worden, zijn respectievelijk 86% en 85%. 
 
In hoofdstukken 8 en 9 wordt onderzocht in hoeverre met diffuse optische 
spectroscopie verschillende vormen van borstweefsels, inclusief borstkankergezwellen, te 
onderscheiden zijn. Hoofdstuk 8 bespreekt een ex vivo studie aan 54 verwijderde 
borstkankergezwellen waarbij aan 5 verschillende soorten weefsels metingen verricht 
zijn, namelijk aan vetweefsel, klierweefsel, fibroadenomen, invasieve carcinomen en 
ductaal carcinoma‟s in situ. Door statistische proeven uit te voeren aan de verschillende 
geëxtraheerde optische parameters is bepaald welke parameters significante verschillen 
opleveren tussen de verschillende weefseltypes. Bovendien is het onderscheidend 
vermogen waarmee de 5 weefseltypes van elkaar te onderscheiden zijn bepaald door het 
oppervlak onder de “receiver operator curve” (AUC) te berekenen, dat varieerde van 86% 
tot 100%. Daarnaast is het onderscheidend vermogen om kwaadaardige kankergezwellen 
van normaal en goedaardig afwijkend weefsel bepaald met behulp van verschillende 
soorten classificatie methoden die al door diverse onderzoeksgroepen, die optische 
spectroscopie metingen uitvoeren, gehanteerd zijn. Bij het vergelijken van de 
verschillende classificatiemethoden volgde dat het onderscheidend vermogen afhankelijk 
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is van de gekozen methode. Het is dus van belang om een zorgvuldige keuze van de 
classificatiemethode te maken. In hoofdstuk 9 is gekeken in hoeverre het onderscheiden 
van kwaadaardige kankergezwellen van normaal en goedaardige gezwellen in 
borstweefsel met diffuse optische spectroscopie beïnvloed wordt door de variaties die er 
zijn tussen verschillende patiënten. Geconcludeerd kon worden dat het onderscheidend 
vermogen beter wordt bij het vergelijken van de weefsels binnen één patiënt in 
vergelijking met wanneer de gegevens van alle patiënten gezamenlijk vergeleken wordt. 
 
In hoofdstuk 10 is onderzocht wat de toegevoegde waarde is van real-time 
optische weefsel karakterisering tijdens medische naald interventies in combinatie met 
medische beeldvorming zoals röntgen doorlichting en echografie. Vooral naald 
interventies aan primaire lever tumoren in bosmarmotten zijn daarbij onderzocht. Terwijl 
tot dusver in de literatuur puntmetingen in gezond weefsel en kankerweefsel vergeleken 
worden, blijkt uit deze studie dat continue diffuse optische reflectie metingen het 
opsporen van de kankergezwelgrenzen op basis van de waarden van bloed concentratie, 
bloedoxygenatie en verstrooiing amplitude duidelijk verbeterd. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 222 
 
Samenvatting 
 
 
 
  
 
Scientific output 
Publications: 
Rami Nachabé, Benno H. W. Hendriks, Adrien E. Desjardins, Marjolein van der Voort, 
Martin B. van der Mark, and Henricus J. C. M. Sterenborg. “Estimation of lipid and water 
concentrations in scattering media with diffuse optical spectroscopy from 900 to 1600 
nm”, Journal of Biomedical Optics 15: 037015, May 2010. (Chapter 2 of this thesis) 
 
Rami Nachabé, Benno H. W. Hendriks, Marjolein van der Voort, Adrien E. Desjardins, 
and Henricus J. C. M. Sterenborg. “Estimation of biological chromophores using diffuse 
optical spectroscopy: benefit of extending the UV-VIS wavelength range to include 1000 
to 1600 nm”, Biomedical Optics Express 18: 1432-1442, November 2010. (Chapter 3 of 
this thesis) 
 
James P. Rathmell, Adrien E. Desjardins, Marjolein van der Voort, Benno H. W. 
Hendriks, Rami Nachabé, Stefan Roggeveen, Drazenko Babic, Michael Söderman, 
Marcus Brynolf, and Björn Holmström. “Identification of the epidural space with optical 
spectroscopy-An in vivo swine study”, Anesthesiology 113: 1406-1418, December 2010. 
 
Rami Nachabé, Daniel J. Evers, Benno H. W. Hendriks, Gerald W. Lucassen, Marjolein 
van der Voort, Jelle Wesseling, and Theo J. M. Ruers. “Effect of bile absorption 
coefficients on the estimation of liver tissue optical properties and related implications in 
discriminating healthy and tumorous samples”, Biomedical Optics Express 2: 600-614, 
March 2011. (Chapter 5 of this thesis) 
 
Adrien E. Desjardins, Benno H. W. Hendriks, Marjolein van der Voort, Rami Nachabé, 
Walter Bierhoff, Guus Braun, Drazenko Babic, James P. Rathmell, Staffan Holmin, 
Michael Söderman, and Björn Holmström, “Epidural needle with embedded optical fibers 
for spectroscopic differentiation of tissue: ex vivo feasibility study”, Biomedical Optics 
Express 2: 1452-1461, June 2011. 
 
Rami Nachabé, Daniel J. Evers, Benno H. W. Hendriks, Gerald W. Lucassen, Marjolein 
van der Voort, Emiel K. Rutgers, Marie-Jeanne Peeters, Jos A. ven der Hage, Hester S. 
Oldenburg, Jelle Wesseling, and Theo J. M. Ruers, “Diagnosis of breast cancer using 
diffuse optical spectroscopy from 500 to 1600 nm: comparison of classification methods”, 
Journal of Biomedical Optics 16 (8): 087010 August 2011. (Chapter 8 of this thesis) 
 
 
 
 
 
 224 
 
Scientific output 
Rami Nachabé, José W. A. van der Hoorn, Roland van de Molengraaf, Rolf Lamerichs, 
Jeroen Pikkemaat, Charles F. Sio, Benno H. W. Hendriks, and Henricus J. C. M. 
Sterenborg, “Validation of interventional fiber optics spectroscopy with MR 
spectroscopy, MAS-NMR spectroscopy, high performance thin layer chomatography and 
histpathology for accurate fat quantification”, Investigative Radiology 47(4): 209-216, 
April 2012. (Chapter 4 of this thesis) 
 
Daniel J. Evers, Rami Nachabé, Houke M. Klomp, Johanna W. van Sandick, Michel W. 
Wouters, Gerald W. Lucassen, Benno H. W. Hendriks, Jelle Wesseling, and Theo J. M. 
Ruers, “Diffuse reflectance spectroscopy: a new guidance tool for improvement of biopsy 
procedures in lung malignancies”, Accepted for publication in Clinical Lung Cancer in 
March 2012. (Chapter 7 of this thesis) 
 
Rami Nachabé, Benno H. W. Hendriks, Henricus J. C. M. Sterenborg, “Modeling diffuse 
reflectance spectroscopy: a review”, Submitted to Journal of Biomedical Optics in 
December 2011. (Chapter 1 of this thesis) 
 
Daniel J. Evers, Rami Nachabé, Daphne Hompes, Frits van Coevorden, Gerald W. 
Lucassen, Benno H. W. Hendriks, Loes van Velthuizen, Jelle Wesseling, and Theo J. M. 
Ruers, “Diffuse reflectance spectroscopy for the discrimination of liver tumors and 
steatosis quantification”, Submitted to Annals of Surgical Oncology in February 2012. 
(Chapter 6 of this thesis) 
 
Rami Nachabé, Benno H. W. Hendriks, Ross Schierling, Jasmine Hales, Judy M. 
Racadio, Drazenko Babic, , and John M. Racadio, “Real-time in vivo characterization of 
primary liver tumors with diffuse optical spectroscopy during percutaneous needle 
interventions”, Submitted to American Journal of Roentgenology in March 2012. 
(Chapter 10 of this thesis)  
 
Daniel J. Evers, Rami Nachabé, Emiel J. Rutgers, Marie-Jeanne Vrancken Peeters, Jos 
A. van der Hage, Hester S. Oldenburg, Gerald W. Lucassen, Benno H. W. Hendriks, Jelle 
Wesseling, and Theo J. M. Ruers, “Diffuse reflectance spectroscopy for real time imaging 
of tumor tissue in liver”, Submitted to Breast Cancer Research and Treatment in April 
2012. (Chapter 9 of this thesis) 
 
Conference proceedings: 
Rami Nachabé, Rik Harbers, Adrien E. Desjardins, Marjolein van der Voort, Guus A. L. 
Braun, and Benno H. W. Hendriks, “Extracting optical properties from diffuse optical 
spectroscopy”, Proc. SPIE 7187, 71871C (2009). 
 
Rami Nachabé, Benno H. W. Hendriks, and H. J. C. M. Sterenborg, “Determination of 
water and lipid concentrations by diffuse optical spectroscopy in lipid emulsions in the 
wavelength range of 1000 to 1500 nm” in Biomedical Optics, OSA paper BTuD88 
(2010). 
 225 
 
Scientific output 
Conference presentations: 
Rami Nachabé, Rik Harbers, Adrien E. Desjardins, Marjolein van der Voort, Guus A. L. 
Braun, and Benno H. W. Hendriks, “Extracting optical properties from diffuse optical 
spectroscopy”, SPIE Photonics West , January 2009, San José, California, USA, Poster 
presentation. 
 
Rami Nachabé, Benno H. W. Hendriks, and H. J. C. M. Sterenborg, “Determination of 
water and lipid concentrations by diffuse optical spectroscopy in lipid emulsions in the 
wavelength range of 1000 to 1500 nm” OSA Biomedical Optics, April 2010, Miami, 
Florida, USA, Poster presentation. 
 
Rami Nachabé, Benno H. W. Hendriks, Marjolein van der Voort, Adrien E. Desjardins, 
Martin M. B. Van der Mark, and Henricus J. C. M. Sterenborg, “Estimation of 
chromophore concentrations with diffuse optical spectroscopy in the near infrared 
wavelength range up to 1600 nm” SPIE Photonics West, January 2011, San Francisco, 
California, USA, Poster presentation. 
 
Rami Nachabé, “UV/VIS/NIR spectroscopy In Vivo”, Fotonica Evenement, March 2011, 
Nieuwegein, The Netherlands, Oral presentation. 
 
José W. van der Hoorn, Roland van de Molengraaf, Rami Nachabé, Marijn Vlaming, 
Charles F. Sio, Rolf Lamerichs, Jeroen De Groot, Oliver C. Steinbach, “In vivo MRS 
analysis of Non-Alcoholic Fatty Liver Disease in a translational model for the metabolic 
syndrome”, XVII International DALM symposium on Diabetes, Obesity, and the 
Metabolic Syndrome, March 2011, Doha, Qatar, Poster presentation. 
 
José W. van der Hoorn, Roland van de Molengraaf, Rami Nachabé, Jeroen Pikkemaat, 
Marijn Vlaming, Charles F. Sio, Rolf Lamerichs, Jeroen De Groot, Oliver C. Steinbach, 
“In vivo MRS analysis of Non-Alcoholic Fatty Liver Disease in a translational model for 
the metabolic syndrome”, 6th European Molecular Imaging Meeting, June 2011, Leiden, 
The Netherlands, Poster presentation. 
 
Rami Nachabé, Daniel J. Evers, G. W. Lucassen, Benno H. W. Hendriks, J. Wesseling, 
and Theo J. M. Ruers, “Tissue composition estimated with an interventional fiber optical 
probe during liver tissue resection”, European Multidisciplinary Cancer Congress, 
September 2011, Stockholm, Sweden, Oral presentation. 
 
José W. van der Hoorn, Roland van de Molengraaf, Rami Nachabé, Jeroen Pikkemaat, 
Marijn Vlaming, Charles F. Sio, Rolf Lamerichs, Jeroen De Groot, Oliver C. Steinbach, 
“In vivo MRS analysis of Non-Alcoholic Fatty Liver Disease in a translational model for 
the metabolic syndrome”, World Molecular Imaging Congress, September 2011, San 
Diego, California, USA, Poster presentation. 
 
 
 226 
 
Scientific output 
Marjolein van der Voort, Arthur Adams, Jurgen E. Mourik, Willem Mali, Tim Nielsen, 
Martin B. Van der Mark, Daniel J. Evers, Rami Nachabé, Gerald W. Lucassen, Benno H. 
W. Hendriks, Jelle Wesseling, and Theo J. M. Ruers, “Optical spectroscopy for the 
detection of breast cancer”, 4th Annual World Cancer Congress of Breast Cancer, 
November 2011, Guangzhou, China, Oral presentation.  
 
Rami Nachabé, Benno H. W. Hendriks, Ross Schierling, Jasmine Hales, Judy M. 
Racadio, Drazenko Babic, , and John M. Racadio, “Real-time in vivo characterization of 
primary liver tumors with diffuse optical spectroscopy during percutaneous needle 
interventions”, Society for Pediatric Radiology 55th annual meetings and postgraduate 
course, April 2012, San Francisco, California, USA, Oral presentation. 
 
  
 
Curriculum Vitae 
Rami Nachabé is born 30
th
 August 1983 in Lebanon. He obtained his bachelor in 
Mathematics and Physics from the Université de Nice-Sophia Antipolis in 2003 and 
obtained in 2006 his Master degree in Physics from Université Louis Pasteur in 
Strasbourg as well as an Engineering degree in medical imaging and robotics. During his 
studies, he performed several internships related to optical simulations such as in the 
LSIIT laboratory in Strasbourg (2004) where he had to write a code to compute light 
scattering from rough surfaces; and at Sony in Stuttgart (2005) where he programmed an 
algorithm to compute grating diffractions of electromagnetic fields. He performed his 
master degree project at Philips Research within the biomedical photonics group (2006) 
where he implemented an algorithm for signal and image processing of protein bindings 
in assays imaged with fluorescence confocal microscopy. In 2007, he worked as an 
imaging scientist within the CTO department of Philips Healthcare in Best, the 
Netherlands. He conducted several phantoms studies, reconstruction code integration and 
clinical studies within an optical mammography project. In 2008, he started his PhD 
fellowship in Philips Research within the minimally invasive healthcare group. His work 
was conducted under the supervision of Dr. Benno Hendriks from Philips Research and 
Prof. Dr. Henricus Sterenborg from Erasmus Medical Center in Rotterdam. During the 
course of his PhD period, he started with the understanding of the fundamentals of diffuse 
optical spectroscopy. He developed and validated mathematical models to derive 
clinically relevant parameters and subsequently gained experience in experimenting, 
writing papers and collaborating with clinical staff such as surgeons, radiologists, 
anesthesiologists, pathologists, etc. Rami spent the last half year of his PhD period at 
Cincinnati Children‟s Hospital Medical Center in the USA where he was working with 
the interventional radiology department in an animal lab equipped with a Philips FD-20 
flat detector C-arm. He learned from this period how to write protocols, perform 
experimental procedures in an interventional radiology room as well as brainstorming 
with interventional radiologists on new ways of performing procedures. 
 
 
 
 
 
 
 
 
 
 
 
 228 
 
Curriculum Vitae 
 
 
  
 
Acknowledgements 
It has been a long journey and I would have never reached the final destination 
without an incredible crew full of talent. 
 
 First of all, I would like to express my gratitude to Dr. Benno Hendriks thanks to 
whom I managed to succeed in my work. Dear Benno, without your guidance and your 
diligent supervision of my work, I honestly think that I could have never reached the 
scientific level I have now. You have been an outstanding mentor and I learned so much 
from you. Besides the professional relation we had together, the private relation was 
fantastic. I also would like to thank you for always being on my side when needed and 
providing me with the right advice. I am truly proud of working for a genuine person like 
you and I am sure that our adventure will continue. You are simply my role model for 
whom I have blind trust. 
 
 I would like to thank Professor Dr. Henricus Sterenborg. Dear Dick, being a PhD 
student of one of the most famous persons in the field of biomedical spectroscopy is a big 
honor. Thank you for the challenging scientific discussions we had. Your very critical 
view to my results and your way of trying to pull the best out of my research was very 
useful. The several discussions I had with you helped me a lot in being efficient at work. 
 I would also like to thank the members of the radiotherapy department at Erasmus 
Medical Center, namely Dr. Arjen Amelink and Dr. Stephen Kanick for the technical 
discussions we had about diffuse spectroscopy as well as for providing me with very 
insightful information on writing scientific publications. 
 
  Furthermore, I would like to express my gratitude to the former and current 
members of the so-called “photonic needle” project. In the beginning, I worked with 
Guus the needle master, Adrien from whom I learned to write scientific papers, Rik my 
friend and lab teacher, Leon who has been a great coach, and Marjolein the first person 
who taught me how to set up clinical experiments. In a later stage of the project, Gerald 
joined us and I discovered a great person that was always of great support. Dear Gerald, I 
always see myself in you as a worker and as a person as well. You have been of a great 
support! Stefan joined at the same period and he was so fun to work with as well as 
Walter the man with the gold fingers. Although she joined for a very short time, I would 
definitely like to thank my friend Joyce Henselmans. Thanks Joyce for the great moments 
we had! During the last period of my PhD, several members: Jeroen, Jasper, Manfred, 
Susanne, Christian, Vishnu, Arnold, Antonie, Geert and Florian. Thanks guys for the 
team spirit! 
 Additionally, I want to thank my colleagues from the “Minimally Invasive 
Healthcare” group in Philips Research, especially the wild scientist Dr. Martin van der 
Mark, Gert „t Hooft known as the walking encyclopedia, and Erik Harks my office mate, 
confident and Dutch teacher. 
 230 
 
Acknowledgements 
 Special thanks to all the group leaders I had during my PhD period: Dr. Nijs van 
der Vaart, Dr. Christopher Busch, and Dr. René Aarnink who were of great support and 
always giving me the right advice to develop my skills. Nijs, thanks for offering me the 
opportunity of preforming my PhD within Philips and also getting me in Healthcare 
where I really wanted to land after my PhD. Christopher, I have highly appreciated your 
support and your constant recognition of my work. René, you have been a great coach 
with a positive attitude and a constant smile on your face, thank you for creating the 
optimal working conditions to excel in Cincinnati. 
 
Obviously, a big part of my work could not have been done without the 
collaboration of great clinicians. First I would like to thank Dr. Michael Söderman and 
Björn Holmström from Karolinska Institute in Stockholm, Sweden. My first experience in 
the clinic was in the research radiology lab in Karolinska which lead to my very first 
results for publication. 
I would also like very much to thank Prof. Dr. Theo Ruers and Dr. Daniel Evers 
from the Ducth Cancer Institute. Dear Theo and Dan, it was such a great collaboration 
together. We have generated so much data together and learned so much about the 
potential of the photonic needle. It is impressive to see all what we have accomplished in 
few years and I am so proud that we are currently doing studies in human in the operation 
room. It has also been fun! I will never forget the great moments we spent at the SPIE 
conference! Thanks for the great time and to all the surgeons and pathologists who were 
and still are involved in the various running studies in the Dutch Cancer Institute.  
I would like to thank all the members of the radiology department from Cincinnati 
Children‟s Hospital Medical Center (CCHMC) where I spent the last half year of my PhD 
period. I would like to thank from the bottom of my heart the great Dr. John Racadio. 
Dear John, thanks a lot for everything! You might not believe it but thanks to you I have 
developed myself so much during my stay in Cincinnati. I gained so much knowledge 
working with you and also a lot of confidence in myself. Thank you for trusting me and 
giving me the opportunity to start up the first experiments in the brand new research lab. 
You are to me the American Benno Hendriks: a person that I can blindly trust and who 
had always made time for me despite the very busy agenda you have. It has definitely 
been THE best period of my PhD period at all levels, professional and personal. I would 
also like to thank Dr. Todd Abruzzo, Dr. Neil Johnson, Dr. Manish Patel, Dr. Kamlesh 
Kukreja and Dr. Russel Hirsh. Special thanks to Ross and Jasmine who have been great 
people to work with in the research lab. I would like to express my gratitude to Dr. Chuck 
Dumoulin for welcoming me in his group and also thank all the members of his research 
group. Special thanks to a lot of people from Cincinnati who made my stay simply 
superb. 
 
I would like to express my gratitude to my collaborators from Philips Healthcare: 
Robert Homan, Dean Rindlisbach, Charlie Gast and most particularly Dr. Drazenko 
Babic. Dear Drazen or Santa Drazen as they call you in CCHMC, thanks a lot for giving 
me the greatest gift I got durig my PhD period: sending me to Cincinnati! Although I did 
 231 
 
Acknowledgements 
not work a lot with you, I can assure you that I had a lot of fun at every single moment we 
spent together and I am sure there is still more to come. 
  
Special thanks to all the co-authors of the publications we had during my PhD 
period: Dr. Rathmell from Massachussetts General Hospital, Dr. Brynolf from Karolinska 
Institute; Dr. Wesseling, Dr. Rutgers, Dr. Peeters, Dr. Van der Hage, Dr. Oldenburg, Dr. 
Klomp, Dr. Van Sandick, Dr. Wouters, Dr. Hompes, Dr. van Coevorden, and Dr. Van 
Velthuizen from the Dutch Cancer Institute; Dr. van der Hoorn from TNO; Dr. 
Molengraaf, Dr. Lamerichs, Dr. Pikkemaat, and Dr. Sio from Philips Research; and Dr. 
Judy Racadio from Cincinnati Children‟s Hospital Medical Center. 
 
Et le meilleur pour la fin. Je tiens à remercier mes amis de toujours; notamment, 
Thomas, Oriane, Nicolas, Jordi, Olga, Sébastien, et Marangai. Je voudrais remercier tout 
particulièrement mes frangins et mes parents sans qui rien n‟aurait été possible. Merci 
pour les valeurs transmises et l‟éducation reçue. Sachez que malgré la distance qui nous 
sépare, vous avez toujours étaient tout proche de mon cœur. Maman, papa, je vous 
adore énormément! 
 
« Eduque-toi mon fils car si un homme averti en vaut deux, un homme instruit en 
vaut trois », 3 février 2012. 
 
Rami Nachabé. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 232 
 
Acknowledgements 
 
 
 
 
 
 
 
 
 
 
 
 
 
